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Abstract 
This thesis describes a study that estimated the health care need for prostatectomy 
in a typical district of 250,000, among men who have both the appropriate indications 
for treatment and who would choose treatment if offered. It established the 
appropriate indications for prostatectomy using a literature review and a nominal 
group type consensus panel consisting of 6 urologists and 3 general practitioners. 
These were expressed in terms of different combinations of type of retention, type and 
severity of symptoms, and level of comorbidity. A 2-stage community survey of 2000 
men aged 55 and over randomly selected from 8 general practices, using postal 
questionnaires, was conducted in North West Thames health region. The surveys 
collected information about: (1) self-reported frequency and severity of lower urinary 
tract symptoms; (2) the impact of these symptoms on daily activities and on health 
status; (3) the advice-seeking behaviour of men with symptoms and consequent 
action of GPs and urologists; and (4) patient preference for treatment. These results 
were combined to estimate the number of prostatectomies required in a typical district. 
The overall response rate was 66% (initial survey=78%, follow-up survey=84%). 20% 
of men reported moderate or severe lower urinary tract symptoms. Of these, 28% 
found their symptoms to be a medium or big problem and that, depending on the 
activity, between 9% and 39% experienced interference with their daily activities. 
Health status, as measured by either the Nottingham Health Profile or the SF-36, 
worsened as symptom severity increased. Forty five per cent of men with symptoms 
had seen their general practitioner for their symptoms. Of these, 62% were referred 
on to a urologist, of which the majority (71 %) were offered, and accepted surgery. 
When presented with details and information on the risks and benefits of 
prostatectomy, a substantial proportion (22%) of men with lower urinary tract 
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symptoms, reported that they would probably, or definitely, refuse treatment, while a 
47% of men were unsure. The estimate of required number of prostatectomies in a 
district with a population of 250,000 ranged from 225 to 4329 depending on the level 
of appropriateness, symptom severity and preference adopted. The decision about 
which estimate to use in purchasing prostatectomy for lower urinary tract symptoms 
must be made by local authorities. 
The copyright of this thesis rests with the author and no 
quotation from it or information derived from it may be published 
without the prior written consent of the author 
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Chapter 1 - Introduction 
A consequence of the 1990 reform of the National Health Service is that health 
authorities must now assess the health needs of their populations and purchase 
appropriate care to meet these needs (1). There is little detailed information on the 
need for health care, (ie. the number of people in the population who would benefit 
from treatment) because: it is difficult to identify those people with appropriate 
indications for treatment in the population; little is known about the acceptability of 
many interventions to individuals; and it may be difficult to relate the prevalence of 
those with appropriate indications to the annual need for treatment. 
Benign prostatic hyperplasia (BPH) is the commonest cause of lower urinary tract 
symptoms affecting middle-aged and elderly men. The provision oftreatment for these 
symptoms has become of increasing interest to health service purchasers because 
there is evidence that they are more common than previously thought (2). In addition 
new forms of treatment are becoming widely available, although their effectiveness 
is still being evaluated and prostatectomy remains the treatment of choice (3-8). 
Knowledge of the prevalence of lower urinary tract symptoms and their impact on men 
form the basis of the four measures required by those involved in the planning and 
provision of services for BPH: 1) the number of men in the population experiencing 
urinary symptoms that bother them (felt need); 2) the number of men with symptoms 
who seek treatment (demand); 3) the number of men considered by general 
practitioners and surgeons to be in need of treatment, based both on men's urinary 
symptoms and on clinical findings (normative need); and 4) whether individuals 
choose to receive treatment after being presented with information about interventions 
and their risks and benefits. Assessing the health care need for prostatectomy should 
be based on these measures, but little information is available. 
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1.1 How many men In the community have lower urinary tract symptoms? 
Detailed information on the prevalence and severity of symptoms is scarce and 
estimates vary widely. In general health surveys of men over the age of 65, between 
16% and 40% report having either urinary symptoms or having had a previous 
prostatectomy, or both [Spain - 16%; USA - 25%; Israel 40%] (9-11). A household 
survey undertaken in Michigan in 1983-84 found that 35% of men over the age of 60 
had one or more symptoms of prostatism (12). A review of general practice case 
notes in the United Kingdom (U.K.) suggested that 6% of men over the age of 60 had 
undisclosed "marked prostatism", based on the presence of four urinary symptoms, 
and a further 14% had "mild prostatism", with three symptoms (13). In a questionnaire 
administered to men over the age of 60 who attended a health screening clinic in the 
U.K., 18% reported five or more urinary symptoms (14). A recent population-based 
study, defining BPH using a combination of urinary symptoms, flow rates, and 
prostatic size, reported a prevalence among Scottish men aged 40 to 79 of 253 per 
1000 (2). A virtually identical study of 2,119 men aged 40-79 in Minnesota found that 
prostatism rose from 26% in the 40-49 age group to 46% in the 70+ group, higher 
than the prevalence found in the Scottish study (15). 
Little is known about the impact, in terms of bothersomeness and health status, that 
urinary symptoms have on men in the community. The only data from a 
representative sample of the general population in the U.K. (the Scottish study 
mentioned above) found that 77% of men with BPH, reported at least one bothersome 
urinary symptom compared with 47.2% of men who did not have the condition and 
that the relative difference increased as the reported number of urinary symptoms 
increased (16). These men were more likely than men without symptoms to have less 
'general well-being'(17) and to experience interference in their activities of daily living 
-14-
such as: limiting fluids before travel (7.5%) or bedtime (10.3%), inability to drive for 
2 hours (5.7%), not having enough sleep (7.4%), limiting visits to places without toilets 
(7.9), limiting playing sports (2.7%) and limiting visits to cinema, theatre, church etc. 
(3.3%) (16). A study that compared the results of two similar studies in Scotland and 
the U.S.A. concluded that although there were differences in the prevalence of urinary 
symptoms (more men in Minnesota reported greater frequency and more bother) the 
impact of symptoms on interference in daily activities was the same (18). 
1.2 Do men with symptoms seek health care? 
There is little evidence about the extent to which men seek medical advice for their 
urinary symptoms, and what factors determine their behaviour. The only study that 
examined this, found that a third of otherwise healthy men in Denmark, with 
frequency, post-micturition dribbling, and a weak stream, believed that their symptoms 
did not justify seeking treatment (19). 
1.3 What are the appropriate indications for prostatectomy? 
Patients proceeding to prostatectomy commonly present with acute retention, chronic 
retention or a complex of lower urinary tract symptoms that include hesitancy, poor 
flow, terminal dribbling, frequency, feeling of fullness, urgency and nocturia (20). A 
review of published reports suggests only limited agreement about the appropriate 
indications for prostatectomy. For example, while some authors state that acute 
retention, in the absence of detrusor failure or neuropathic obstruction, is an absolute 
indication (21), others argue in favour of conservative treatment for those who can 
void successfully after a period of catheter drainage (22,23). A urologist in Scotland 
reported that acute retention was the only indication for which he would perform a 
prostatectomy (24). A recent study of the practice behaviour of urologists concluded 
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that consensus about appropriate practice has yet to be achieved (25). 
The range of clinical opinion about the appropriateness of surgery is reflected by wide 
variation in prostatectomy rates both between and within countries (26). Reported 
prostatectomy rates in western countries vary considerably, from 60 to 368 per 
100,000 (27-30). The standardized prostatectomy ratio adjusted for age and private 
sector contribution varies in English regions from 77 to 144 (England=100) (29,31). 
There is little evidence that the variation results from differences in the prevalence of 
BPH, but rather, from the supply of surgical services, including the availability of 
surgeons and their judgment of the clinical appropriateness of surgery (30,32,33). 
There is further controversy about whether to treat lower urinary tract symptoms or 
to treat clinical measures of obstruction and whether to perform surgery early to avoid 
the greater risk when the patient grows older or to limit surgery to those patients with 
symptoms significantly affecting their quality of life (33). These arguments have 
assumed greater importance following the publication of reports casting doubt on 
previous beliefs about the level of risk associated with transurethral resection of the 
prostate (TURP)(3) and claims that up to 75% of TURPs performed in the United 
States may be inappropriate (34). 
1.4 Do men want treatment? 
Even after being offered treatment, men may not wish to accept it. In a British study, 
30% of 107 men with 'minimal symptoms' on a waiting list for prostatectomy declined 
surgery after being reassured about the natural history of prostatic obstruction (35). 
An American study to validate a quality of life questionnaire among men awaiting 
prostatectomy was forced to exclude 37 men (55%) when they elected not to have 
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surgery (36). An initiative to clear a waiting list for prostatectomy in the U.K. reported 
that 38 (16.4%) declined urological surgery, although the authors did not provide a 
detailed breakdown to permit identification of those awaiting prostatectomy (37). In 
another Danish study, 11 men out of 72 (15%) who were referred for surgery refused 
treatment because they did not perceive their symptoms to be severe enough (38). 
Preliminary results from studies in the United Kingdom and the United States of 
symptomatic men considering prostatectomy suggest that many choose to decline 
surgery after viewing an interactive video disc that provides information on the risks 
and benefits of treatment (39,40). 
As part of the American Health Care Policy and Research (AHCPR) review of clinical 
practice guidelines for the treatment of BPH, a panel conducted two preference 
analyses (7). The first panel presented non-urologist physicians and Ph.D. medical 
researchers over the age of 60 with symptom severity scenarios and asked them to 
rank treatment outcomes in order of importance. The second surveyed actual patients 
with mild, moderate and severe symptoms. In both groups, most patients with mild 
symptoms chose 'watchful waiting', those with moderate symptoms showed a wide 
range of preferences, and those with severe symptoms chose surgery (7). 
1.5 Conclusion 
The health care need for prostatectomy has not been assessed adequately because 
there is insufficient information about: 1) the prevalence and severity of lower urinary 
tract symptoms; 2) whether men with symptoms seek treatment; 3) the appropriate 
indications for prostatectomy; and 4) whether prostatectomy is acceptable to men with 
the appropriate indications. The purpose of this thesis is to estimate the number of 
men in a typical district who would benefit from having a prostatectomy and who 
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would accept treatment if offered it. The following two chapters will: 1) review the 
literature on health care needs assessment; 2) review the methodological issues 
relevant to assessing the need for prostatectomy; and 3) present a plan of the thesis. 
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Chapter 2 - Health care needs assessment 
Introduction 
A need for health care has been defined as 'the ability of an individual to benefit from 
health care and exists where he or she has a condition for which there is an effective 
and acceptable intervention' (41). The definition emphasizes the 'benefit arising from 
the intervention', which can be curative, preventive or palliative. Benefit depends on 
the effectiveness of care and is achieved through a change in health status (42). In 
theory and in practice, there are many difficulties in assessing health care need. 
These arise because different disciplines bring their own perspectives to need and 
because the terms need, demand and use are often used interchangeably and 
incorrectly to equate use and demand to need. This chapter will: 1) explain the recent 
interest in needs assessment in the U.K.; 2) outline several concepts of need; 3) 
distinguish between need, demand and use; 4) describe the different approaches to 
needs assessment; and 5) propose a model for assessing health care need. 
2.1 Recent background to needs assessment in the U.K. 
In 1988 and 1989, the government published two important white papers on health 
which resulted in a major restructuring of the NHS. The first of these, Public Health 
in England (the Acheson Report), called for strengthening traditional public health 
interventions and recommended that district health authorities make their planning 
and management decisions on the basis of epidemiological assessments of the 
population (43). The Acheson report was followed by Working for Patients, published 
in 1989, that created an internal market for health care within the NHS (1). The 
internal market, dividing the provision of health care into purchaser and provider 
organisations, came into effect on April 1 st, 1991. Health authorities and general 
practitioners holding their own budgets became responsible for purchasing health care 
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from providers, which included hospitals managed directly by health authorities and 
others that opted for managerial autonomy within the NHS. The reforms arising from 
Working for Patients require purchasers of health care to negotiate contracts with 
providers in order to ensure that the delivery of health care meets the health care 
needs of the population. The government believes that the reforms will enable the 
NHS to provide a higher quality service to those who need it in an effective and 
efficient way. Working for Patients clearly stated: 
District health authorities can then concentrate on ensuring that the 
health care needs of the population for which they are responsible are 
met; that there are effective services for the prevention and control of 
disease and the promotion of health; that their population has access 
to a comprehensive range of high quality, value for money services (1). 
The idea of assessing the health needs of the population is not recent. There have 
been several attempts to measure the need for and evaluation of, health services 
(44). In 1957, Morris proposed an 'epidemiology of health services' and cautioned that 
assessing need as a basis for health planning was a formidable exercise (45). In 
1975, the Resource Allocation Working Party (RAWP) was established in an attempt 
to allocate health care resources to regions in Britain according to need (46). 
However, they had no direct measure of need and were forced to use standardized 
mortality ratios (SMRs) as an indirect measure of health, rather than health care need. 
A review undertaken to explore the use of hospital utilisation data as an alternative 
to using SMRs as part of the RAWP formula found that hospital utilisation data were 
a poor measure of need because they provided no indication of the appropriateness 
of different rates of hospital use among socia-economic groups, or of the distribution 
of unmet need needs in the population (47). In addition the allocation formula 
reflected existing pattern of supply of hospital services. Subsequently, more 
sophisticated models have been constructed, using two-stage least squares 
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regression, in an attempt to separate supply factors from need (48). 
Aside from the specific factors in the U.K., there are several more general reasons 
for the current interest in using needs assessment in the planning and provision of 
health care. Increasing costs and demands in all industrialised countries have forced 
governments to examine and reform their health systems. Increasing evidence of 
variations in rates of clinical interventions has led to questions about the provision of 
many forms of treatment (49,50). Politicians and managers have drawn attention to 
many treatments shown to be harmful or inefficacious, or not demonstrated to be 
beneficial (51,52). Purchasers of health care are interested in these findings because 
they suggest that treatments are either being withheld or provided inappropriately. 
This will be 1) expensive for the purchaser, 2) harmful to patients from whom 
treatment is withheld; or 3) harmful to patients who are treated unnecessarily. The 
necessity to rationalise expenditures coupled with the knowledge that some 
interventions may be ineffective, has stimulated the government to create a situation 
for health authorities and general practitioners to purchase care that is both effective 
and for which there is a demonstrated need in its population. 
Since the publication of Working For Patients in 1989, a number of publications about 
needs assessment have appeared (53-57). In general, these papers, written by public 
health physicians, managers, planners, academics and clinicians, began to propose 
methods for, and discuss some of the pitfalls of health care needs assessment. To 
clarify the Department of Health's position, the NHS Management Executive published 
a discussion paper in 1991 identifying three levels of health needs assessment: 
corporate, comparative and epidemiologic/economic (58). The paper advocated a 
pragmatic approach that would facilitate decision making in the short term. This 
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approach combined corporate needs assessment (the opinions of specialists and 
GPs) and comparative needs assessment (the comparison of service provision with 
other areas) to provide an achievable 'needs agenda' for many district health 
authorities. Subsequently, the NHS Management Executive commissioned a series 
of reviews summarizing existing knowledge about incidence, prevalence and 
effectiveness (59). 
2.2 Concepts of health care need 
There is considerable confusion about the definition of health care need. First, there 
is a difference between the health care need of an individual (of interest to individuals 
and to carers), and the sum of these needs in the population (of interest to 
purchasers and providers of health care). The health care need representing the 
aggregate need for health care in a population is the focus of this discussion. 
Secondly, there is a distinction between the need for health, and the need for health 
QS@. It is well recognized that health implies much more than the absence of disease 
and is influenced by factors outside of the health sector such as education, income 
level, environment. By comparison, health care refers to a specific intervention, 
offered with the aim of improving an individual's health status. An aggregate health 
care need may be said to exist where a population has the ability to benefit from an 
intervention. This health care need has been termed a 'health care requirement' as 
distinct from health needs, or the neediness of the population as used by the 
nineteenth century social reformers (55). It has been argued that the confusion 
between these meanings has been responsible for the lack of interest in determining 
the level of need for particular health care interventions (55). 
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A further problem has arisen as a result of the different disciplines that have been 
involved in assessing need, including epidemiology, health economics, health services 
research and sociology. There have been few attempts to bring these groups 
together. Epidemiologists are interested in measuring the distribution and 
determinants of health in the population. Consequently, their activities have 
traditionally been directed towards describing the incidence and prevalence of disease 
in the population rather than measuring the number of individuals in a population who 
could benefit from treatment. 
An economic approach to assessing health care need is based on the principle that 
resources are scarce, and that some health needs can be shown to be greater than 
others by using measures of relative benefit such as quality-adjusted-life-years 
(QAL Ys). The implicit assumption of the health economic approach is that priorities 
can be set to maximize benefit within available resources. It has been argued that 
economic needs assessment can determine a threshold level for treatment or 
services, below which funding would be unavailable (60), although others have 
countered that the use of priority setting is not needs assessment, but rather follows 
from it (61,62), as it must be based on evidence that the intervention studied can 
bring about benefits to the target group. A well publicised attempt, in Oregon, to 
generate a set of health care priorities using cost-benefit analyses has proved 
unworkable (63). 
A framework developed by a sociologist has been often used to distinguish different 
types of social need (64). The framework is comprised of four different types of need: 
normative, felt, expressed and comparative. Normative needs are identified by experts 
or professionals and are often defined in terms of standards or thresholds. 
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Comparative need, or the comparison of needs between groups in the population, 
defined on the basis of area of residence, gender or social class, is based on the 
assumption that different areas require similar provision of services, reflecting equal 
need relative to each other. Felt need is need that is perceived by individuals. 
Expressed need, or demand, is a felt need expressed as a demand for a service. 
Although this classification is useful in distinguishing different aspects of needs, its 
use in assessing the need for health care is limited. Normative needs assessment, 
on its own, is of little use in identifying the need for health care for several reasons: 
1) professionals may disagree about appropriate standards; 2) standards may change 
over time as new knowledge about interventions becomes known; and 3) it does not 
consider the population distribution of health care needs. Information about the 
effectiveness and appropriateness of the intervention, if explicit, is usually determined 
from literature reviews or by clinical consensus. Comparative need is confounded by 
other explanations for differences in rates between areas, such as supply factors 
(number of beds or surgeons, or differences in clinical practice) (47,48). The definition 
of comparative need often contains the implicit assumption that the higher rate is 
correct, which may be untrue. Felt need is a poor measure of the need for health care 
because individual's perception of their own health is affected by their own values and 
knowledge. Individuals differ in their expectations of health and in their knowledge 
about the benefits of treatment. Illness behaviour varies between personalities and 
cultures. The need for health care may not be recognized by individuals if they are 
asymptomatic. Finally, these four categories of need are not mutually exclusive and 
different combinations are possible. For example, a need for a service may be 
normatively defined (recognized by professionals), felt (perceived by individuals) but 
not expressed (individuals do not seek treatment). 
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2.3 Need, demand and use 
Further confusion over the use of the term 'need' has arisen because the terms need, 
demand and use are often used incorrectly. They are distinguished as follows: need 
is what people can benefit from, demand is what people ask for, and use is what 
people obtain (56). Thus the demand for health care occurs when an individual 
perceives their health status to warrant lay or formal health care. If the carer judges 
that the individual will benefit from care, then the demand for care is translated into 
the use of health care. The differences between need and demand can arise from 
differences in illness behaviour and those between demand and use arise from 
differences in clinical judgment. Measures of demand and use are often incorrectly 
equated with need. Figure 2.1 illustrates the relationship between need, demand and 
use. Measures of need should be free of the influence of supply or availability of care 
(thus population based) and should reflect contemporary population characteristics 
rather than historical ones. 
2.4 Measuring health care needs 
The variety of approaches to measurement of health care needs reflects the confusion 
surrounding the definitions used. They depend on which approach to need is being 
considered. Thus they can include: epidemiology, demography, effectiveness of 
services, quality of services, comparative analysis with other districts or regions, 
consumer's views of services, a corporate review, which takes account of the interests 
of local people, general practitioners, providers, clinicians, other agencies, the 
regional health authorities and the NHS executive. Health care 'needs' have been 
measured both directly and indirectly (65). Direct measures have included: health care 
utilisation data, case registries and population reports of morbidity. Indirect measures 
have included socio-demographic characteristics, measures of deprivation and 
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Figure 2.1 The relationship between need, demand and use. 
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measures of mortality. Data sources for assessing health care need include: 1) health 
indicators; 2) existing utilisation data; 3) waiting lists as a measure of expressed 
demand; and 4) surveys (66). 
2.4.1 Health indicators 
Health indicators include routinely collected data such as mortality rates or morbidity 
rates from disease registers. Their application to assessing health care need is limited 
because the data: 1) measures health (or lack of it). not health care need; 2) mortality 
data reflects the experience of people who have already died and are thus of largely 
historic relevance; and 3) does not account for health problems that people do not 
seek care for. Methodological problems include errors arising from misdiagnosis, 
incomplete death certification and classification, and coding errors. 
2.4.2 Existing utilisation data 
Utilisation data are derived from routinely collected statistics from hospital or from 
primary care. Need derived from hospital utilisation is biased because it is heavily 
dependent on existing levels of supply of services and historical patterns of care (47). 
Supply factors, such as the number of beds or the number of physicians, and access 
to care, are an important determinant of the utilisation of these services. In addition, 
needs assessments based on 'utilisation data assumes that the existing level of 
service provision does not change over time and that the existing service is both 
appropriate and comprehensive. Health care needs assessment based on utilisation 
data relies on historical patterns of care which may have become entrenched and may 
be of little value to local needs. An example of this is the high density of hospitals in 
inner London, when most of the population now live outside London. Data are also 
subject to varying levels of inaccuracy (67). A further problem arises from the 
exclusion of data from the private sector (68,69). It has been estimated that routine 
information sources cover only 80 per cent of elective surgery conducted in England 
and Wales and there are systematic regional differences (31). 
Where no local utilisation data are available, needs assessment may be modelled by 
applying age-sex-specific utilisation rates from elsewhere to local population 
characteristics, using epidemiological data from elsewhere. In addition to suffering 
from the same limitations as above, modelling health care needs on the basis of 
demographic characteristics also assumes that the characteristics in the population 
used as the basis for assessing need are the same - this assumption may be untrue. 
2.4.3 Waiting lists as measure of demand 
The demand for health care, reflecting both felt and expressed need, is usually 
measured by using waiting lists to estimate health care need. Waiting lists do not 
reflect the true need for treatment for several reasons. First, they are notoriously 
inaccurate. Close examination of lists for surgery showed that 40% of those on the 
list had either: died, migrated, got better, already been treated or did not want an 
operation (70). Waiting lists do not consider the severity and urgency of an individual's 
condition requiring treatment. In addition, health professionals may be uncertain about 
the appropriate treatment and use the waiting list as a way to ration care (71). 
2.4.4 Prevalence surveys as a measure of need 
It is now generally agreed that the most accurate method of assessing the need for 
health care in a population is by a community based survey measuring the prevalence 
of certain conditions in individuals (59,61). Health care needs derived from local 
survey data are directly relevant to the local population. Local surveys allow the 
investigator to determine thresholds for need, if there is agreement about who will 
benefit from treatment. Nevertheless, there are still problems. Surveys do not always 
ask questions pertinent to clarifying true need. It may be difficult to develop an 
operational definition of a condition that can be measured simply. Only well-defined 
conditions that can be determined by a questionnaire are amenable to survey 
methods. Those requiring more invasive examinations for diagnosis will be costly and 
raise ethical issues. The results are often biased due to methodological limitations 
such as sampling errors, reporting and non-response bias and problems of reliability 
and validity of the instrument used. The need for health care determined from a 
survey only provides information about prevalent need and does not tell us about one 
about what to do once the backlog has been cleared. New treatments emerge and 
thresholds for treatment change. The rapid change in technology combined with the 
time required to undertake research means that the results of needs-based research 
may be dated by the time they are published. 
2.5 NHS Management Executive needs assessment 
In recognition that health authorities will not have either the skills or resources to 
assess all of the health care needs of their populations, the NHS Management 
Executive commissioned a number of epidemiologically-based needs assessments 
(formerly known as Project 26) (59). The purpose of these reviews was to summarise 
the health care needs of a typical district, for a specific disease and to compile the 
best available information on the incidence and prevalence of a particular disease and 
information on the effectiveness ofthe service. A two volume compendium of reviews 
has just been published for seven conditions (diabetes mellitus, renal disease, stroke, 
coronary heart disease, respiratory disease, lung cancer and colorectal cancer), six 
elective surgical procedures (hernia repair, varicose vein treatment, prostatectomy for 
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BPH, total hip replacement, total knee replacement, and cataract surgery) 5 mental 
health topics (adult mental illness, dementia, learning disabilities, alcohol and drug 
abuse), infertility and community child health services (59). These diseases and 
services currently reflect approximately one third of health spending, and were 
selected because they were either: high cost, high volume, high morbidity or high 
mortality (59). 
The underlying basis of the epidemiologically based needs assessment reviews were 
that they be 'disease driven', and that their focus be on the incidence and prevalence 
of disease in the population, and on the effectiveness of care (72). Each assessment 
was required to follow a detailed protocol that included: 1) estimates of the size of the 
problem, 2) a summary of the available services, 3) a review of the effectiveness and 
cost-effectiveness ofthe services, 4) the development of models of care based on this 
information and 5) the identification of outcome measures, targets and information 
requirements, and research priorities. In a paper outlining their experience of 
managing the project, Stevens and Raftery reported that they had difficulty in 
measuring the level of current services primarily due to problems in obtaining accurate 
data and in defining models of care, such as prevention, treatment, care and 
rehabilitation (72). 
In addition to these difficulties. the reviews did not examine: 1) the appropriateness 
of the indications for treatment; and 2) no consideration was given to patient 
preference for treatment. The extent of these problems will depend on the condition 
or service under consideration. The suggestion that corporate or comparative needs 
assessments (also known as marginal needs assessments) are adequate does not 
recognize that corporate self-interest groups will have an interest in promoting 
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supplier demand. The suggestion that an economic approach should be coupled with 
an epidemiologically based needs assessment does not recognize the crucial 
distinction between the two. Although it has been argued that needs can be 
determined from an economic perspective (60,73), these arguments do not distinguish 
between a true need for health care that exists in the population regardless of the 
costs of a treatment, and priorities for various treatments derived from societal values. 
In addition to the NHS initiative, a number of other publications by other groups are 
beginning to appear. These include assessing the needs of the elderly (74) and those 
with visual disability (75). Many other topics for needs assessments are recorded by 
the Needs Network, a register of individuals and organisations involved in assessing 
health care needs in the U.K. established by the Institute of Public and Environmental 
Health at the University of Birmingham (76). 
2.6 Towards a model for assessing health care need 
There is emerging agreement about the best way to assess the health care need or 
the requirements for specific interventions (61,77.79). The first step is to reach 
consensus, based on the best available evidence, about the appropriate indications 
for the intervention. This should include a review of the published scientific literature 
and, where the evidence is incomplete or conflicting, a panel of people with expertise 
andlor a legitimate interest in the topic to discuss the appropriate indications for 
treatment. The second step is to estimate the population prevalence of individuals 
with appropriate indications. The final step is to determine which individuals with 
clinically appropriate indications actually want the intervention in question. Despite the 
importance of this kind of research, relatively little of it has been undertaken. 
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The need for hip replacement is one of few attempts to assess true need with a 
prevalence survey (80). Individuals with symptoms of hip disease in a defined 
population were identified in two stages - initial screening and detailed follow-up of 
possible cases. The threshold for treatment was defined as the lowest level of 
symptoms, using validated scores, found among those on a waiting list for hip 
replacement. When the results were used to estimate the required number of 
operations in England and Wales, the figure derived was less than half of the actual 
number of operations performed in 1978 (81). This study highlighted the importance 
of identifying explicit thresholds and considering that the prevalence of symptoms may 
over-estimate the need for treatment as it may include individuals who are unfit for 
surgery. 
2.7 Summary 
The recent NHS reforms have given district purchasing authorities the responsibility 
for assessing the health needs of their populations. A recent series of 
epidemiologically based needs assessment reviews was inadequate because; few 
were based on studies of the prevalence of disease in defined local populations; there 
was little information on the appropriateness of the indications for treatment; and it did 
not consider the acceptability of the treatment to patient. Health care needs 
assessments must incorporate these steps if they are to be of value to purchasers of 
health care. 
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Chapter 3 - Rationale for examining prostatectomy 
Introduction 
Prostatectomy to remove obstruction of the urethra arising from benign prostatic 
hyperplasia (BPH) is one of the commonest elective surgical procedures, accounting 
for 42,000 operations in the U.K. in 1989/90 (82). Information on the prevalence of 
BPH and on the indications for treatment is hindered by confusion over the definition 
of BPH and debate about the relative importance of clinical measures of obstruction 
and patient-perceived measures of symptom severity, health status and quality of life. 
These problems are compounded by the poorly understood natural history of BPH. 
This chapter reviews the literature relevant to assessing the need for prostatectomy 
for BPH and consists of the following sections: 1) a definition of BPH; 2) indications 
for treatment; 3) effectiveness of treatment; 4) alternative treatments; and 5) previous 
work that sought to assess the need for prostatectomy in the U.K. Finally, it presents 
the aims and objectives of the thesis. 
3.1 Definition of BPH 
Benign prostatic hyperplasia (BPH) is an adenomatous growth of the prostate gland, 
surrounding the urethra at the outlet of the bladder, that gradually obstructs the 
urethra leading to difficulty in urinating. The consequences of an untreated obstruction 
may include: progressively severe obstructive and irritative symptoms, episodes of 
acute retention, and chronic urinary retention predisposing to bladder and renal 
damage (83). 
Confusion exists over the use of the term BPH. The terms benign prostatic 
hypertrophy (increase in the size of cells) and benign prostatic hyperplasia (increase 
in the production of cells) are used interchangeably. Strictly speaking, the latter is the 
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correct term as it correctly describes the underlying pathology. Although both are 
descriptions of the histology of an enlarged prostate gland, they are often used as a 
term to describe the symptoms associated with obstruction. The expressions 
'prostatism' and 'symptoms of benign prostatic hyperplasia' have also been used to 
describe these symptoms. A recent editorial advocated the use of the term 'lower 
urinary tract symptoms' (84) because 1) the same urinary symptoms also occur in 
women, despite the impossibility oftheir having an enlarged prostate; 2) there is poor 
correlation between urinary symptoms and prostatic enlargement; and 3) possibly up 
to 35% of men with symptoms do not have obstruction (8). Urologists often define 
BPH on the basis of clinical measures of obstruction such as uroflometry, postvoid 
residual urine, and pressure-flow studies. The definition of BPH may be considered 
in terms of three overlapping concepts: 1) histological evidence of benign prostatic 
hyperplasia; 2) lower urinary tract symptoms; and 3) clinical evidence of obstruction. 
3.2 Indications for treatment 
Most men who seek treatment do so either because of an episode of acute retention 
or because their symptoms bother them and interfere with their daily activities. Lower 
urinary tract symptoms include hesitancy, poor flow, terminal dribbling, frequency, 
feeling of fullness, urgency and nocturia (20). In a prospective study of men 
undergoing prostatectomy, there were 3 principal diagnostiC categories: 35% patients 
were symptomatic only, 37% had chronic retention (with or without a history of acute 
retention and/or symptoms) as defined by their surgeon and 28% had a history of 
acute retention (with or without symptoms) (85). Seventy seven per cent of these 
patients had more than one indication. Routine investigations are conducted to rule 
out other possible causes of symptoms. These include a detailed medical history (to 
check for haematuria, urinary tract infection, diabetes, nervous system disease or 
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medication), a physical examination including a digital rectal examination, urinalysis 
using either a dipstick test or by examining the spun sediment (to rule out urinary tract 
infection or haematuria) and measurement of serum creatinine (to rule out renal 
insufficiency) (7). 
The absolute indications for prostatectomy are difficult to define (33). A review of 
published reports suggests only limited agreement about the appropriate indications 
for prostatectomy. There is complete agreement about the need for surgery in the 
presence of chronic retention, though a lack of consensus as to the definition of the 
condition. While some authors state that acute retention, in the absence of detrusor 
failure or neuropathic obstruction, is an absolute indication (21), others argue in 
favour of conservative treatment for those who can void successfully after a period 
of catheter drainage (22,23). Yet a urologist in Scotland reported that acute retention 
was the only indication for which he would perform a prostatectomy (24). A recent 
study of the clinical practice of urologists concluded that consensus about appropriate 
practice has yet to be achieved (25). Some of this difficulty arises from the debate 
about whether to treat symptoms or urological measures of obstruction. 
3.2.1 Symptoms 
Symptoms are often thought to be due to either the direct effects of obstruction on 
urinary flow [obstructive symptoms: hesitancy, poor flow, dribbling, fullness], or to 
secondary changes in bladder function [irritative symptoms: frequency, urgency, 
nocturia, dysuria], although there is little evidence to support the usefulness of this 
distinction (33). It has been suggested that obstructive symptoms be referred to as 
'voiding symptoms' and that irritative symptoms, should be referred to as 'filling 
symptoms' (84), although there is no agreement over which particular symptoms are 
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associated with BPH. 
In general symptom measures have been developed by urologists and have not been 
fully evaluated in patients and men without symptoms (82). Two main symptom 
scoring systems have been developed in the U.S.A. to measure symptoms (86). With 
the first, the Madsen-Iversen index, patients are interviewed about the quality of their 
urinary stream, straining to void, hesitancy, intermittency, bladder emptying, stress 
incontinence or postvoid dribbling, urgency, frequency and nocturia. Symptoms are 
graded on a scale from 0 to 4 and a total score of 27 calculated by summing 
individual symptom scores. This index is derived from a questionnaire completed by 
the clinician rather than the patient and thus is inappropriate for survey purposes. 
The widely used Boyarsky index considers the severity of nocturia, frequency, 
hesitancy, intermittency, terminal dribbling, urgency, impairment in size and force of 
stream, dysuria, and sensation of incomplete voiding. Symptoms are graded on a 
scale from 0 to 3 and a total score of 27 calculated by summing individual symptom 
scores. The items consist only of a list of symptoms being measured, rather than 
defining the question asked. The scoring is inconsistent; for some items the first point 
is 'no symptoms', for others, 'symptoms less than 20% of the time'. 
To overcome the limitations of these methods the American Urological Association 
formed a measurement committee to develop a symptom index and quality of life 
questionnaire to provide a measure of outcome for the treatment of BPH (87). A 73-
item pilot questionnaire was administered to patients with a clinical diagnosiS of BPH, 
and to younger control patients without urinary symptoms drawn from general 
practice. Individual symptom questions were correlated with an overall question about 
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bother. Those that were highly correlated (incomplete emptying, frequency, 
intermittency, urgency, weak stream, hesitancy and nocturia) were tested further for 
internal consistency, and test-retest reliability. An index of these symptoms was 
developed by summing the individual scores. This index was highly correlated (r=0.78) 
with patients' global rating of their urinary problems and with comparable elements 
of the Madsen-Iversen (r=0.85) and Boyarsky (r=0.93) indices (88). 
The seven questions were then modified based on comments from subjects and the 
7 item index re-validated in 107 patients with clinically diagnosed BPH and 49 
controls. Each item response ranged from 'not at all' to 'almost always', on a scale 
from 0 to 5. These items were then summed to produce an overall symptom score 
ranging from 0 to 35. The results of the second validation study found high internal 
consistency (Cronbach's alpha = 0.86) and high test-retest reliability (r = 0.92). The 
scores were highly correlated with subjects global ratings of their urinary symptoms 
and the index was able to distinguish BPH patients from control subjects. Finally, the 
sensitivity of the index was examined by administering it to 27 men immediately 
before prostatectomy and 1 month after. The scores dropped from a mean of 17.6 to 
7.1. 
The results of the validation studies were compared with how bothered patients were 
by their symptoms, in order to create three severity categories: none/mild [0-7], 
moderate [8-19], and severe [20-35]. The committee noted however, that these 
categories were somewhat arbitrary, and that descriptions of ranges of scores should 
be tailored to the purpose for which they are being used. 
The AUA symptom score has recently been adopted by the World Health Organization 
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(89) and recommended for use by the U.S. Department of Health and Human 
Services (7). It is now referred to as the International Prostate Symptom Score (IPSS) 
and consists of a self-administered 7 -item questionnaire about symptoms where item 
responses range from 'not at all' to 'almost always' (87). The index, the sum of the 
7 items, can then be divided into 3 categories of symptom severity: none/mild [0-7], 
moderate [8-19] and severe [20-35]. 
3.2.2 Urological measures 
The decision to offer treatment is based on a combination of urinary symptoms and 
the results of clinical investigations. There is controversy about the relative importance 
of symptoms and outflow obstruction defined by urodynamic tests which determine 
the functional and anatomic status of the bladder and urethra. These tests include 
uroflometry (measurement of urinary flowrate during micturition), postvoid residual 
urine (urine remaining in the bladder following micturition) and pressure flow studies 
(measurement of pressure in bladder during voiding). Two other investigations, 
cystometry (measurement of bladder capacity & presence of detrusor contractions), 
and imaging (intravenous urography) are not recommended (7). 
3.2.2.1 Urofiometry 
Flow rates include the peak flowrate (Qmax) and average flowrate (Q.ve)' Results of 
studies that correlate these measures with symptom severity are conflicting. Some 
studies have demonstrated a relationship between symptoms and low flow rates or 
high urethral resistance (90-92), while others found a poor correlation (91,93-97). A 
current surgical textbook advocates the use of urodynamics (98) even though studies 
have concluded that measurements of urinary flow are not associated with symptoms 
or with the outcomes of prostatectomy (25,26,95,99.104). Possible reasons for the 
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conflicting results include: discrepancies between manual and automatic 
measurements, and that although Qmax decreases with age and voided volume, no 
age or volume correction factor is used (7). Flowrates could not distinguish between 
obstruction and detrusor instability as the cause of a low Omax (7). Studies that have 
examined the value of uroflow to predict the outcome of prostatectomy have shown 
symptom improvement in men with a Qmax of less than 10 mils (105). Frimodt-Moller 
found no association between symptoms and outflow obstruction as defined by 
urodynamics and concluded that urodynamics were of no help in either confirming a 
clinical impression or identifying parameters that might alter diagnosis or treatment 
(95). Support for the view that uroflowmetry is not an aid for decision making comes 
from a recent study in the UK that found that urodynamic studies were conducted in 
only 26% in patients (106) and the AHCPR clinical guidelines recommend their use 
as optional only (7). 
3.2.2.2 Postvoid residual urine 
Postvoid residual urine (PVR) refers to the volume of urine left in the bladder following 
emptying and is commonly measured using urethral in-and-out catheterization or by 
ultrasound. Bruskewitz found that there was no correlation between PVR and 
urodynamic findings, and symptoms (107). Residual urine may originate from other 
causes than outflow obstruction and some patients with severe obstruction may 
present with no PVR (108). No study has reported a positive correlation between pre-
operative residual urine and post-operative outcome (33). It has been suggested that 
the PVR should be carried out for men who have selected a non-surgical intervention 
such as watchful waiting or medical treatment (7). 
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3.2.2.3 Pressure flow studies 
Pressure flow studies distinguish between those who have a low Qmax resulting from 
obstruction and those who have bladder detrusor instability, by measuring the 
pressure of the bladder during voiding. The measure is the difference between the 
intra-abdominal pressure and the intravesical pressure (P del) and if it exceeds 100 cm 
during peak flow, then there is evidence of urethral obstruction. Evidence supporting 
the use of pressure flow studies is conflicting. A study that examined outcomes in 
terms of both P del and Qmax and symptom assessment found that a urethral resistance 
cutoff value 0.6 mllsec was not predictive of success in terms of Qmax. detrusor 
pressure, resistance, or symptoms (97). Furthermore, men who were dissatisfied with 
the outcome of prostatectomy were incorrectly classified pre-operatively on the basis 
of urological testing (105). 
A recent study examining the correlation between AUA symptom scores and both 
uroflow rate and prostate size in 198 men presenting to urologists, found no 
correlation, although it did show significant correlations with a 3-item general health 
index, 3-item activity index and a 5-item mental health index (109). The authors 
concluded that AUA symptom index is more precise than any of the commonly used 
physiological measures (109). Bruskewitz found that symptom scores and urodynamic 
studies were poorly correlated in 46 patients undergoing prostatectomy and concluded 
that symptoms were a better predictor of post-operative outcome (97). 
Those who favour urodynamics pOint out the non-specificity of symptom scores, as 
indicated by similar results of their application in women, for whom prostatic 
obstruction is an impossibility (110-112). Second, if there is a suspicion of detrusor 
instability indicated by frequency, urgency and urge incontinence, then pressure flow 
-40-
studies may be important in order to avoid unnecessary and inappropriate surgery 
(113). Given that most surgery is carried out to improve quality of life, which is highly 
correlated with symptom severity (16,17,114), the presence of urinary symptoms is 
the main factor that should be taken into consideration in the decision to offer 
treatment unless it can be shown that other measures will accurately predict patients 
who will benefit. The AHCPR clinical guidelines suggest that uroflometry, postvoid 
residual urine and pressure-flow studies be considered as optional tests after the 
initial evaluation has shown these men to have moderate to severe urinary symptoms 
based on the AUA symptom score. 
In summary, the AUA symptom index should not be used as the only way of 
diagnosing BPH in individual patients because the symptoms are not specific for BPH 
(ie urinary tract infection, neurogenic bladder dysfunction, urethral stricture and 
prostate cancer). When these causes have been ruled out, the AUA symptom index 
is appropriate for use in treatment, planning and in the measurement of outcomes of 
the symptoms characteristic of BPH. At a population level, however, this is less of a 
problem as the other causes of urinary symptoms are much less common than BPH. 
3.4 Effectiveness of prostatectomy 
In order to assess the need for health care it is necessary to demonstrate the benefit 
of the intervention in question through effectiveness studies. Effectiveness is studied 
by examining outcomes following treatment. Commonly used measures of outcome 
are: mortality, complications, symptom change, general health status, quality of life 
and re-operation. This section examines the effectiveness of prostatectomy from data 
derived from: 1) case series which follow patients for up to one year; 2) longitudinal 
administrative data bases with follow-up of mortality, further illness episodes and re-
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operation rates; and 3) randomised clinical trials that have compared the outcomes 
of TURP with open prostatectomy. The following section refers exclusively to the 
outcomes of TURP. 
3.4.1 Mortality 
Published case-series from several different countries suggest that 90 day post-
operative mortality rates range from 1 % to 9% (25,28,115-123). The age-adjusted 
cumulative risk of dying obtained from population-based studies within 90 days was 
found to be 1 % and 4% in two studies (122,124). In-hospital mortality rates are of little 
relevance as sixty per cent of deaths within 90 days occur after discharge from 
hospital (125). A meta-analysis incorporating the results of 150 studies and reflecting 
a sample of 50,000 patients determined that the mean 90 day mortality was 1.5% 
[95% confidence interval 1.3-1.7] (113). Mortality increases with increasing length of 
time after surgery. Roos and colleagues have reported that the risk of death in three 
different countries [Canada, Denmark and the U.K.] increased from 10% at 1 year to 
50% at 8 years (115,125,126). Different investigators may use different inclusion 
criteria for patients (selection bias), and results are more likely to be reported if they 
demonstrate an improvement on previous case-series. 
The extent to which deaths are associated with TURP is uncertain. Results of 
comparing post-operative death rates with mortality in the general population are 
conflicting. In Rochester, Minnesota, average annual mortality rates over a 6 year 
period following prostatectomy were not statistically different from the rates of men 
who had not undergone prostatectomy (28). Similar results were obtained in the U.K. 
(20). In contrast, a study in men between the ages of 65 and 69 undergoing 
prostatectomy had more than twice the expected mortality rate compared with age-
-42-
matched men who had not undergone prostatectomy (26). There are considerable 
differences in the mortality achieved by different hospitals. There appears to be an 
association with hospital size in the U.S.A. (125). Compared with hospitals of 300 
beds, the relative risk of death is 1.51 [95% CI, 1.01-2.27] in hospitals of 150-300 
beds and 1.79 (95% CI, 1.24-2.59) in hospitals of under 150 beds. Studies which 
examined mortality were based on linking routine hospital data with national mortality 
records; although the use of routine hospital data must be interpreted with caution 
because of their limitations which include: incompleteness, inaccurate coding and 
misdiagnosis (127), difficulties in identifying deaths following discharge (128), and 
failure to adjust for case-mix (129). In summary, the 90 day mortality associated with 
TURP is around 1.5%. 
3.4.2 Complications 
The incidence of post-operative complications prior to discharge has been reported 
as about 16% to 23% (20,25,116,130). A meta-analysis reported that 'general 
complications' will develop in 6% - 32% following surgery (113). Problems arise in 
measuring the prevalence of complications because: definitions differ; severity is 
dependent on who reports the symptoms; and there is variation in the length of 
fol/owup after surgery. The most common complications of prostatectomy are 
bleeding, urinary retention, urinary infection, incontinence and impotence. The 
incidence of complications depends partly on whether the surgeon or the patient is 
the source ofthe information; patients report complications more often than surgeons 
(101 ). 
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3.4.2.1 Bleeding 
Widespread differences in the reporting of bleeding following prostatectomy can be 
attributed to differences in the definition of bleeding. Bleeding requiring transfusion 
has been reported in 3% - 4% of cases prior to discharge, although surgeons are 
likely to differ in their tendency to transfuse (120,131). Bleeding leading to clot 
retention was found in 11 % before discharge (20). Most patients (90%) reported some 
post-operative bleeding, but only 14% saw their general practitioner and only 1% 
required readmission (20). In two studies, 2.3% - 5.8% of patients required re-
hospitalization because of bleeding (28,124). 
3.4.2.2 Urinary retention 
Between 15% and 19% of patients reported one or more episodes of urinary retention 
due to blood clots within 3 months of surgery (102). In two studies, 4% - 5% 
developed retention serious enough to require hospitalization following surgery 
(20,28). Five years post-discharge, 19% of patients reported the 'sensation of 
retention' (103). 
3.4.2.3 Infection 
Urinary tract infection (UTI) is a commonly reported complication of prostatectomy. 
Reported rates following surgery vary from 2% - 20% (20,100,102,120,116), reflecting 
how a UTI was defined - the low rate of 2% referred to UTI confirmed by 
bacteriological culture. 
3.4.2.4 Incontinence 
Thirty eight per cent reported incontinence 3 weeks after discharge (20). One year 
after surgery, studies have reported between 1 % and 20% (95,100,102,103,119,120) 
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and 3% after 5 years. A meta-analysis of 150 studies combining the results from 
50,000 patients, reported the long-term prevalence of incontinence was 0.8% [95% 
el, 0.6%-1.2%1 (113). 
3.4.2.5 Sexual problems 
Sexual problems such as erectile impotence or retrograde ejaculation are reported 
following surgery. Of men who were able to have an erection before surgery, 5% 
reported that they were unable to have an erection 3, 6, and 12 months after surgery 
(102,131). A study in Germany reported that surgery had no significant effect on the 
prevalence of impotence (104). A meta-analysis of 150 studies combining the results 
from 50,000 patients suggested that 3.4% [95% CI, 3.3 - 3.5] will develop erectile 
impotence (113). Between 50% and 93% of men reported retrograde ejaculation 
(103,121). Thirty four percent of sexually active men reported that the operation had 
made their sex life worse (121). It has recently been suggested that the increase in 
sexual dysfunction is related to age, and a recently published prospective study 
supports the view that impotence following TURP is no more common than in men 
who receive no treatment (7). 
3.4.2.6 Urethral strictures 
The occurrence of stricture is a recognised complication of transurethral surgery. 
Stricture after surgery occurs in 0.6% - 0.8% of cases (100,120,121). Stricture that 
was serious enough to require regular intermittent dilatation or a urethroplasty ranged 
from 1.2% to 7% one year after discharge (100,124). Between 3.9% and 4.6% had 
a stricture serious enough to have dilatation within 5 years of discharge. 
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3.4.2.7 Cardio-vascular complications 
The occurrence of pulmonary embolism as a result of deep vein thrombosis has been 
reported in two case-series as 0.1 % and 0.4% (120,132). 
3.4.2.8 Perforation of the prostatic capsule 
Perforations that were large enough to be noticed and serious enough to warrant 
drainage have been reported in 0.4% - 0.5% of patients undergoing TURP (120,132). 
3.4.3 Change in symptoms 
A number of studies have assessed change in symptoms using symptom scoring 
indices, where ordinal scales for symptoms obtained by a questionnaire are combined 
into a single measure. Following prostatectomy, the proportion of men who reported 
an improvement in symptoms ranged from 70% to 90% (20,102,113,120,121,133-
140). These studies are summarised in Table 3.1. The extent of improvement is 
related to: pre-operative severity; at what time following surgery that symptom severity 
is reported, differences in the patient perceptions of severity, and patient expectations 
(141). After one year, 93% of severely symptomatic and 79% of those with moderate 
symptoms experienced improvement in a symptom index (102). Seventy two per cent 
reported that they passed water more easily, between 5 and 8 years following their 
operation (121). Nevertheless, a small percentage (5%) of patients reported a 
worsening of symptoms, and 7% of those with severe symptoms reported no 
improvement (102). Further, it has been estimated that symptoms improve 
spontaneously in 50% of men between the ages of 45 and 80 without treatment, and 
31 % will experience an improvement in their symptoms within 5 years of having 
presented with symptoms of BPH (99). However, until further stUdies of natural history 
are undertaken, the true remission rate remains uncertain. 
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Table 3.1 Summary of results of studies examining symptom improvement 12 months following transurethral resection of the prostate. 
Study (ref) 
Singh (120) 
Chilton (100) 
Meyhoff (134) 
Dorflinger (137) 
Larsen (138) 
Malone (121) 
Fowfer (102) 
Kadow (142) 
Nielsen (135) 
lepor (133) 
Doll (20) 
Soonawalfa (136) 
Kabafin (139) 
Dahlstrand (140) 
AHCPR guidelines (7) 
Year 
1973 
1978 
1986 
1987 
1987 
1988 
1988 
1988 
1988 
1990 
1992 
1992 
1993 
1993 
1994 
Design 
case-series 
case-series 
RCT 
RCT 
RCT 
case-series 
cohort 
RCT 
RCT 
cohort 
cohort 
RCT 
ReT 
RCT 
meta-analysis 
N 
804 
1,004 
75 
38 
37 
184 
263 
38 
49 
32 
388 
220 
12 
40 
4,945 
Measure 
patient opinion 
patient opinion 
symptom index 
Madsen-Iversen index 
Madsen-Iversen index 
6 items 
5-item symptom index 
symptom index 
frequency 
Boyarsky index 
7-item symptom index 
subjective improvement 
AUAindex 
Madsen-Iversen 
'quantitative' 
Degree of improvement 
97% 'very good' or 'improved' 
92% 'cured' or 'better' 
90% improvement 
95% improvement 
94% improvement 
80% asymptomatic 
79% (moderate symptoms), 93% (severe 
symptoms) improved 
71% improvement 
78% improvement 
84% voiding symptoms significantly improved 
90% improvement 
90% improvement 
83% improvement 
'Significant improvemenf 
88% median probability for improvement 
3.4.4 General health status 
The Nottingham Health Profile (NHP) has been used to assess self-perceived health 
status in a cohort of 388 men at 3,6, and 12 months following surgery (114). Sixty per 
cent of those with a health problem prior to operation reported an improvement a year 
after surgery. Patients experienced improvement for all dimensions of health status, 
most notably sleeping, although those with more severe symptoms showed greater 
improvement than those with moderate symptoms (114). 
3.4.5 Quality of life 
A series of 263 patients in Maine, were interviewed about their quality of life before 
and after pro~tatectomy, using 3 standard indices: an activity index, a mental health 
index and a general health index (102). Twelve months following surgery, quality of 
life had improved only in those patients who had reported severe symptoms (and 
especially those with a history of acute retention) before surgery. Modelling has been 
used to predict that immediate surgery for a 70 year old man with moderate 
symptoms would result in a loss of 1 month in life expectancy, and a net benefit of 3 
quality-adjusted life months (143). In a prospective series of 100 patients, quality of 
life improved significantly, although the authors did not provide information about how 
they measured quality of life (104). 
3.4.6 Re-operation 
Re-operation rates vary depending on the type of study; case-series may report lower 
rates because of selection and reporting biases, and shorter length of, or incomplete, 
follow-up. One study reported a two year cumulative probability of a repeat operation 
of 3% (144). The probability of having a repeat prostatectomy increases with length 
of follow-up. At 6 months, reported rates vary from 1 % to 9% 
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(20,25,28,103,113,115,120). The eight year cumulative re·operation rate is 12% - 20% 
(115,124,125,145,146). A study using decision analysis with American data suggested 
that a 70 year old man undergoing prostatectomy for moderate symptoms but with no 
evidence of chronic retention had a cumulative probability of at least one further 
operation during his lifetime of 21% (143). In a case series of 2015 cases, 12% 
reported a previous TURP (130). 
3.5 Alternative treatments 
A number of alternative treatments for lower urinary tract symptoms for BPH are 
available. These include: watchful waiting, operation (TURP, transurethral incision of 
the prostate (TUIP), open prostatectomy), medical treatment (alpha blockers, alpha 
reductase inhibitors, hormonal manipulation), and non-invasive procedures (balloon 
dilation, hyperthermia, thermal therapy, laser prostatectomy, prostatic stents). These 
are all under investigation (7). The evidence about effectiveness, in terms of long-term 
improvement in symptoms, is limited because these treatments are too recent for their 
to be long term follow·up of outcomes. Furthermore, data that does exist, has often 
failed to assess the response of symptoms to treatment. 
Watchful waiting is a widely used term but one that is poorly defined. The patient 
receives no intervention and is monitored by his physician, although there appears to 
be little consensus about how active the monitoring should be and when it should be 
abandoned in favour of treatment. It is based on the observation that up to 50% of 
men with untreated 'prostatism' will experience an improvement in their symptoms 
(99). 
Transurethral incision of the prostate (TUIP) involves making an incision in the 
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prostate and prostate capsule using an instrument passed through the urethra. It is 
more commonly used with smaller prostates. In an open prostatectomy, a suprapubic 
or perineal incision is made and the inner portion of the prostate gland is excised. 
Balloon dilatation is a procedure where a balloon is placed in the urethra in the 
location of the obstruction and inflated to displace the obstructing tissue. 
Medical treatments include alpha-adrenergic receptor blockers which cause the 
relaxation of the smooth muscle of the prostate and bladder neck, and 5-alpha 
reductase inhibitors which prevent the conversion of testosterone to 
dihydrotestosterone, resulting in some shrinking in the size of the prostate. 
A number of other surgical approaches have been used, and are undergoing further 
evaluation. These include prostatic stents (a tube of specially treated wire is placed 
endoscopically into the prostatic urethra and left there), hyperthermia (a probe is 
inserted into the urethra or rectum and microwaves are generated to heat the 
prostate), and lasers. 
In preparing the AHCPR clinical guidelines, the BPH panel prepared a comparison of 
the percentage of patients experiencing changes in globally assessed BPH symptom 
status following treatment. These results should be interpreted cautiously because the 
studies that report on alpha-blockers and balloon dilatation examined few patients, 
and because of differences in the way that symptom improvement is reported (eg. 
some report the presence or absence of change, while others measure the extent of 
symptom change). There is little evidence about the long-term improvement in 
symptoms. Furthermore, there has not been a randomized trial that directly compares 
the results of these different treatments with TURP, and until such time as there is, 
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no definitive statements can be made about the relative efficacy of these alternative 
treatments. 
Following an exhaustive review, U.S. clinical practice guidelines recommended that: 
patients with mild symptoms (AUA symptom index score less than 7) be followed with 
a strategy of watchful waiting; patients with moderate symptoms (AUA score greater 
than or equal to 8) be given information about the benefits and harms of watchful 
waiting, medical therapies, balloon dilation and surgery (7). Most surgeons believe 
prostatectomy is the treatment of choice for lower urinary tract symptoms (3-6,8) and 
it remains the most widely used treatment in both the U.K. (147) and in the U.S.A. 
(116). However, the use of 5-alpha reductase inhibitors is increasing rapidly although 
this and associated marketing techniques used, have generated considerable 
controversy (148). The U.S. guidelines advocate that once, the patient has decided 
to choose surgery, then the choice of specific procedure (TURP, open or TUJP) 
should be left to the surgeon (7). 
3.6 Previous work related to assessing need for prostatectomy 
An epidemiologically based needs assessment for prostatectomy for BPH 
commissioned by the Department of Health was based on 3 types of evidence: 1) 
epidemiological and utilisation data; 2) evaluation studies; and 3) economic analyses 
(82). Data were taken from existing information sources and publications in order to 
determine the required annual level of provision of prostatectomy for each district. The 
authors highlighted the difficulties of using prevalence data to assess need for 
prostatectomy: 1) existing information was primarily about the distribution of prostate 
size rather than about symptoms; 2) symptoms of BPH may often revert 
spontaneously without treatment; and 3) no information exists about the acceptability 
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of the surgery to the patient. The review estimated that 250 men over the age of 55, 
were likely to be referred for treatment per year in a typical district of 250,000 people, 
although this figure was acknowledged by the authors to be an approximation due to 
several shortcomings (82). The limitations included: 1) the absence of consensus 
about the appropriate indications for treatment; 2) prevalence estimates of BPH were 
derived from published sources of questionable validity, and 3) patient preference for 
treatment was not taken into consideration. The authors emphasized that there was 
a wide range of benefits for patients with different degrees of severity. They 
concluded with the recommendation that more research be directed towards the 
perceptions and experience of men with BPH, to investigate the reasons for their 
willingness or unwillingness to tolerate their urinary symptoms, and to establish a 
process to involve patients in decisions about treatments (82). 
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3.7 Summary & plan of thesis 
The recent NHS reforms have highlighted the role of assessing the need for health 
care in the population. The need for prostatectomy, a surgical treatment shown to 
benefit men with moderate or severe urinary symptoms, has not been adequately 
determined because: 1) there is a lack of consensus about the appropriate indications 
for treatment; 2) data on the prevalence and incidence of the symptoms of BPH in the 
population are lacking; and 3) there is little information about the acceptability of 
prostatectomy to men with symptoms. Despite the emergence of treatment 
alternatives for men with urinary symptoms, prostatectomy is the preferred treatment 
and results in the highest proportion of men experiencing improved symptoms, and 
the greatest improvement in symptoms. Nevertheless, there are risks associated with 
the procedure. TURP is associated with post-operative mortality rates of 
approximately 1.5%. The main complications of surgery include: bleeding, infection, 
incontinence, sexual dysfunction, and strictures. 
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The aims of this thesis are: 
1. to determine the appropriate indications for transurethral resection of the 
prostate for BPH. 
2. to measure the prevalence and severity of lower urinary tract symptoms in 
men aged 55 and over. 
3. to determine: (1) the extent to which lower urinary tract symptoms affect the 
daily activities and health status; and (2) whether men with lower urinary tract 
symptoms would choose treatment. 
4. to estimate of the health care need for prostatectomy in a typical district with 
a population of 250,000. 
The objectives of this thesis are: 
1. to use a consensus panel of urologists and general practitioners to determine 
the appropriate indications for prostatectomy. 
2. to conduct a survey of men aged 55 and over, in North West Thames health 
region. 
3. to conduct a follow-up survey of men who reported mild, moderate or severe 
urinary symptoms. 
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Chapter 4 • Methods 
Introduction 
This chapter describes the methods used to assess the health care need for 
prostatectomy, including the nominal group technique to determine appropriateness 
and the two surveys employed. The first section describes the consensus panel, 
including the preparation of the background material, the selection of the panellists, 
the conduct of the panel and the analysis of the panel results. Second, the initial 
survey is described, including the selection ofthe sample, the questionnaire, the case-
note review, and the scoring of comorbidity, retention and symptom severity. Third, 
the second survey is described, including the selection of the second sample, the 
follow-up questionnaire (both the NHP and the SF-36 versions), the scoring of patient 
preference and the investigation of response bias. Fourth, the methods used to 
estimate the number of prostatectomies required in a district are described. Finally, 
details of data handling and analysis are presented. 
4.1 Consensus panel 
A study of the prevalence of individuals with appropriate indications for treatment 
requires that an agreed case definition be developed, based on the best available 
evidence about appropriateness of the treatment in question. Ideally, such a definition 
would be derived from the results of large, high quality randomised controlled trials 
that relate specific indications to treatment outcomes. These would incorporate 
outcomes that are relevant to the patient and are sufficiently generalisable, both in 
terms of patients included and treatment settings. Unfortunately, in many areas of 
health care, such trials have not been conducted. 
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Where such evidence does not exist, but where smaller and perhaps less 
generalisable randomised controlled trials are available, the next best alternative is 
generally believed to be a systematic review, using meta-analysis to combine the 
results of these trials. This technique is being increasingly used to provide overviews 
of evidence and to resolve inconsistencies in the results of published studies. A meta-
analysis was not possible here due to a lack of relevant trials. Although there were 
some observational studies and a few small trials of particular therapies for lower 
urinary tract symptoms, they were of limited value in determining the indications for 
prostatectomy because the results were not representative of those for whom 
treatment might be considered and many were conducted in "centres of excellence", 
which may be atypical (149). 
An alternative approach where the information required for meta-analysis is lacking 
is formal consensus development, although it has been subject to relatively little 
research and is accepted to have many limitations. It enables the experience of those 
with expertise or a legitimate interest in the topic to bring together their ideas in a 
formal and structured way, along with the available evidence. It explicitly recognises 
that disagreement and uncertainty may remain at the end of the process. The use of 
consensus development in the health care field has been used to examine issues in 
health service organisation, definition of professional roles, design of educational 
programmes, long-term projections of need for care for particular client groups and 
development of criteria for appropriateness of interventions (150). 
This formal structure, involving explicit incorporation of the available evidence, is felt 
to be an improvement, at least in process terms, on the alternatives such as 
committees in which a few individuals may dominate the discussion and in which 
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evidence may be suppressed. Moreover, individuals are often unready to retract long-
held and publicly stated opinions in open committees, even when these have proven 
to be false. Committee decisions are also subject to influences as diverse as the size 
of the committee, the extent of discussion, time constraints, seating positions, and the 
presence or absence of rules of procedure (151). 
One approach, the nominal group method, has been increasingly used in recent years 
in health services research. It consists of two rounds where panellists rate their 
agreement with a series of statements, discuss them and then reconsider their initial 
ratings in view of the distribution of initial scores and subsequent discussion. The 
process was developed in the U.S.A. in the 1960s and has been applied to problems 
in social service, education, other areas of government activity and industry (152). It 
is the method used most frequently to identify agreed indications for a particular 
surgical or medical intervention based on the judgement of panellists, informed by a 
detailed literature review and their clinical judgement, where the evidence is 
conflicting or miSSing (153). The leading proponent of this method has been the 
RAND corporation in the U.S.A.. 
In the U.K., the nominal group method has been used less extensively but its 
applications have included: coronary angiography (154), coronary artery bypass 
grafting (154), cholecystectomy (155) and total hip replacement (156). Other work has 
examined the out-of-hours work of junior doctors (157-161), the use of diagnostic 
tests out of hours (162), the work of house officers (163) and the avoidance of 
emergency hospital admissions (164). 
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4.1.1 Literature review 
A review of the literature on the epidemiology of BPH. methods of treatment. 
indications and outcome of prostatectomy was performed. Initially. MEDLINE was 
searched for the following medical subject headings (MeSH): prostatectomy. 
symptoms. standards. statistics and numerical data. and utilisation (165). The search 
covered the years 1983 to 1991 and included papers in aU languages. The review was 
supplemented by examination of major textbooks. follow-up of additional references 
quoted in the papers located. and personal communication with other investigators 
known to be conducting research on this topic. both in the U.K. and the U.S.A. In 
total. 175 papers were reviewed. of which eighty-two were included in the literature 
review [Appendix A1]. 
4.1.2 Selection of panel 
The panel was composed of 5 consultant urologists. one senior registrar in urology 
and 3 general practitioners. In forming the panel. 13 consultant urologists in the North 
West Thames health region and 15 general practitioners. selected on the basis of 
previously expressed interest in the topic. were approached and asked to participate. 
The final selection of the panel was based on availability to attend the discussion 
panel. The urologists on the panel represented teaching and non-teaching hospitals, 
as well as urban and rural districts. It was decided to limit the panel to medically 
qualified individuals. This is consistent with the approach taken with previous panels 
examining appropriateness in the U.K. but it inevitably leads to the development of 
a medical case definition. 
There is clearly a need for incorporating the views of health consumers but there are 
two ways of doing so. In this case. the panel was established to identify those men 
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to whom urologists would offer surgery rather than those who would accept it. The 
issue of patient views was tackled primarily by seeking information on treatment 
preference at a later stage in the study from those with possible indications for 
surgery. If it had been desired to incorporate the views of patients at this stage, a 
further obstacle would have been the absence of experience in how best to do this. 
With a relatively small panel. there is a danger that one or two patients, potential 
patients, or their representatives would be marginalised by the medical participants. 
There is also a real problem in identifying such individuals and asseSSing their 
representativeness, although to some extent the selection of general practitioners 
poses a similar problem. 
In the first round, panel members were sent the literature review and a questionnaire 
(developed from the literature review and with advice from a consultant urologist), that 
asked them to rate the appropriateness of potential indications for TURP [Appendix 
A2]. The indications were grouped into four categories of retention (acute, chronic, 
acute on chronic, and no retention), with differing types and levels of symptoms and 
different levels of comorbidity. 
4.1.3 Definition of indications 
Chronic retention was defined as a post-void residual volume of 400 ml or greater, on 
the basis of advice from the panel. Symptoms were classified as irritative (frequency, 
nocturia and dysuria), obstructive (hesitancy, poor flow, dribbling and feeling of 
fullness) or a combination of both irritative and obstructive. Levels of symptom 
severity were categorized as none (symptoms never occur), mild (symptoms present 
occasionally or nocturia occurs once per night), moderate (symptoms present about 
half the time or nocturia occurs 2 - 3 times per night) and severe (symptoms present 
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most or all of the time or nocturia occurs 4 or more times per night). Life expectancy 
was used as proxy measure of comorbidity. High comorbidity was defined as life 
expectancy of less than a year, medium comorbidity as at least a year but less than 
five years and low comorbidity as five years or more. The raters were guided by these 
examples: less than 1 year = inoperable cancer with secondaries, 1 to 4 years = 
chronic obstructive airway disease with dyspnoea on moderate exertion; angina on 
moderate exertion, and 5 or more = no co-morbidity, hypertension controlled by 
treatment, osteoarthrosis. It was assumed that there was no pre-operative evidence 
of prostatic cancer and that patients were fit enough to undergo general or spinal 
anaesthetic. Other forms of treatment such as drug therapy or stents were assumed 
to be available, so that if they were appropriate as first line therapy, TURP was 
deemed to be inappropriate. 
Each combination of these four factors (type of retention, type of symptoms, severity 
of symptoms and comorbidity) was taken to describe a category of patient. For 
example, one such category might represent patients in acute retention with mild 
obstructive symptoms and low comorbidity. If symptom severity was 'none', further 
breakdown by symptom type was not applicable, and if there were no retention and 
no symptoms, further breakdown by comorbidity was not applicable. On this basis a 
total of 118 unique patient categories were assessed. 
4.1.4 Scoring of appropriateness 
Appropriateness was scored using a 9 point scale, in which 1 indicated that the risk 
of TURP always outweighed the benefits and so surgery was always inappropriate, 
and 9 indicated that the benefits ofTURP always outweighed the risks and so surgery 
was always appropriate. A score of 5 indicated that the risks and benefits were equal. 
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After completing and returning the questionnaire, panellists attended a structured 
meeting at which they were presented with a summary of the first round responses 
to the questionnaire showing the median and the range of scores. Each patient 
category, where there was disagreement, was discussed in turn, followed by the 
opportunity for panellists to reconsider their previous responses. The discussion 
enabled panellists both to clarify their interpretation of the indication and to discuss 
areas of genuine controversy. This final rating was used in the analysis. 
Agreement was defined as when, after discarding the single highest and lowest 
ratings, the ratings of the seven remaining panel members fell within a 3 point range. 
Panellists were judged to have disagreed if, after discarding the highest and lowest 
ratings, at least one rating fell in the 1-3 range and at least one rating in the 7-9 
range. Categories about which there was neither agreement nor disagreement were 
classified as partial agreement. For patient categories about which the panel agreed, 
surgery was judged to be inappropriate if the median rating fell between 1-3 and 
appropriate if the median rating fell between 7-9. A rating of 4-6 was judged to be 
equivocal. This is the system used in the RAND consensus conferences and other 
studies undertaken previously in the U.K. (153,155,163). 
4.2 Initial survey 
4.2.1 Selection of sample 
A cross-sectional population survey of the prevalence of urinary symptoms in men 
aged 55 and over was carried out in North West Thames region. This age group was 
selected on the basis of the results of a study in the Oxford and North West Thames 
regions in which more than 99% of men undergoing prostatectomy were aged 55 or 
more (20). Initially thirty general practices were selected randomly from all practices 
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in North West Thames region and invited to participate. The fifteen practices that 
expressed an interest in the study were sent further information and the panel 
literature review. Seven practices withdrew at this stage. The remaining eight 
practices were distributed throughout the region and included inner city, suburban and 
rural practices. These practices were asked to provide a list of all men aged 55 years 
and over. In total, 3716 men were identified, with the number of men in each practice 
ranging from 143 to 1180. With the exception of the smallest practice, where the 
entire list was used, 265 men were randomly sampled from the whole of each 
practice's list to create a database of 2000 names and addresses. This number was 
chosen to yield 95% confidence intervals of ± 1.5% if the true prevalence of moderate 
or severe symptoms was around 25%. 
4.2.2 Urinarv symptom questionnaire 
A two page questionnaire [Appendix A3], together with a personally addressed 
covering letter [Appendix A4] signed by the individual's general practitioner and the 
author, and a stamped, addressed envelope for reply, was sent to each man. 
Non-respondents were sent a reminder letter and a second questionnaire one month 
later. The questionnaire sought information about the men's socio-demographic 
characteristics [age, ethnicity and proxy measures for income (housing tenure and car 
ownership] and about any urinary symptoms they had experienced overthe preceding 
month. Questions on urinary symptoms were taken from the American Urological 
Association (AUA) symptom index (87), with some minor modifications to the wording 
of the questions to make them more appropriate for a British population. For example, 
the AUA question on fullness 'Over the past month or so, how often have you had a 
sensation of not emptying your bladder completely after you finished urinating?' was 
changed to 'In the past month, how often did you feel that your bladder did not empty 
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fully after urinating?'. A pilot version of the questionnaire, sent to 30 men selected 
from a general practice in North East Thames region, achieved a response rate of 
80% and led to minor modifications in the layout of the questions. For comparison, 
population estimates and demographic information for residents of North West 
Thames region were obtained from the 1991 census (166). Ethical approval was 
sought and obtained from the relevant district ethics committees. 
4.2.3 Case-note review for non-response bias 
To investigate the possible effects of response bias, general practice case notes from 
100 randomly selected non-respondents were compared with the case notes of 100 
randomly selected respondents. Information taken from these case notes included 
age, history of urinary symptoms, previous prostate surgery, and medical history. 
Reasons for the unavailability of any case-notes, such as the patient having died or 
moved away, were recorded. 
4.2.4 Scoring of symptom severity 
A symptom index, ranging from 0 to 30, was calculated by summing the scores of six 
urinary symptoms (fullness, frequency, intermittency, urgency, poor flow and 
hesitancy) where each symptom was assigned one of the following values: never-O, 
hardly ever=1, less than half the time=2, about half the time=3, more than half the 
time=4 and almost always=5. The symptom index was categorized into five levels of 
severity; none [0], very mild [1], mild [2-9], moderate [10-18] and severe [19-30]. 
These cutoff points were consistent with those used in a cohort study of men 
undergoing prostatectomy in Oxford and North West Thames region (167) and with 
the definitions used in the consensus panel where 'none' and 'very mild' symptoms 
were grouped together. Responders were also asked about how bothersome any 
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trouble with urinating had been in the preceding month, with possible responses on 
a five point scale: no problem, very small problem, small problem, medium problem 
and big problem. 
4.1.5 Definition of retention 
An episode of acute retention was defined as respondents reporting a previous 
episode of ever being blocked up completely so that they were unable to urinate. The 
presence of chronic retention, defined to be post-void residual urine of> 400 mIs, 
could not be determined from a postal questionnaire. 
4.1.6 Scoring of comorbiditv 
To measure comorbidity respondents were asked the open-ended question 'do you 
have any other health conditions that affect the way you feel, or the things that you 
can do at this time?' Their responses were then reviewed independently by two 
doctors and rated on the basis of life expectancy on a scale of 1 to 3 [1 =Iess than 1 
years, 2=2-4 years, and 3=greater than 5 years]. The raters were guided by the 
examples used in the consensus panel discussion. As with levels of urinary 
symptoms, these categories were designed in order to be consistent with those used 
by the consensus panel. Where there were disagreements between raters, the higher 
rating (ie. a longer life expectancy) was used. Where the respondent's life expectancy, 
as determined from the life table for England and Wales 1989-91 (168) on the basis 
of age alone, was lower than the comorbidity rating, the life table value was used. 
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4.3 Forrow-up survey 
4.3.1 Selection of second sample 
The 516 (34.9%) men in the initial survey who reported a symptom score of 7 or more 
and lor a history of acute retention, were sent a second questionnaire 6 weeks later 
that sought information about the impact of lower urinary tract symptoms on their 
health status, behaviour and preference for treatment. To avoid unnecessary distress 
to families, a list of these men was sent to all GP practices beforehand, in order to 
ensure that any men had not died since the initial survey. 
4.3.2 Follow·up questionnaire 
A seven page questionnaire [Appendix A5] was sent together with a personal covering 
letter [Appendix A6] from the individual's GP and a stamped, addressed envelope for 
reply. All non-respondents were sent a reminder letter and a second questionnaire 
one month later. Interference in daily activities was determined by asking whether 
men: worried about needing a toilet or wetting self in public, avoided using a toilet, 
were embarrassed about using a toilet often or limited the amount they drank. 
Participants were asked whether they had sought advice for their urinary symptoms 
and from who, whether they had visited their GP or urologist, and what had been the 
results of these consultations. Health status was measured using one of two standard 
instruments: the Nottingham Health Profile (NHP) or the SF-36. Each version of the 
questionnaire was randomly allocated to half the sample. 
4.3.2.1 Nottingham Health Profile 
The Nottingham Health Profile is a valid and reliable self-administered questionnaire, 
widely used in the UK (169). Respondents were asked to agree or disagree with 38 
statements about their health; ego 'I find it painful to change position', 'I feel I am a 
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burden to people'. Using the methods recommended by the creators of the NHP, all 
item responses were weighted and combined into 6 dimensions [energy (3 items), 
pain (8 items), emotional reactions (9 items), sleep (5 items), social isolation (5 items) 
and physical mobility (8 items)]. Possible scores ranged from 0 (perfect health) to 100 
(poor health) (169). The use of weights is suggested if the study is confined to the 
UK, for use in comparing results with other studies (169). It was hypothesized a priori 
that emotional reactions, sleep and social isolation would be affected by lower urinary 
tract symptoms, but that the other dimensions would not. 
4.3.2 MOS 36-ltem Short Form Health Survey 
The SF-36 was developed for the Medical Outcomes Study and by the RAND 
corporation in the U.S.A. (170), and adapted for use in the UK by the Medical Care 
Research Unit at the University of Sheffield (171). There is considerable evidence as 
to its reliability and validity in the U.K. (171-173). It consists of 36 items. Where 
applicable, item responses were transformed so that all 36 items were scored from 
o - 5. A higher score indicates better health. Item scores were then combined into 
eight different dimensions of health as recommended [Appendix A7](174). Four 
dimensions relate to general health status: physical functioning (10 items), mental 
health (5 items), energy/vitality (4 items) and general health perceptions (5 items). 
Three relate to general quality of life: limitations due to physical role problems (4 
items), social functioning (2 items), and limitations due to emotional role problems (3 
items). One relates to both health status and quality of life: pain (2 items). Where item 
scores were missing, they were imputed by taking the average of other items in the 
relevant health dimension. Out of a possible 7812 responses (36 items, 217 
questionnaires), 387 (5%) answers were missing. It was hypothesized that social 
functioning, vitality and mental health would be significantly affected by urinary 
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symptoms, and that general health perceptions would be affected to a lesser extent. 
The availability of published NHP scores in 388 men undergoing prostatectomy (114) 
allowed for a comparison of health status in the sample at similar symptom severity 
scores. Similarly, health status as measured by the SF-36 were compared with 
published population norms (172). 
4.3.3 Patient preference for treatment 
In order to discover whether men would accept treatment or not, participants were 
presented with currently available evidence about the outcome of treatment and a 
simple description ofthe procedure. The information was worded was as follows: 'The 
most common treatment for urinary problems caused by enlargement of the prostate 
gland is surgery. This involves passing an instrument like a small telescope up the 
penis to clear the blockage. It usually involves a hospital stay of about 8 days. About 
80% of men experience an improvement in their symptoms following surgery, about 
15% are unchanged and 5% worse off. Some men will also have difficulty getting an 
erection after surgery. In addition, about 10% have complications, such as bleeding, 
infections and leakage of urine, which normally clear up within a few weeks. If your 
urinary symptoms were found to be due to an enlarged prostate and you were offered 
surgery for it, feeling the way you do now, would you choose to have it?' Respondents 
were asked to score their preference on a scale of 0-5 [O=definitely want, 1 =probably 
want, 2=not sure, inclined to yes, 3=not sure but inclined to no, 4=probably don't 
want, 5=definitely don't want. 
4.3.4 Investigation of response bias 
To investigate the possible effects of response bias in the follow-up survey, the 85 
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(16%) non-respondents were compared with the respondents in terms of age, severity 
of symptoms, previous surgery and acute retention, using data from the initial survey. 
4.4 Estimating need 
The prevalence of appropriate indications [the results of the consensus panel and the 
results of the initial population survey], were combined with information on patient 
wants [the results of the follow-up survey] to calculate: 1) the age-specific rates of 
those with mild (symptom score less than 10), moderate (score 10-18) or severe 
(score 19-30) urinary symptoms; 2) the age-specific rates of those with the 
appropriate indications for prostatectomy; and 3) the age-specific rates of those for 
whom prostatectomy was indicated and who would accept treatment if offered. These 
rates were then applied to the age-specific population estimates from North West 
Thames region obtained from the 1991 census (166), to predict the prevalent need 
in a population of 250,000. This population was selected to represent the catchment 
population of a typical district hospital. Prevalent rates per 1000 were calculated with 
95% confidence intervals. Sensitivity analyses were undertaken to investigate the 
effect of varying the definitions of 'appropriate' and 'wanted' by altering the symptom 
severity threshold, the level of agreement required of the panel, and the level of 
certainty about surgery required of the patient (Table 4.1). In addition, rates were 
calculated, based on the actual behaviour ofthose men who had already been offered 
surgery by their urologist. Data on prevalent need was used to estimate the incident 
need, based on a number of assumptions about current utilization, remission rates, 
operative risk, and differing risks of developing symptoms. Details of the model are 
presented in Appendix A8. 
-68-
Table 4.1. Combination of definitions used in the sensitivity analysis. 
Symptom .evertty Level of Igreement PIU.nt preference 
Mild, moderate, severe 
Agreement 
definHely want 
dellnHely or probably want 
deflnHely or probably want, or inclined to yea 
Agreement + Equivocal 
dellnHely want 
deflnHely or probably want 
dellnHely or probably want, or Incllneclto yea 
Based on action 01 those offered lurgery 
Moderate, severe 
Agreement 
deflnHely want 
definHely or probably want 
deflnHely or probably want, or Inclined to yes 
Based on action of those offered surgery 
Severe 
Agreement 
dellnHely want 
dellnHely or probably want 
definHely or probably want, or Inclined to yea 
Based on action 01 thole offered lurgery 
4.5 Data processing and analysis 
Data from the consensus panel and both surveys was manually entered by a 
professional data-entry clerk, into a database using a data-entry program written in 
Paradox (175). The data was then transferred to a mainframe computer with a CMS 
operating system for analysis. The lists of patient names and addresses provided by 
the general practitioners were entered and converted into an ASCII file using an 
optical scanner, and maintained in a Wordperfect (176) mail-merge list. Each 
individual was assigned a unique identifying number which allowed for the merging 
of the files containing the results of the initial survey with those of the follow-up 
survey. One variable from each data record was compared with the corresponding 
response on the questionnaires in order to ensure that the data had been entered 
accurately. All computer print-outs were closely examined for unexpected results or 
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unusual findings. All errors were corrected before the data were analyzed. 
Data analysis consisted offrequency distributions. Confidence intervals for proportions 
were calculated at the 95% level using the method of Fleiss (177). The significance 
of observed differences was calculated using chi-squared statistics (178). Wilcoxon 
matched-pairs signed-ranks were calculated to test for a change in bothersome ness 
and frequency. A chi-squared approximation, the Kruskal-Wallis test was used to test 
the relationship between SF-36 dimension scores and symptom status. All analyses 
were conducted using procedures written in SAS (178). 
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Chapter 5 - Results 
Introduction 
This chapter reports the results of: (1) the consensus panel that considered the 
appropriate indications for prostatectomy; (2) the initial survey of 2000 men in North 
West Thames; (3) the follow-up survey that measured the impact of men's mild, 
moderate or severe lower urinary tract symptoms on their health status and choice 
of treatment; and (4) estimates of need in a typical district. 
5.1 Results of the consensus panel 
The panel was held at the London School of Hygiene and Tropical medicine over the 
course of an afternoon. Participants were given a lunch and travelling expenses were 
reimbursed. GPs were also paid at locum rates for their time. One of the invited 
consultants did not attend, although this possibility had been anticipated. The panel 
was chaired by a senior lecturer in public health medicine. After an introductory 
explanation, participants discussed each item on the questionnaire. 
The panel discussion was lively with all members contributing and very little clear 
disagreement. The main findings ofthe consensus panel were: (1) the panel attached 
little importance to mild symptoms; (2) history of urinary retention, the severity of 
urinary symptoms and the degree of comorbidity were given roughly equal weight by 
the panel; and (3) while a history of acute retention was important, the type of 
retention was less so, although acute-on-chronic retention was a stronger indication 
than either acute or chronic retention alone. Where there was agreement, there was 
no difference in the appropriateness of treatment for either chronic retention or no 
retention in terms of symptom severity and level of co morbidity. The panel confirmed 
that comorbidity does playa part in determining appropriateness, despite the view of 
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some that it is unimportant because prostatectomy can be done under spinal 
anaesthesia. 
The panel did not consider that surgery was necessarily appropriate in patients with 
a history of acute retention, although there is a large group ofthese patients in whom 
surgery will sometimes be appropriate. There was some discussion about 'trial without 
catheter' and one panellist reported that urologists disagree about the 'evidence' 
about the length of trial, and another said 'if there is a consensus about trial without 
catheter - it depends on results in terms of their symptoms'. 
Some panellists felt that the exercise had involved an artificial distinction between 
obstructive and irritative symptoms which was seldom made in practice, whereas 
others expressed the view that prostatectomy should be performed for obstructive 
symptoms but not for irritative symptoms, because irritative symptoms were caused 
by detrusor instability rather than an enlarged prostate. One urologist said 'patients 
don't come through the door and say "I can't pee fast or it takes a long time to start", 
rather they have frequency, nocturia and dysuria' and another urologist said 'you don't 
do a prostatectomy for irritative symptoms only for obstructive symptoms and the 
patient doesn't present with 400 mls residual urine, he presents with symptoms'. 
The panel debated about distinguishing chronic retention from no retention because 
virtually all people have incomplete emptying of the bladder and men have severe 
chronic retention with D.Q symptoms. One urologist noted that with chronic retention 
with significant obstruction, surgery was performed to remove the obstruction, 
regardless of irritative symptoms, in order to protect the bladder. Another urologist 
said 'irritative symptoms in chronic retention are due to a full bladder not an enlarged 
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prostate'. 
Finally, all participants stated that they had enjoyed the exercise and felt they had 
benefitted from the discussion. One GP said "As a GP I came to learn, I have', and 
another said 'I am gOing to refer more and my urologist isn't going to thank me'. One 
urologist commented 'by the time I finished the questionnaire, I wondered what on 
earth I'm doing this operation for'. 
The panel reached agreement on 67% of the patient categories (Table 5.1), with 45% 
appropriate for surgery, 17% inappropriate, and 5% equivocal. Clear disagreement 
occurred in only 6%. The patient categories for which surgery was considered 
appropriate, unclear or inappropriate are summarised in Figure 5.1, in which no 
distinction is made between the type of symptoms. Ratings for each item are 
presented in Appendix A9. In general, surgery is indicated for chronic retention or 
acute retention if symptoms are severe, or if symptoms are moderate and life 
expectancy is greater than five years. Acute on chronic retention is an indication for 
surgery regardless of symptom severity, if life expectancy is greater than one year. 
For patients with neither acute nor chronic retention, surgery is indicated for patients 
with severe symptoms, or moderate symptoms and a life expectancy of greater than 
five years. Surgery is inappropriate for chronic and acute retention if symptoms are 
non-existent or mild, and life expectancy is less than 1 year, and for those without 
retention and with only mild symptoms. Although the panel felt that surgery was 
appropriate for men with mild symptoms, no comorbidity and no retention, at similar 
levels of symptom severity and comorbidity, the panel felt equivocal about men with 
acute retention. Further details of the consensus panel have been published and may 
be found in Appendix A 10. 
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Figure 5.1 Indications for prostatectomy 
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Table 5.1 Final ratings of Indications for transurethral resection of the prostate by the panel. 
Yes (%) 
Agreement 79 (67) 
Appropriate 53 (45) 
Equivocal 6 (5) 
Inappropriate 20 (17) 
Partial agreement 32 (27) 
Disagreement 7 (6) 
Total 118 (100) 
5.2 Results of the initial survey 
5.2.1 Characteristics of the sample 
Of the 2000 men that were sent a questionnaire, 21 had died and 74 were unknown 
at the address in the general practice records, so that the final study population was 
1905 (Table 5.2). The response rate following the first mailing was 64%, rising to 78% 
(1480 returned questionnaires) following a postal reminder. The age-structure of those 
responding was similar to that of all men living in North West Thames region, except 
for those in the 55 to 59 age group, who appeared to be under-represented in our 
sample (Table 5.3). Responders were more likely to be white than would be expected 
from the male population in this age group. 
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Table 5.2 Response rates to the Initial survey. 
Responded 
Not returned 
Returned without response 
Not known at address or moved 
Died 
Total 
Response rate among valid responders (1480/1905) Is 78% 
N 
1480 
405 
20 
74 
21 
2000 
(%) 
(74) 
(21) 
(1) 
(4) 
(1) 
(100) 
Table 5.3. Demographic characteristics of responders, urinary symptom prevalence survey, 
North West Thames region, 1992. 
Sample (%) Population (%) 
Age group 
55-59 Years 275 (19) 89,073 (24) 
60-64 Years 322 (22) 80,261 (22) 
65-69 Years 298 (21) 68,962 (19) 
70-74 Years 236 (16) 51,837 (14) 
75-79 Years 157 (11) 41,059 (11) 
80-84 Years 104 (7) 23,932 (6) 
85+ Years 51 (4) 13,437 (4) 
Total 1,443 (100) 368,561 (100) 
Ethnlclty 
(> 55 years) 
White 1,389 (97) 345,756 (92) 
Non-white 40 (3) 30,829 (8) 
Total 1,429 (100) 376,585 (100) 
(1) Missing data are not included In column totals. 
(2) Population estimates for NWTRHA are taken OPCS 1991 Census, County Monitors 
The comparison of sub-samples of responders and non-responders found no 
difference in mean age (70 vs. 71 years). Apparent non-responders included 8% that 
had either died, moved or the general practitioner had no evidence of having the 
medical record (Table 5.4). In addition, for 2% of responders and 11 % of non-
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responders, although there was evidence that a record existed, these records could 
not be located. Comparison ofthe medical records available revealed that responders 
were more likely to have undergone previous prostate surgery (7% vs. 1%; p<O.05), 
but there was no significant difference in the histories of their reported urinary 
symptoms. 
Table 5.4 Characteristics of responders and non-responders, urinary symptom prevalence 
survey, North West Thames region, 1992. 
Status 
On GP list 
Deceased/moved/ghost 
Notes not found 
Total 
Urinary symptoms 
No urinary symptoms 
Previous prostate surgery 
Urinary symptoms 
Urinary symptom, referral 
Other urology 
Total 
SE • Standard error of the difference 
• p < 0.05 
" P < 0.01 
Responders 
N (%) 
98 
o 
2 
(98) 
(0) 
(2) 
100 (100) 
79 (81) 
7 (7) 
5 (5) 
4 (4) 
3 (3) 
98 (100) 
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Non-responders 
N (%) 
81 (81) 
8 (8) 
11 (11) 
100 (100) 
72 (89) 
1 (1) 
4 (5) 
2 (2) 
2 (2) 
81 (100) 
SE 
4.17" 
2.71" 
3.43" 
5.33 
2.80' 
3.92 
2.50 
2.31 
5.2.2 Prevalence and severity of symptoms 
The distribution of each urinary symptom by level of severity is shown in Figure 5.2. 
While most men report that they never, or hardly ever, experience these symptoms, 
a substantial percentage of men experienced urinary symptoms more than 'hardly 
ever': some did not feel that their bladder emptied fully after urinating (21%); some 
often had to go again within 2 hours of urinating (37%); some stopped and started 
when they urinated (22%); some found it difficult to postpone urinating (22%); some 
had a weak stream (24%); and some had to push and strain to start urinating (10%). 
The distribution of the Symptom Index is also strongly skewed to the left (Figure 5.3); 
few men experience high composite symptom scores. On categorising the data, 
20.8% report no symptoms, 10.4% very mild symptoms and 48.5% mild symptoms 
(Table 5.5). The overall proportion of men with moderate/severe symptoms was 
20.4%. This increased from 16.2% in those aged 50 to 59 to a plateau of between 
20% and 25% in those aged between 65 and 79 years. It then fell to 11.9% in those 
over the age of 85. 
Table 5.5. Frequency distributIon of symptom severity by age group, men aged 55 and over, 
North West Thames region, 1992. 
Symptom severity 
Age group None Very mild MilcModerate Severe Moderate & Severe 95% 
(years) % % ';' '/0 % combined Cis 
55-59 (n=272) 21.0 11.8 51.1 12.8 3.3 16.2 12.1 to 20.8 
60-64 (n=310) 23.2 11.0 46.6 15.8 3.6 19.4 15.2 to 23.9 
65-69 (n=287) 22.0 10.5 46.7 17.1 3.8 20.9 16.4 to 25.8 
70-74 (n=228) 18.9 9.7 45.8 16.7 9.2 25.9 20.4 to 31.7 
75-79 (n=148) 20.3 7.4 52.0 14.9 5.4 20.3 14.3 to 27.1 
80-84 (n=94) 12.8 10.6 51.1 19.2 6.4 25.5 17.3 to 34.6 
85+ (n=42) 23.8 9.5 54.7 11.9 0 11.9 4.5 to 23.5 
Total (n=1381) 20.8 10.4 48.5 15.6 4.8 20.4 18.3 to 22.5 
N=1480. 99 missing; percentages have been rounded. 
Cls= Confidence Intervals 
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Figure 5.2. Distribution of urinary symptoms, men aged 55 and over, 
North West Thames, 1992 . 
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Figure 5.3. Distribution of Symptom Index, (95% confidence intervals), 
men aged 55 and over, North West Thames region, 1992. 
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5.2.3 Impact of symptoms 
The extent to which men were bothered by their symptoms increased significantly with 
increasing symptom severity (Table 5.6). Ofthose with mild symptoms, only 0.5% felt 
they were a medium or big problem; this increased to 15.9% of those with moderate 
symptoms and 66.2% of those with severe symptoms. Of those with mild symptoms, 
2.8% reported interference in their daily activities most or all of the time (Table 5.7). 
This increased to 17.9% for those with severe symptoms. When asked about 
spending the rest of their life with their current symptoms, 43.1 % of men with 
moderate or severe symptoms reported they would feel unhappy or terrible (Table 
5.8). This proportion varied by symptom severity from 3.5% of those with very mild 
symptoms to 76.4% with moderate symptoms. 
Table 5.S. Frequency distribution of bothersome ness by symptom severity, men aged 55 and 
over, North West Thames region, 1992. 
Symptom .ev.rlty 
Both.raom.n ... Non. Very mild Mild Moderat. S.v.ra 
% "I. "I. % % 
No problem 99.0 97.3 73.7 20.5 5.9 
Very .mall problem 1.0 2.7 20.8 3-4.9 ••• Small problem 0 0 •. 9 28.8 23.5 
Medium problem 0 0 0.6 1 •. 0 ".1 
Big problem 0 0 0 1.9 22.1 
Total n-293 n-148 "-690 "-215 n-68 
N=1480, 68 missing; percentages have been rounded. 
Cls= Confidence intervals 
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Mod.rlt. & Itv.r. 
combined 
17.0 
27.6 
27.6 
21.2 
8.7 
n-283 
TOliI 85% 
CI. 
70.0 12.91021.6 
16.2 22.15 10 32.9 
7.9 22.15 10 32.9 
•. 5 16.71028.1 
1.. •. 21010.0 
n-1412 
Table 5.7. Frequency distribution of Interference In daily activities by symptom severity, men 
over the age of 55, North West Thames region, 1992. 
Symptom IIverlty 
Interference In None V.ry mild Mild Mod.rate 
dilly 'ctlvltl .. % % % % 
Never 99.0 100 92.8 71.8 
Some of the time 1.1 0 8.9 25.6 
Most of the time 0 0 0." 2.8 
All of the time 0 0 0 0 
Total n-287 n-145 n-685 n-215 
N=1480, 81 missing; percentages have been rounded. 
Cls= Confidence intervals 
S.vtraMod.ratt & Stvert 85% 
% combln.d Total CII 
(%) 
35.8 63.1 88.1 57.2 to 68.4 
"8.3 30.5 10.4 25.2 to 35.9 
13.4 5.3 1.3 3.1 to 8." 
".5 1.1 0.2 0.3 to 2.8 
"-67 n-282 "-1399 
Table 5.S. Frequency distribution of perception of future by symptom severity, men over the 
age of 55, North West Thames region, 1992. 
Symptom .. verity 
Perc.ptlon of None v.ry mild Mild Moderatt S.vert Mod.rat. & S.v.rt Total 15% 
future % % % % % comblntd CII 
Delighted 75.3 59.9 27.1 1.4 0 1.1 35.0 0.3 to 2.8 
Pleased 20.9 33.1 "5.9 22.8 ..... 18." 33.8 14.11023.1 
Not bothered 3.9 7.0 22.9 "3.3 19.1 37.5 20.4 31.9 to 43.0 
Unhappy 0 0 ".1 30.2 63.2 38.2 9.9 32.5 to 43.8 
Terrible 0 0 0 2.3 13.2 ".9 1.0 2.8 to 7.9 
Total n-283 n-' .. 2 n-677 n-215 "-68 "-283 n-1385 
N=1480, 95 missing; percentages have been rounded. 
Cls= Confidence intervals 
5.2.4 Previous prostate surgery and other urological symptoms 
The prevalence of urinary symptoms is dependent on previous prostatectomy rates 
and the effectiveness of this surgery. One hundred and sixty four (12%) of men 
reported having undergone previous prostate surgery. To allow for the different 
numbers of men at risk of having first-time surgery, the probability of having first-time 
surgery when in each age group was calculated by dividing the number of men who 
had surgery when in each age group by the number of men that had reached that age 
group (Table 5.9). The probability of having surgery (derived by subtracting the 
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number of years reported since surgery from their current age) when under 50 years 
of age was only 0.1 % and increased to 8% in the age group 75 to 79. This is 
equivalent to a doubling in the probability of having surgery every five years. Because 
there are fewer men in older age groups, this gives a different picture from that seen 
in urological practice. Almost half (45.7%) the men who had undergone surgery were 
aged between 60 and 69. 
Table 5.9. Experience of prostate surgery, men over the age of 55, North West Thames 
region, 1992. 
Age Sample population Number of men % probability Current age of Current 01. 
group having reached or having surgery of having men with previous of having had 
(years) exceeded age group within age category surgery surgery previous surgery 
N (%) N (%) by age 
< 50 1443 2 (1.3) 0.1 
50-54 1443 8 (5.2) 0.6 
55-59 1443 17 (11.1) 1.2 7 (4.3) 0.5 
60-64 1168 34 (22.2) 2.9 17 (10.4) 1.5 
65-69 846 36 (23.5) 4.3 31 (18.9) 3.7 
70-74 548 21 (13.7) 3.8 32 (19.5) 5.8 
75-79 312 25 (16.3) 8.0 34 (20.7) 10.9 
80-84 155 8 (5.2) 5.2 26 (15.9) 16.8 
85+ 51 2 (1.3) 3.9 17 (10.4) 33.3 
Total 153 (100) 164 (100) 
N=169 with previous surgery; missing age at previous surgery=16, missing current age=5 
Of the 156 (6%) of men who reported a previous episode of acute retention, only 
38.5% had undergone surgery (Table 5.10). 8% percent of men reported a previous 
urinary tract infection. When asked about urinary incontinence, 7.5% leaked enough 
urine to be embarrassed, and 0.8% needed to wear pads. 
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Table 5.10. Distribution of previous surgery by acute retention, men aged 55 and over, North 
West Thames region, 1992. 
Previous surgery 
Yes No Total 
Yes 60 (38.5) 96 (61.5) 156 (100) 
Acute retention 
No 24 (1.9) 1239 (98.1) 1263 (100) 
Total 84 (5.9) 1335 (94.1) 1419 
5.2.5 Summary 
The current pattern of urinary symptoms among men aged 55 and over and the 
urological response to them is best illustrated by combining the data on the 
prevalence of men with a history of prostate surgery (Table 5.9) and the prevalence 
of urinary symptoms (Table 5.5). Figure 5.4 shows the proportions of men in each age 
group in each of the following states: (a) no or mild symptoms and no previous 
surgery; (b) moderate/severe symptoms but no previous surgery; (c) previous surgery 
with no current moderate/severe symptoms; and (d) previous surgery and current 
symptoms. The percentage of men having either moderate or severe symptoms or a 
history of previous prostate surgery, or both increased from 17% at age 57 to 38% at 
age 81. The percentage of men with moderate/severe symptoms who have not had 
prostate surgery increases until the age of 73 and then appears to decrease. Of men 
who have had prostatectomy, the percentage with recurrence or persistence of 
moderate or severe symptoms appears to remain relatively constant across the age 
range, at about 30%. 
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Age-specific probabilities of moderate/severe symptoms and previous prostate surgery, 
North West Thames region, 1992. 
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5.3 Results of the follow-up survey 
5.3.1 Characteristics of the sample 
Of the 516 men who were sent a questionnaire (34.9% ofthe original sample), 8 had 
died and 3 had moved, so that the final study population was 505 (Table 5.11). 72 
questionnaires were not returned and a further 13 questionnaires were returned 
without response, so that the response rate was 83.2% (420/505). A comparison of 
non-responders and responders showed little difference in mean age (69.5 vs. 67.1 
years). Responders were significantly more likely to have moderate or severe 
symptoms (Table 5.12). Responders were also more likely to have had previous 
prostate surgery, and to have experienced an episode of acute retention, although 
these differences were not significant. In total, 420 men with a symptom score or 7 
or more, or a history of acute retention were included in the analysis. 
Table 5.11 Response rates to the follow-up survey, North West Thames region, 1992. 
Responded 
Not returned 
Returned without response 
Not known at address or moved 
Died 
Total 
Response rate among valid responders 420/505 = 83.2% 
N 
420' 
72 
13 
3 
8 
516 
% 
(81) 
(14) 
(3) 
(1) 
(2) 
(100) 
Response rate for: Nottingham Health Profile 2211258 = 85.7%, SF-36 217/258 = 84.1% 
-86-
Table 5.12. Characteristics of responders and non-responders to the follow-up survey, North 
West Thames region, 1992. 
Responders Non-responders SE 
N % N % 
Symptom severity 
Mild 181 43.1 76 89.4 4.12" 
Moderate 185 44.0 5 8.2 3.84" 
Severe 54 12.9 2 2.4 2.3 
Total 420 85 
Previous prostate surgery 
Yes 77 18.4 9 10.6 3.84-
No 342 81.6 74 89.4 
Total 419 85 
Missing=1 
Acute retention 
Yes 53 13.0 6 7.2 3.44" 
No 355 87.0 77 92.8 
Total 408 74 
Missing=12 
~E= Standard error of the difference 
p < 0.01 
To test the extent to which men's urinary problems may have changed between the 
initial survey (from which their Symptom Index scores were derived) and the follow-up 
survey (from which patient preference was determined), questions on bothersome ness 
and frequency of urination were included in both. The results of a Wilcoxon matched-
pairs signed rank test confirmed that there had been no significant change in the 
extent of bothersomeness of symptoms (Z=-0.12, p=0.90S). However, there was a 
slight, but statistically significant, decrease in the severity of frequency of urination 
between the two surveys (z=-3.02, p=.002S). The median score of 2 remained the 
same, while the mean score decreased from 2.2 to 2.1. 
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5.3.2 Impact of urinary symptoms on daily activities 
The distribution of the impact of severe symptoms on daily activities is shown in 
Figure 5.5. While, the majority of men did not find that their symptoms interfered with 
their activities, substantial percentages of men were affected in some aspects more 
often than 'hardly ever': some worried about needing a toilet (18%), some worried 
about wetting themselves in public (23%), some avoided using public toilets due to 
difficulty starting to urinate (38%), some were embarrassed about having to use the 
toilet often (36%) and some limited the amount they drank (57%). In contrast, men 
with mild symptoms reported little interference with their activities - the proportion 
ranged from 3% who worried about wetting themselves in public to 16% who limited 
the amount they drank. Overall, 90% of men reported interference with at least one 
of these activities. 
5.3.3 Association with health status 
NHP scores by symptom severity are presented in Table 5.13. The median NHP 
scores increased (ie. health worsened) as symptom severity increased for energy, 
emotional reactions and physical mobility. The Spearman's correlation coefficients for 
these dimensions were statistically significant (p<0.01). Although the median score 
for sleep remained constant at 13 across the symptom severity categories, the 
Spearman correlation coefficient was significant (p=0.005). The median values were 
o (perfect health) for all other dimensions. The most striking finding was that the 
changes in median values, affecting energy, emotional reactions and physical mobility, 
occurred between moderate and severity categories. This was inconsistent with the 
view of the panel that moderate and severe symptoms should be treated in the same 
way. 
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Table 5.13. Median Nottingham Health Profile scores by symptom severity, among men aged 55 and over in a population sample, interquartile range, North 
West Thames region, 1992. 
Mild Moderate Severe Spearmans 
N Medlan range N Median range N median range corntlallon p 
coemclent 
Energy 76 0 (0-24) 88 0 (0-24) 29 24 (0-63) 0.19 0007 
Pain 71 0 [0-0) 83 0 (0- 0) 30 0 (0-13) 0.12 0.101 
Emotional reactions 70 0 [0 -7] 85 0 [0 -10) 30 10 [0- 24) 0.22 0.002 
Sleep 75 13 [0- 16) 83 13 [0 - 34) 31 13 [0 - 38) 0.20 0.005 
Social Isolallon 73 0 [0 - 0) 88 0 (0-0) 31 0 [0-0) 0.06 0.374 
Physical mobility 70 0 [0- 0) 89 0 [0-9) 30 11 (0- 22) 0.22 0.002 
I 
CO 
<0 
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Table 5.14. Median SF-36 scores, interquartile range, by symptom severity, men aged 55 and over (n=205), North West Thames region, 1992. 
Mild Moderate Severe 
Spearmans corntlatlon p 
N Mecllan range N Medlan range N Median range Coefficient 
Physical Functioning 87 85 6Q.95 81 85 5!>-95 18 75 44-95 -.990 0.073 
Physical Role 85 100 50-100 75 75 2!>-1oo 18 88 0-100 -.193 0.009 
Bodily Pain 93 84 62-100 85 84 41-100 20 62 50-100 -.123 0.080 
General Health Perceptions 89 72 59-75 81 62 79-n 18 62 47-82 -.206 0.004 
Vitality 90 60 50-76 85 60 4!>-75 20 58 50-69 -.209 0.003 
Social Functioning 94 100 7!>-100 85 100 63-100 19 75 0-100 -.212 0.002 
Emotional Role 87 100 33-100 76 100 33-100 19 100 0-100 -.107 0.147 
Mental Health 93 84 72-92 85 76 60-88 20 74 54-91 -.269 0.0001 
Figure 5.5 Interference with activities, men aged 55 and over with severe urinary 
symptoms, North West Thames, 1992. 
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Median SF-36 scores by symptom severity are presented in Table 5.14. For most 
dimensions health status decreased as symptom severity increased from mild to 
severe. The exceptions were emotional role and vitality where there was little 
difference between men with moderate and with severe symptoms. The dimensions 
for which there was a statistically Significant (p<O.01) decrease in scores with 
increasing symptom severity were physical role, social functioning, mental health, and 
general health perceptions. As with the NHP, the greatest changes in the medians 
occurred between moderate and severe, with relatively little difference in median 
values between mild and moderate symptoms. 
5.3.4 Association with bothersomeness 
Median NHP scores by bothersomeness are presented in Table 5.15. Median scores 
for emotional reactions increased as the reported 'bothersome ness' of symptoms 
increased (p=O.004). Statistically Significant relationships were also observed for sleep 
(p=O.019) and pain (p=O.045). Median SF-36 scores by bothersome ness are 
presented in Table 5.16. The association between health status and bothersomeness 
was more marked than for symptom score, with highly significant associations and 
higher correlation coefficients for each dimension. 
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Table 5.15. Median NHP scores, interquartile range, by'bothersomeness', men aged 55 and over, North West Thames region, 1992. 
No Of' 'very small' problem Small problem Medium Of' big problem Spearmans 
correlation p 
N Median range N Median range N Median range coemclent 
Energy 138 0 [0-24) 40 0 [0-0) 30 24 [0-63) 0.06 0.390 
Pain 127 0 [0-0) 40 0 [0-0) 29 0 [0-15) 0.14 0045 
Emotional reactions 129 0 [0-0) 40 0 [0-10) 29 10 [0-41) 0.20 0.004 
Sleep 133 13 [0-29) 40 13 [0-44) 29 13 [0-34] 0.17 0.019 
Social Isolation 135 0 [0-0) 39 0 [0-0) 30 0 [0-22) 0.08 0.251 
Physical mobility 132 0 [0-10) 41 0 [0-11) 30 0 [0-22) 0.10 0.173 
Table 5.16. Median SF-36 scores, interquartile range, by 'bothersome ness', men aged 55 and over (n=217), North West Thames regIon, 1992. 
I 
<0 
I\) No Of' 'very smlll' problem Small problem Medium or big problem Spearmans 
I 
correlation P 
N Median range N Median range N Median range coemclent 
Physical Functioning 131 85 [55-95) 44 75 [60-901 25 85 [45-95) -O.IS 0.0103 
Physical Role 129 100 [67-1001 39 50 [33-100) 26 100 [0-100) -0.25 0.0004 
Bodily Pain 144 84 [62-100) 44 62 [41-92) 28 62 [41-100) -0.22 0.0009 
General Health Perceptions 137 72 [57-82) 41 60 [47-77) 25 57 [47-721 -0.24 0.0004 
Vitality 141 65 [50-80) 42 53 [45-70) 28 53 [48-60) -0.24 0.0004 
Social Functioning 145 100 [75-100) 44 75 [50-100) 27 88 [50-100) -0.32 0.0001 
Emotional Rot. 133 100 [50-100) 39 67 [1>-100) 26 67 [1>-100) -0.24 0.0006 
Mental Health 144 84 [72-92) 42 71 [52-84) 28 68 [52-86) -0.30 0.0001 
5.3.5 Comparison with men undergoing prostatectomy and in the general population 
A comparison of median NHP scores in men with urinary symptoms with men 
undergoing prostatectomy is shown in Table 5.17. There was no significant difference 
in symptom score between men undergoing surgery (median=10) and men in the 
population with moderate or severe urinary symptoms (median=O, Mann-Whitney=-
0.55, p=0.58). A relatively high proportion of NHP scores were 0 for men in the 
population with symptoms and the surgical cohort (Table 5.17). In all dimensions other 
than energy, the percentage of men with scores greater than zero was greater for 
those men undergoing surgery (5.18). The differences reached statistical significance 
for 3 dimensions: emotional reactions (p=0.004), pain (p=0.004), and energy 
(p=0.032). 
A comparison of mean SF-36 scores in men with urinary symptoms with published 
population norms is shown in Table 5.19. Men with moderate and severe symptoms 
reported worse health than the general population. These differences were statistically 
significant for all dimensions except physical functioning. The smaller group whose 
symptoms were bothersome to the extent of being a medium or big problem had a 
greater relative general health status for all dimensions. Comparison with published 
age-adjusted SF-36 mean scores with other conditions in the general population 
revealed that, in general, men with moderate and severe symptoms reported worse 
scores than people with varicose veins, but better scores than those with low back 
pain, menorrhagia, and suspected peptic ulcer (Figure 5.6). 
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Table 5.17. 
Energy 
Pain 
Median and InterquartiJe ranges for the Nottingham Health Profile In men with 
moderate or severe symptoms In a cohort of men before prostatectomy In Oxford 
and North West Thames, 1988, and a population sample from North West Thames, 
1992. 
Surgical cohort Population sample 
NMedlan Range N Median Range 
220 0 [0-24] 238 0 [0-24] 
218 0 [0-13] 234 0 [0-131 
Emotional reactions 219 10 [0-301 236 8 [0-27] 
Sleep 221 13 [1~] 240 13 [13-36] 
Social Isolation 220 0 [0-16] 234 0 [0-05] 
Physical mobility 218 0 [0-22] 235 0 [0-22] 
Source: Doll HA et al. Patient perceived health status before and up to 12 months after TURP for benign 
prostatic hypertrophy. Soc Sci Med 1993; 37:115-22. 
-94-
I 
«) 
01 
I 
Table 5.18. Proportion of cases with scores greater than zero among men with moderate or severe lower urinary tract symptoms either undergoing 
prostate surgery or In the population. 
Energy Pain Emotional Sleep Social Physical 
reactions isolation mobility 
(% > 0) 95% CI (%> 0) 95% CI (°/. > 0) 95% CI (% > 0) 95% CI (%> 0) 95% CI (% > 0) 95% CI 
Men undergoing 32.0 [25.9 - 8.2] 41.5 [34.9 - 47.9] 57.8 [50.9 - 63.9] 76.9 [70.7 - 81.8] 25.6 [20.0 - 31.5] 42.9 [36.2 - 49.3] 
surgery with 
Men in the 40.2 [31.3 - 48.8] 21.2 [14.3 - 29.2] 34.8 [26.3 - 43.4] 57.1 [66.7 - 74.3] 16.9 [10.9 - 24.3] 32.8 [24.6 - 41.2] 
population 
Wilcox p value 0.032 0.004 0.0004 0.07 0.322 0.153 
Table 5.19. Comparison of SF-36 scores in men aged 55-65 with moderate & severe urinary symptoms, North West Thames region, with healthy men aged 
55-64 in Oxford Regional Health Authority area, 1991-92. 
Physical Functioning 
Physical Role 
Emotional Role 
Social Functioning 
Bodily Pain 
Mental Health 
Vitality 
General Health Perceptions 
Source of population nonns: 
Moderate & severe symptoms Healthy population norms 
N Mean [95% Cis] N Mean [95% CIs] Difference p 
39 81.5 [75.3 - 87.7] 619 BO.9 [79.2 - 82.6] 0.6 0.5596 
37 65.5 [51.2 - 79.8] 619 80.2 [77.5 - 82.9] -14.7 0.0071 
37 70.3 [57.0 - 83.6] 619 86.6 [84.3 - 88.9] -16.3 0.0006 
38 81.4 [72.9 - 89.9] 619 87.5 [85.8 - 89.2] -6.1 0.0495 
39 72.8 [65.7 - BO.4] 619 79.0 [77.6 - 80.4] -6.2 0.0158 
39 68.5 [60.8 - 76.2] 619 78.0 [76.4 - 79.6] -9.5 0.0026 
39 57.6 [51.6 - 63.6] 619 63.2 [61.3 - 65.1] -5.6 0.0735 
38 61.0 [53.0 - 69.0] 619 68.5 [66.8 - 70.2] -7.5 0.0179 
Jenkinson C, Wright L. Coulter A Quality of life measurement in health care: A review of measures, and population norms for the UK SF-36. Health 
Services Research Unit, Department of Public Health and Primary Care, University of Oxford, 1993. 
cO 
0> 
I 
Figure 5.6. 
1.5 
1.4 
E g 1.3 
c 
,g12 CIS • 
'5 
0.. &. 1.1 
g 
~ 1 
o g 
c 0.9' 
CIS 
Q) 
.: 0.8 
o 
o 
'§ 0.7 
a: 
0.6 
Ratio of mean SF-36 scores, for three categories of symptom severity, to population 
mean, men aged 55-64, for North West Thames region, 1992. 
-- Mild 
-t- Moderate 
...... Severe 
Population 
n~LI------~----________________________________________________________ ___ 
*~ * ~ ~ .~ *-5 ~ -5 e 'c [ m ~ m 
iii .Q >- .r: $ .r: 
c '0 == - Gi o c: "'0 S .... ~ ~ ~; ~ 
C - :::i: Q) w .~ ~ 
~ g 
e 
(ij 
0 
'in 
>-
E .r: a. 
L 
>- w 
.r: 
a. 
* p < 0.05 SF-36 dimension 
5.3.6 Advice-seeking behaviour 
The pattern of the advice-seeking behaviour of men with symptoms is shown in Table 
5.20. About half the men (51.7%) had not sought any advice for their symptoms; this 
behaviour was more common among those with mild (56.9%) or moderate (51.9%) 
symptoms than among those with severe symptoms (33.3%). Of those seeking 
advice, the principal source was their GP (89% of those with moderate symptoms, 
97% ofthose with severe symptoms). The percentage of men who sought advice from 
their GP about their symptoms increased from 40.3% of those with mild symptoms to 
64.8% with severe symptoms. 
Table 5.20. Source of advice used by men with symptoms, by symptom severity, men aged 55 
and over, North West Thames region, 1992. 
Symptom severity 
Mild Moderate Severe Total 95% CIs 
% % % % 
No advice 56.9 51.9 33.3 51.7 56.8 to 56.3 
Relatives 2.0 1.1 1.9 1.7 0.7 to 3.2 
Friends 1.0 3.2 0 1.7 0.7 to 3.2 
Nurse 0 1.1 0 0.5 0.1 to 1.5 
GP 40.3 42.7 64.8 44.6 39.7 to 49.2 
Total n=181 n=185 n=54 n=420 
Cls= Confidence intervals 
5.3.7 Action of GPs and Urologists 
Of the 187 men who had consulted their GP, 21.1% were reassured, 16.6% were 
prescribed medication, and 62.3% were referred to a surgeon (Table 5.21). The 
decision to refer for consultant opinion was independent of symptom severity [mild 
(62.3%), moderate (63.5%) and severe (60.0%)]. Of the 109 men who were referred, 
9 were still waiting to see their surgeon. The majority (71.4%) had been offered and 
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accepted surgery (Table 5.22). Of the remainder, 15 had been reassured, 4 had 
been prescribed medication and 7 had been offered and declined surgery. Again, the 
decision to offer treatment was independent of symptom severity although the 
numbers in each group were small. 
·98· 
Table 5.21. Action taken by GP, by symptom severity, for men aged 55 and over who 
consulted their GP [n=187], North West Thames region, 1992. 
Mild 
% 
Reassured 17.4 
Prescribed 20.2 
Referral 62.3 
Total n=69 
Cls= Confidence intervals 
Missing=12 
Symptom severity 
Moderate Severe Total 95% Cis 
% % % 
25.4 20.0 21.1 15.5 to 27.5 
11.3 20.8 16.6 11.6 to 22.5 
63.4 60.0 62.3 54.6 to 68.9 
n=71 n=35 n=175 
Table 5.22. Action taken by urologist or surgeon, by symptom severity, for men aged 55 and 
over who had consulted a urologist [n=100], North West Thames, 1992. 
Symptom severity 
Mild Moderate Severe Total 95% Cis 
% % % % 
Reassured 10.3 20.0 23.5 16.5 9.8 to 24.8 
Prescribed 0 11.4 0 4.4 1.4 to 10.0 
Declined surgery 10.3 5.7 5.9 7.7 3.4 to 14.3 
Accepted surgery 79.5 62.9 70.6 71.4 60.9 to 79.2 
Total n=39 n=35 n=17 n=91 
Cls= Confidence intervals 
Missing=9; Still waiting to see urologist=9 
The health care sought by men with urinary symptoms and the response of GPs and 
urologists have been summarised in a decision tree (Figure 5.7) that provides a model 
of the effect of each of the factors described earlier in a population of 1000 men aged 
55 and over. 
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Figure 5.7. Decision tree for men with mild, moderate and severe urinary symptoms, 
North West Thames region, 1992. 
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5.3.8 Patient preference for treatment 
Table 5.23 shows the distribution of patient preference for treatment by symptom 
severity. At their current level of symptoms, 30.6% of men would definitely or probably 
choose to have a prostatectomy, while 22.1 %. would probably or definitely not want 
treatment. Nearly half of men (47.3%) were unsure what they would choose, although 
more men were inclined to have the operation than not (32.0% vs. 15.3%). Overall, 
men were more likely to choose surgery (62.6% vs. 37.4%). The proportion of men 
choosing surgery was not significantly related to symptom severity, a history of 
previous prostate surgery or of an episode of acute retention (Table 5.24). 
Table 5.23. Patient preference for treatment, by symptom severity, for men aged 55 and over 
who had not seen a urologist [n=315], North West Thames, 1992. 
Symptom severity 
Mild Moderate Severe Total 95% CIs 
% % % % 
Definitely want 13.9 17.2 25.8 16.7 12.7 to 21.3 
Probably want 14.8 14.1 19.7 13.9 10.2 to 18.2 
Not sure, inclined to yes 32.0 32.8 29.0 32.1 26.7 to 37.5 
Not sure, inclined to no 13.9 16.4 16.1 15.3 11.4 to 19.8 
Probably don't want 8.2 6.3 12.9 7.8 5.1 to 11.4 
Definitely don't want 17.2 13.3 6.5 14.2 10.5 to 18.6 
Total n=122 n=128 n=31 n=281 
Missing=34; Table excludes those not seen by their urologist 
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Table 5.24. Distribution of choice, by symptom severity, previous surgery, acute retention, 
men aged 55 and over who had not seen a urologist [n=315], North West Thames 
region, 1992. 
Choosing 
Prostatectomy 95% Cis 
N % [Low. High] 
Symptom severity 
Mild 74 (60.7) [51.4.68.5] 
Moderate 82 (64.1) [55.1 ·71.5] 
Severe 20 (64.5) [45.4 • 77.6] 
Total 176 (62.6) [56.7 • 67.9] 
Missing=34, Mantel·Haenszel X2=0.15, p=0.70 
Previous surgery 
Yes 10 (71.4) [42.0 • 86.0] 
No 166 (62.4) [56.3 • 67.B] 
Total 176 (62.9) [56.9 • 68.1] 
Missing=35, X2=0.46, p=O.50 
Acute retention 
Yes 15 (68.2) [45.1 • 82.0] 
No 155 (61.3) [54.9 • 66.9] 
Total 170 (61.8) [55.8 - 67.2] 
Missing=41, X2=0.41, p=O.52 
A separate analysis was undertaken of only those men who expressed a firm view 
about surgery (i.e that they definitely or probably would or would not choose it). In this 
group, men who had consulted their GP were more likely to have indicated that they 
definitely or probably would choose surgery (63, 71.6%) than those who did not 
consult their GP (64, 57.1 %). Although this difference was small, it was statistically 
significant (chi-squared = 4.4, p=O.035). 
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5.4 Estimating need 
The age-specific prevalence rates for those with appropriate indications who would 
choose surgery increased from 58.8 per 1000 in the 55-59 age group to 201.8 per 
1000 in the 70-74 age group, before declining to 190.5 per 1000 in the over 85 year 
olds (Table 5.25). When these rates were applied to men over the age of 55 in a 
typical district of 250,000, the prevalent need for prostatectomy was 4295. This figure 
dropped to 2664 if men with mild symptoms were excluded from the calculation of the 
rates (Table 5.26) and to 741 if only those men with severe symptoms were 
considered (Table 5.27). The effects of the sensitivity analyses are shown in Table 
5.28. The central estimate of prevalent need [based on men with moderate or severe 
symptoms who probably or definitely would want surgery and had indications which 
the panel viewed unequivocally as appropriate, was 1405. Although this estimate was 
consistent with the panel's ratings, inspection of the relationship between symptom 
level and health status (Section 5.3.3) suggests that it may be more suitable to 
consider men with severe symptoms separately. Accordingly, the estimate was 
reduced to 225 by considering only those men with severe symptoms who would 
definitely want surgery. This figure was 4329 if men with mild symptoms, men who 
were only inclined to want surgery, and indications about which the panel members 
were equivocal, were included. 
Modelling incident need involved the matching of modelled age-specific incremental 
incidence rates to the observed prevalence rates found in the survey, using a process 
of fitting curves to the observed data. The results suggest that in a population 
containing 35,000 men aged between 50 and 90 (a typical figure for a catchment 
population of 250,000) there would be 400 to 500 new cases of men with moderate 
or severe lower urinary tract symptoms, who would probably or definitely choose 
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surgery. The model is described in detail in Appendix AS. 
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Table 5.25. 
Age 
group 
55-59 
60-64 
65-69 
70-74 
75-79 
~ 80-84 
<f 85+ 
Total 
Age-specific prevalence rates per 1000, mild, moderate & severe symptoms, appropriate indications, and chosen, 95% confidence intervals, and prevalent 
need in a district with a population of 250,000, men aged 55 and over, North West Thames region,1992. 
Sample 
N 
272 
310 
287 
228 
148 
94 
42 
1381 
Current symptoms 
N Rate [95% Cis] 
66 242.6 [193.8 - 295.0] 
84 271.0 [223.0 - 321.3] 
90 313.6 [261.0 - 367.6] 
73 320.2 [261.0 - 381.0] 
59 398.6 [320.1 - 475.7] 
32 340.4 [247.8 - 435.3] 
12 285.7 [162.3 - 423.2] 
416 301.2 [277.3 - 325.6] 
Appropriate 
N Rate [95% Cis] 
59 216.9 [170.4 - 267.7] 
79 254.8 [208.0 - 304.5] 
75 261.3 [212.3 - 313.2] 
65 285.1 [228.4 - 344.6] 
47 317.6 [244.9 - 392.9] 
25 266.0 [182.5 - 357.5] 
8 190.5 [91.4 - 319.6] 
358 259.2 [236.5 - 282.6] 
Appropriate & Chosen Population Need 
N Rate [95% Cis] men> 55 N 
16 58.8 [35.1 - 91.2] 6,254 368 
56 180.6 [140.4 - 225.6] 5,636 1018 
53 184.7 [142.5 - 231.7] 4,842 894 
46 201.8 [152.9 - 256.2] 3,640 735 
39 263.5 [196.2 - 336.2] 2,883 760 
19 202.1 [129.0 - 288.4] 1,680 340 
8 190.5 [91.4 - 319.6] 943 180 
237 171.6 [152.3 - 192.0] 4295 
I 
~ 
0 
Table 5.2S. 
Age 
group 
55-59 
60-64 
65-69 
70-74 
75-79 
80-84 
85+ 
cP Total 
Age-specific prevalence rates per 1000, moderate & severe symptoms, appropriate indications, and chosen, 95% confidence intervals, and prevalent need 
in a typical district with a population of 250,000, men aged 55 and over, North West Thames region, 1992. 
Sample 
N 
272 
310 
287 
228 
148 
94 
42 
1381 
Current symptoms 
N Rate [95% Cis] 
35 128.7 [92.4 - 171.7] 
49 158.1 [120.2 - 201.1] 
56 195.1 [151.9 - 243.0] 
48 210.5 [160.7 - 265.7] 
26 175.7 [120.0 - 241.2] 
19 202.1 [129.0 - 288.4] 
4 95.2 [31.0 - 205.5] 
237 171.6 [152.3 - 192.0] 
Appropriate 
N Rate [95% Cis] 
33 121.3 [86.1 - 163.4] 
49 158.1 [120.2 - 201.2] 
52 181.2 [139.4 - 228.0] 
45 197.4 [149.0 - 251.5] 
22 148.6 [97.5 - 211.0] 
18 191.5 [120.4 - 276.6) 
3 71.4 [18.6 - 174.2) 
222 160.8 [142.0 - 180.7] 
Appropriate & Chosen Population Need 
N Rate [95% Cis] men> 55 N 
9 33.1 [16.2 - 59.3] 6,254 207 
36 116.1 [83.7 - 154.8] 5,636 654 
37 128.9 [93.5 - 170.7] 4,842 624 
32 140.4 [99.3 - 189.0] 3,640 511 
18 121.6 [75.6 - 180.2) 2,883 351 
14 148.9 [86.7 - 228.5] 1,680 250 
3 71.4 [18.6 - 174.2] 943 67 
149 107.9 [92.3 - 125.0) 2664 
, 
Table 5.27. 
Age 
group 
55-59 
60-64 
65-69 
70-74 
75-79 
80-84 
85+ 
C; Total 
...... , 
Age-specific prevalence rates per 1000, severe symptoms, appropriate indications, and chosen, 95% confidence intervals, and prevalent need in a typical 
district with a population of 250,000, men aged 55 and over, North West Thames region, 1992. 
Sample 
N 
272 
310 
287 
228 
148 
94 
42 
1381 
Current symptoms 
N Rate [95% Cis) 
8 29.4 [13.7 - 54.6] 
8 25.8 [12.0 - 48.0] 
9 31.4 [15.4 - 56.3] 
16 70.2 [42.0 - 108.3] 
7 47.3 [20.9 - 90.0) 
5 53.2 [19.7 - 111.5] 
0 0 
53 38.4 [29.1 - 49.5] 
Appropriate 
N Rate [95% Cis) 
8 29.4 [13.7 - 54.6] 
8 25.8 [12.0 - 48.0] 
9 31.4 [15.4 - 56.3] 
16 70.2 [42.0 - 108.3] 
7 47.3 [20.9 - 90.0) 
5 53.2 [19.7 - 111.5] 
0 0 
53 38.4 [29.1 - 49.5] 
Appropriate & Chosen Population Need 
N Rate [95% Cis) men> 55 N 
6 22.1 [9.0 - 44.8] 6,254 138 
6 19.4 [7.9 - 39.4] 5,636 109 
6 20.9 [8.5 - 42.5] 4,842 101 
13 57.0 [32.0 - 92.4) 3,640 207 
5 33.8 [12.5 - 92.1) 2,883 97 
5 53.2 [19.7 - 111.5] 1,680 89 
0 0 943 0 
41 29.7 [21.7 - 39.6] 741 
Table 5.28. Sensitivity analyses for the prevalent need for prostatectomy, In a typical district 
of 250,000, North West Thames, 1992. 
Symptom' level of' Patienf 
severity agreement preference 
Mild, moderate, severe 
(symptom score 7 - 30) 
Agreement 
definitely want 
definitely or probably want 
definitely or probably want, or inclined to yes 
Agreement + Equivocal 
definitely want 
definitely or probably want 
definitely or probably want, or inclined to yes 
Based on action of those offered surgerl 
Moderate, severe 
(symptom score 10 - 30) 
Agreement 
definitely want 
definitely or probably want 
definitely or probably want, or inclined to yes 
Based on action of those offered surgery 
Severe 
(symptom score 19 - 30) 
Agreement 
definitely want 
definitely or probably want 
definitely or probably want, or inclined to yes 
Based on action of those offered surgery 
1 Symptom severity measured in initial survey 
2 Level of agreement from consensus panel 
3 Patient preference measured in follow-up survey 
N Rate 
per 1000 
67 48.5 
107 77.5 
211 152.8 
78 56.5 
122 88.3 
231 167.3 
169 122.5 
49 35.5 
75 54.3 
137 99.2 
97 70.3 
12 8.7 
15 10.9 
21 15.2 
29 21.0 
4 65 men in the sample had been offered and accepted surgery for their symptoms 
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Need 
(N) 
1242 
2005 
3954 
1462 
2285 
4329 
3170 
919 
1405 
2567 
1819 
225 
282 
393 
543 
Chapter 6 - Discussion 
Introduction 
This study has estimated the population prevalence and incidence of British men with 
appropriate indications who would want surgery for BPH. It is one of the few health 
care needs assessments undertaken to inform the purchasing process in the reformed 
NHS. This chapter summarizes the results of the study and considers the limitations 
of the methods used. The results are interpreted with respect to other relevant 
research. Finally, the implications of the study, both in terms of further research and 
policy are presented. 
6.1 Summary of results 
The main findings of the consensus panel were: 1) the panel attached little 
importance to mild symptoms; 2) history of urinary retention, the severity of urinary 
symptoms and the degree of comorbidity were given roughly equal weight by the 
panel; and 3) while a history of acute retention was important, the type of retention 
was less so, although acute-on-chronic retention was a stronger indication than either 
acute or chronic retention alone. 
The initial survey described the prevalence and severity of urinary symptoms in British 
men aged 55 and over. Although most men reported no urinary symptoms, 20% 
reported moderate or severe symptoms. Of these, only 28% found their symptoms a 
medium or big problem. Thirty seven per cent of those with moderate or severe 
symptoms experienced interference with their daily activities at least some ofthe time, 
and 43% would be unhappy at the prospect of a future with their symptoms continuing 
at their current level. 
Although, the majority of men with moderate or severe symptoms reported no 
interference in their daily activities, a substantial proportion reported that their 
activities were limited more than 'hardly ever'. Some aspects of health status and 
quality of life measured by both the Nottingham Health Profile (energy, emotional 
reactions and physical mobility) and the SF-36 (physical role, social functioning, 
mental health and general health perceptions) deteriorated with increasing symptom 
severity. Men with moderate or severe symptoms reported worse health, as measured 
by the SF-36, than men of similar age in the population, especially for physical role, 
emotional role and mental health. 
Slightly fewer than half (45%) of men with symptoms reported that they had consulted 
their general practitioner, of whom the majority (62%) were referred to a surgeon, and 
of these the majority (71 %) reported that they were offered and accepted surgery. 
However a substantial proportion (22%) of men said that they would choose to accept 
their symptoms and forego surgery, and a further 47% were unsure whether or not 
to go for surgery. 
The best estimate of prevalent need for prostatectomy in a typical district of 250,000 
among men who (a) have appropriate indications as defined by a consensus panel, 
and (b) would choose treatment if offered was 1405, but sensitivity analyses suggest 
that the figure could range from 225 to 4329, depending on the threshold for 
intervention adopted. The results of modelling incident need, corresponding to this 
prevalence, suggest that in a population containing 35,000 men aged between 50 and 
90 (a typical figure for a catchment population of 250,000), there may be around 400 
to 500 new cases with moderate or severe urinary symptoms per year who would 
choose to have surgery. 
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6.2 Limitations of methods 
Before any conclusions may be drawn, the problems associated with undertaking 
health care needs assessments and the resulting limitations must be considered. This 
section discusses the limitations of: 1) developing an agreed case-definition; 2) 
consensus methods; 3) those associated with survey methods including bias, and 
problems of reliability and validity of the instrument used; and 4) inferring incidence 
from prevalence. 
6.2.1 Developing an agreed case definition 
The clinical decision to offer treatment is generally based on a combination of urinary 
symptoms and the results of urological investigations such as flow rates and residual 
volume. Currently there is debate in the urological literature about the relative 
importance of symptoms and urological measures, and several studies have shown 
a poor correlation between them (92,93,109,179). The panel members were equivocal 
about whether asymptomatic chronic retention (defined by them as post-void residual 
urine of greater than 400 mls) was an indication for surgery. This could not be 
detected in the population using a questionnaire. For practical purposes, its 
prevalence was assumed to be zero, because only 2% of the members of a group of 
388 men in North West Thames & Oxford regions undergoing prostatectomy, had 
chronic retention without also reporting some symptoms (20), and analysis of 
unpublished data on 227 men in a community survey in Scotland that used transrectal 
ultrasonography found no asymptomatic men with a post-void residual urine of greater 
than 200 mls (2). Given that most surgery is carried out to improve quality of life, 
which is highly correlated with symptom severity (16, 17, 114), the presence of urinary 
symptoms was considered to be the most important factor in determining need for 
surgery in a population. 
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Ideally, indications for treatment would be based on high-quality evaluative research 
relating pre-intervention test results and symptoms to outcome, measured in terms of 
improvement in symptoms and quality of life, from men in a wide range of 
age/symptom level combinations. Such evidence is not available for prostatectomy; 
randomised clinical trials often exclude patients who have less well defined symptoms, 
have comorbidity or are older. Those RCTs that have examined symptomatic 
improvement in men undergoing TURP or open prostatectomy are of limited use, 
because they use different definitions of symptoms, and follow-up is only up to one 
year. In addition, neither symptoms nor urinary flow rates have strong power in 
predicting outcomes. Several observational studies of men undergoing prostatectomy 
were available, but it was still necessary to combine available research results with 
opinion from a consensus panel. 
6.2.2 limitations of consensus methods 
A review of the literature on the management of lower urinary tract symptoms in men 
showed that there was little evidence about the effectiveness of treatment for men 
with differing types and severity of symptoms and, specifically, there were no relevant 
randomised controlled trials. This precluded the use of a meta-analysis. Consequently, 
to develop an agreed case definition, a method was required that used the limited 
evidence available optimally. Four possible altematives were considered. These were: 
a committee, a delphi technique, a consensus development conference, and a 
nominal group. 
The use of a simple committee was rejected for several reasons. First, there is 
evidence that committees are often dominated by one individual or by a coalition 
representing vested interests. This was seen as a potential problem because of the 
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mix of urologists and general practitioners. Second, the decisions made are 
susceptible to many factors extraneous to the topic of discussion. For example, 
increasing group size promotes more extreme positions, side by side seating 
promotes greater polarisation than face-to-face seating, limiting discussion time and 
tight rules of procedure promote compromise (151). Third, the traditional committee 
format does not enable explicit rating of the potential indications for treatment and 
prior identification of extreme positions. 
The delphi technique is more appropriate to situations where there is little or no 
evidence. It typically involves two postal questionnaires, where participants rate their 
responses to specific questions and incorporates feedback of the first round results 
to inform the second round. It is primarily a means of measuring rather than 
developing consensus as it does not incorporate a method for resolving 
misunderstandings and definitional issues. The importance of this is the subject of 
debate in the literature. It has been argued that the absence of discussion forces an 
artificial consensus and weakens the validity of the conclusions (180), although in 
practical terms, the difference is slight (181). In contrast, others believe that there are 
no significant advantages in a meeting based approach (182, 183). In establishing the 
appropriate indications for prostatectomy, it was felt that a meeting could provide 
additional qualitative information on the factors underlying disagreement. It was for 
this reason that a delphi technique was rejected. 
Consensus development conferences, consist of a jury that considers the evidence 
of both expert and lay individuals. The jury then reaches a decision and releases a 
consensus statement. This would have been a viable alternative although it does not 
incorporate a means for explicitly addressing all of the possible combinations of 
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indications and thus may have been less useful in identifying areas of residual 
uncertainty. It was not used here because it because of the considerable time 
required by the participants (typically 2 days and an overnight stay) and its resulting 
prohibitive expense. 
Having rejected the alternatives, a nominal group consensus panel was selected. The 
methods adopted were described in section 4.1. Despite their use in the health field, 
consensus development methods have been the subject of little rigorous evaluative 
research, especially when compared with the work on the dynamics of committees. 
Some has, however, been conducted in the areas of behavioural science and 
forecasting (181,184). 
Consensus methods, in particular Delphi, have been described as methods of 'last 
resort' (185) with defenders warning against overselling the methods and suggesting 
that they should be regarded more as methods for structuring group communication 
than as a means for providing answers. There is clearly a danger that the fact that 
these approaches have a prescribed method and are often used to generate 
quantitative estimates may lead the casual observer to place greater reliance on their 
results than might be warranted. Unless findings can be tested against observed data, 
it is uncertain that the methods have produced the correct answer. 
It has been argued that the delphi method fails to meet the standards normally set for 
scientific methods (180). The criticisms are based on the past poor quality stUdies 
rather than fundamental critiques of the method, ego poor questionnaire design, 
inadequate testing of reliability and validity of methods, and the methods of defining 
and selecting experts. It is also argued that the method forces consensus and is 
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weakened by not allowing participants to discuss issues. 
In this study, there are several limitations to consensus methods that need to be 
remembered. First, there is a potential bias in the selection of the panellists. The 
extent to which the panel reflected the views of other urologists and general 
practitioners is uncertain and could only be ascertained by repeating the process with 
a different group. Although it has been shown that doctors who are willing to 
participate in expert panels are representative of their colleagues in terms of 
measurable demographic, educational and employment variables (186), the exact 
composition of a panel can effect the results obtained (187). In this study, all the 
panel members came from one health region, in which the prostatectomy rate was 
23% lower than the national average in 1985 (29). It may well be that a panel 
consisting of consultants from other regions would have given different results. It has 
been suggested that urologists from other regions would have placed greater 
importance on urinary flow-rates than symptoms (188). 
Second, it is unclear how far stated opinions correspond to actual clinical practice. 
This question could only be answered by a detailed study of the patients seen and 
treated by panel members. In practice some of the combinations of signs, symptoms 
and comorbidity that the panel were asked to consider may be very rare. This may 
explain the one anomaly in the results of the panel. The indications defined as 
appropriate by the panel were generally consistent with each other, with the exception 
of men with mild symptoms and low comorbidity, for which the panel felt equivocal 
about whether surgery was appropriate for men with acute retention. The panel were 
not given an opportunity to re-score on the basis of the final results as shown in 
Figure 5.1. If they had done so, they might have identified this apparent anomaly and 
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re-scored accordingly. It is, however, reassuring that out of 45 cells, there was only 
one obvious inconsistency. 
Several approaches to aggregating the results of nominal group type consensus 
panels have been described (153). Four definitions of agreement have been 
proposed: 1) A9S - all nine of the ratings fell within a single 3-point region - 1 to 3, 
4 to 6, 6 to 9; 2) A9R - all nine of the ratings fell within any 3-point range; 3) A7S -
after discarding one extreme high and one extreme low rating, the remaining seven 
ratings all fell within a single 3-point region - 1 to 3, 4 to 6, 7 to 9; and 4) - A7R after 
discarding one extreme high and one extreme low rating, the remaining seven ratings 
all fell within any 3 pOint range. Disagreement can be defined in the same way. In this 
study, the relaxed definitions A7R and D7R were used. There is no clearly preferred 
approach. It has been suggested that A7R can be used where unanimity is not 
essential. As this study sought to identify areas for which there was a broad degree 
of agreement, not necessarily unanimity, it was decided to use A7R. The effect of 
using a stricter definition (eg. AS9) would have decreased the extent of agreement. 
Fourthly, the ratings of a panel are dependent on the definitions used. As in many 
areas of clinical work, terms in everyday use are used differently by different 
clinicians. Although there was some uncertainty among a few of the panellists at first, 
agreed definitions were developed and used as a basis for the second round, in some 
cases leading to modification of earlier scores. It is unknown to what extent panellists 
made use of the literature review that had been provided, although most stated that 
they had found it helpful. 
Finally, the existence of a consensus does not in itself mean the consensus view is 
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correct and there is a danger that the nominal group process will arrive at collective 
ignorance rather than wisdom. As such it is not a replacement either for rigorous 
scientific reviews of published literature or for research, but rather a means of 
identifying current medical opinion and areas of disagreement. Unless these findings 
can be tested against observed data, we can not be sure that these the method has 
produced the correct answer. Ideally indications for surgery should be based on high 
quality evaluative studies that relate patient characteristics and clinical outcome. Such 
studies, whether experimental or non-experimental are beginning to become available. 
6.2.3 Survey methods 
If a set of indications can be established, the next step is to assess their prevalence 
in the population. Surveys are subject to sampling and response bias. Those 
responding to the initial survey may not have been fully representative of the general 
population. Men in the 55 to 59 age group were under-represented compared with the 
general population. 
Second, those who do not respond to surveys may differ in some way from those who 
do. From the examination of case notes, 8% of men who did not respond had died, 
moved or had no general practice medical records. This suggests that the true 
response rate may have been as high as 80%. Non-responders did not differ from 
responders in terms of their history or lower urinary tract symptoms as recorded in 
general practice records, although they were less likely to have had previous prostate 
surgery. However, those who responded to the follow-up survey were more likely to 
report symptoms than those who did not. This suggests that the number of men 
seeking and receiving treatment may have been slightly overestimated. 
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There was a six week gap between the initial surgery and the follow-up survey in 
which patient preference, health status and quality of life was measured. Could the 
symptom severity have altered between the two surveys? There was no significant 
change in the 'bothersomeness' of symptoms, which is highly correlated with symptom 
severity (87), and no change in the median score for frequency of urination. There 
was a slight decrease in the mean score for frequency of urination (2.2 to 2.1), which 
could be explained by regression towards the mean, a statistical phenomenon in 
which, if a follow-up sample is chosen on the basis of extreme scores, their retest 
scores will tend to be closer to the population mean than the initial scores. As the 
difference was of little clinical significance (2.2 to 2.1), the time gap between the 
collection of data on symptom severity and on health status probably did not introduce 
any significant bias. 
6.2.4 Reliability and validity of questions 
The way the questions were phrased could bias the results. Where possible, 
questions with known reliability and validity were used; these included questions on 
lower urinary tract symptoms, and health status. The question about patient choice 
was designed specifically for this study. 
6.2.4.1 Lower urinary tract symptoms 
The index used to measure urinary symptoms was similar to the American Urological 
Association symptom index, which has been extensively tested and has been shown 
to be internally consistent and have good test-retest reliability, as judged by Pearson 
correlation coefficients (87). The index used here differed from the AUA index in two 
respects. Firstly the wording of the questions was modified slightly to make them 
clearer to U.K. responders in response to comments during the pilot survey. For 
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example, the AUA question on fullness 'Over the past month or so, how often have 
you had the sensation of not emptying your bladder completely after you finished 
urinating?' was changed to 'In the past month, how often did you feel that your 
bladder did not empty fully after urinating?'. Although these changes were minor, and 
probably did not affect reliability and validity, in retrospect, it would have been better 
to have left them as they were. 
Secondly, the question on nocturia mistakenly used daytime frequency response 
categories, rather than night-time categories. This resulted in nocturia categories that 
were too crude to use (times per night = 1-3, 4-5, 6-7, 8-9, 10-11, 12 or more). 
Consequently, nocturia was excluded from the calculation of the symptom index so 
that it ranged from 0-30 rather than 0-35. It is unlikely that this had a significant effect 
on the results because: 1) nocturia has many other causes, such as cardio-vascular 
disease and the person's fluid intake before going to bed; 2) nocturia is the symptom 
that responds least well to prostatectomy (155); and 3} in a validation study of the 
AUA index, the highest inter-symptom correlation was between nocturia and frequency 
and frequency was already included in the index. To examine the consequences of 
omitting nocturia from the initial analysis of the first questionnaire, a 7 -item index was 
calculated forthe 420 men who received the follow-up survey. This was accomplished 
by adding the nocturia result from the second questionnaire to the 6-item index 
derived from the initial questionnaire. The total score for the 7 item index was re-
scaled to give values that ranged from 0 to 30. When the 2 indices were compared 
there was little difference in the proportion of men in each severity category (mild 
43.1% vs. 45.1%), moderate (44.0%vs.42.7%) and severe (12.9% vs. 12.1%). These 
differences were not statistically significant. 
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Symptom severity categories were derived from cutoff points used in a previous study 
(167). The use of different cutoffs would have important implications for the numbers 
of individuals in each category. For example, moderate or severe symptoms were 
defined as a symptom index score of greater than 9, giving a prevalence in the male 
population aged 55 and over of 204 per 1000. Reduction of the threshold to 8 would 
result in a prevalence of 227 per 1000; a threshold of 11 would result in a prevalence 
of 170 per 1000. Since the survey was undertaken, American guidelines have been 
published using a lower threshold. Had this been available at the time, it would have 
been used. 
Although the categories of symptom severity (mild, moderate and severe) used in the 
consensus panel were similar to those used in the prevalence survey, they were not 
equivalent. In the panel, participants used their own subjective definitions of these 
categories, while in the survey, the severity categories corresponded to those of the 
AUA symptom index. In retrospect, it might have been better to present the AUA 
symptom categories to the panel as an example. This question could only be 
examined by a detailed study that compared the subjective assessment of a clinician 
using these categories of severity, with the symptom categories in patients derived 
from the AUA symptom index. 
6.2.4.2 Health status and quality of life 
The Nottingham Health Profile has been extensively tested and shown to be both 
reliable and valid in a variety of contexts (169). It has been shown to be sensitive to 
changes in health status following prostatectomy (189). However, it is not 
recommended that the NHP be used on the general population, or for those with 
relatively mild medical conditions because most of a sample with low disability will 
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score zero, which makes it unsuitable for comparative purposes (169). 
The SF-36, an increasingly used measure of generic health status, has also been 
tested for its reliability and validity (171-173). While the internal consistency of the SF-
36 has been shown to be good, the test-retest reliability remains uncertain (190). The 
SF-36 has been criticised because it does not include sleep (191), which is often an 
important factor for men with urinary symptoms. The interpretation of the SF-36 is 
confined to younger age groups because there are no published norms for those over 
the age of 65 (172). 
6.2.4.3 Patient preference 
The question about patient preference was developed specifically for this study and 
has not been tested for its reliability and validity, in particular its power to predict the 
decision that a man will take in practice. Nevertheless, it was discussed extensively 
with researchers who have considerable experience in questionnaire design. It was 
decided not to include information on possible post-operative mortality in the question 
about patient choice because the risk is small (1.5%) and because it might 
unnecessarily frighten men. Similarly, although retrograde ejaculation is a reported 
complication, it was considered to be another form of sexual dysfunction, and 
information about difficulties in getting an erection was already included. Furthermore, 
it was difficult to come up with a simple but accurate and comprehensible form of 
wording that described this complication. 
Most of the published work about patient preferences has been applied to choices for 
specific treatment alternatives in cancer patients (192) [especially breast cancer 
(193,194)]. women undergoing abortion (195), rheumatic disease (196), 
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cardiovascular risk management (197), and hypothetical lung cancer in ambulatory 
patients with chronic conditions (198). The studies typically examine tradeoffs 
between quality of life and life expectancy, which use econometric methods such as 
standard gamble and time tradeoffs (199). 
These methods are subject to many biases, arising from their underlying assumption 
that people make rational choices in situations of uncertainty. The evidence that this 
assumption is not always true has been reviewed at length (200,201). In brief, the 
potential biases include: social desirability, in which respondents give answers they 
feel will be welcomed, although it is unclear whether this is context dependent or 
reflecting an underlying trait of individuals (202); acquiesence or 'yea-saying', in which 
respondents tend to answer positively regardless of the question (203); biases that 
relate to the construction of scales or range of choices such as end aversion, positive 
skews, and halo effects (200); and framing, in which the formulation of the choices 
influences the decisions taken, probably because many people are risk averse when 
gain is involved and risk takers where loss is a possibility (204,205,198). They have 
also been criticised on the basis of low levels of test-retest reliability (206), and for the 
way that utility values are assigned to different health states (207). The approaches 
are quite complex and it has been have noted that they should be administered by 
a trained interviewer, making them unsuitable for this study (200). 
It was unclear whether the considerable additional investment that would have been 
required could have been justified on the basis of the current state of knowledge of 
methods for assessing patient preference. The constraints of the question used in this 
survey are apparent but a better alternative was not obvious and it was felt necessary 
to obtain some measure of patient preference, even though it had many limitations. 
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This work does, however, highlight the need for much more methodological research 
in this complex but important area. 
The probabilities of specific outcomes in the description of the procedure relates to 
the total population of patients undergoing prostatectomy regardless of symptom level. 
Ideally, the information for each level of symptom severity would be specific to the 
situation of each respondent. This was not done because information was not 
available for many outcomes by level of symptom severity. Quantification of lower 
urinary tract symptoms by symptom severity is relatively new and little relevant 
outcomes research has been published. The information on outcomes provided on the 
question on patient choice was primarily derived from two studies. A cohort of 263 
men found that the relative improvement in symptom severity was 93% in the severe 
category and 79% in those with moderate symptoms. 80% of men with mild pre-
operative symptoms reported either no change or an improvement within 12 months 
of surgery (102). 
In another study conducted in men undergoing prostatectomy in North West Thames 
and Oxford regions, the relative improvement in symptom severity was: severe (96%), 
moderate (90%) (20). Eighty percent was chosen as a conservative estimate for the 
probability in symptom improvement for those with moderate or severe symptoms. 
However, this figure did not apply to those with mild symptoms, of only whom only 
18% reported symptom improvement 12 months following surgery (20). Consequently, 
the estimate of patient preference in this group was misleading. Nevertheless, the 
proportion of those in each choice category was consistent with the expected trend 
by symptom severity, ie. the relative proportions of those who definitely wanted 
surgery increased from mild to severe, and decreased for those who definitely didn't 
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want surgery. Second, the inclusion of information by three levels of symptom severity 
(mild, moderate & severe) would have made the question relatively complex to 
understand and could have contributed to more responders leaving the question 
unanswered. 
In retrospect, the question could have been tailored to the symptom severity of each 
individual, as determined from the first questionnaire, despite the limitations of the 
evidence upon which to base this process. This raises the question which is 
unresolved, of how closely to match the probabilities of differing outcomes. A 
compromise would have been to have three questionnaires for those with mild, 
moderate or severe symptoms. This would have added to the complexity of the 
process of questionnaire distribution, although it would not have been insurmountable. 
This issue should be addressed by others seeking to assess need in this way. 
6.2.4 Inferring incidence from prevalence 
Once the level of prevalent need in the population has been established, the next step 
is to estimate the level of incident need. In view of the number of variables involved, 
it was necessary to construct a model to do this [Appendix AS]. The model was quite 
complex, but even so, a number of potentially desirable features were left out. For 
example, no distinction was made between moderate and severe symptoms, and it 
was not possible to take symptom duration directly into account. Instead, the 
probability of surgery depended on age, which provides only a proxy indicator of 
severity and duration. 
In addition to these limitations, many combinations of assumptions were possible and 
the confidence intervals around the observed rates were wide, so that many scenarios 
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could provide adequate fits to the prevalence curves. Thus it is difficult to know which 
assumptions are tenable and which are not. First, a very steep rise in incident need 
between the ages of 55 and 59, remaining more or less constant thereafter, was a 
necessary feature of any plausible scenario. Second, the results were sensitive to 
candidate withdrawal rates. They were not sensitive to post-surgical relapse rates, 
which is fortunate because the assumptions about the pattern of post-surgical relapse 
were arguably some of the least well-founded. Third, it was not possible to reproduce 
the observed prevalence curve with any precision without introducing a high risk 
group. This was modelled by creating two cohorts at birth, with the annual increment 
in incidence rate in the high risk group a fixed multiple of that for the low risk group. 
There are many other ways this could have been done, and in reality one might 
expect not two but many groups, and a spectrum of risks. In using this model, two 
groups provided a better fit than a single homogenous population, and the best fits 
were associated with a relatively small high-risk group at a very substantially 
increased risk. 
6.3 Interpretation of the results 
6.3.1 Prevalence of lower urinary tract symptoms 
It has been suggested that there is a large proportion of men in the British population 
with undiagnosed but symptomatic prostatism (2). This study supports this view. The 
only other study on the prevalence of urinary symptoms in men in the U.K. has been 
reported by Garraway et. al. They reported a prevalence among men aged 40-79 
years of 104 per 1000 (16). These figures referred to men with a symptom score of 
at least 11 out of a possible 48 pOints (eight symptoms each with a maximum score 
of six). An equivalent cut-point in this study, 7 out of 30, would produce a prevalence 
of 292 per 1000. However, some important methodological differences between the 
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two studies remain. In the study by Garraway, the men were younger (over 50% were 
under 55 years), 9% of men in the study population were excluded and the response 
rate was lower (only 64% (16) compared with 78%). All of these might explain why 
they obtained a lower estimate of prevalence. These factors could therefore reconcile 
these results with theirs. 
The finding that 61.5% of men with a history of acute retention had not undergone 
surgery indicates that the view that this is an almost absolute indication for surgery 
(208) is no longer held. This finding is consistent with the views of the consensus 
panel on the appropriate indications for prostatectomy. Furthermore, some men who 
recovered from an episode of acute retention subsequently had only minor symptoms. 
This is consistent with an emerging theory that the condition may have a different 
aetiology from BPH, perhaps involving vascular events in the prostate. 
These results and evidence from other studies suggest that prostatism begins to 
develop in some men under the age of 50. The sample was chosen on the basis of 
evidence that prostatectomy was almost never performed on men under the age of 
55 (20). The relatively high prevalence of moderate or severe symptoms among men 
in the 55 to 59 age group indicates that future studies should include younger men. 
This is consistent with the population based survey by Garraway that described the 
onset of urinary symptoms among men in their forties (2) and a review of autopsy 
data by Berry et. a/. suggesting the first changes in prostatic weight appear in men 
as young as under 30 (209). From the age of 55 until the early seventies, the 
percentage of men with moderate or severe symptoms who have not had surgery 
increases slowly from 15% to 20%, decreasing thereafter. A few individuals have 
surgery under 50, but the probability of surgery only exceeds 1 % in the 55 to 59 age 
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group. Thereafter it increases steadily. This leads to a progressive increase in the 
number of men who have had surgery by the age of 85. Of those who have had 
surgery, the proportion who have residual or recurring symptoms is roughly constant. 
The figure of about a third in this study is higher than that found in two cohort studies 
of men undergoing surgery (1 02,167) but both followed up patients for only one year. 
Some of the men in our survey had surgery up to 10 years previously. 
These results suggest that lower urinary tract symptoms shown by the prevalence of 
either symptoms or a past history of prostatic surgery, increases steadily throughout 
middle and old age, with the first signs appearing below the age of 55 and with almost 
40% of men having been affected by the age of 80. After 80, the prevalence of lower 
urinary tract symptoms does not increase further, and may actually decrease. These 
findings may occur by chance because there were only 29 men over the age of 80 
in our sample with moderate or severe symptoms, but if true, there are three possible 
explanations. The first is that some cases of BPH resolve spontaneously. This has 
been suggested by other authors and seems to be a view held by many urologists, 
although there is no strong empirical supporting evidence (210). 
Second, most of those men who are going to suffer from lower urinary tract symptoms 
begin to do so by the time they reach 80, and that the population contains subgroups 
with varying susceptibilities to the disease, with those reaching 80 without having 
developed symptoms likely to remain in this state. Some support for this hypothesis 
comes from a review of series of autopsy data that suggested that at least 10% of 
men have no histological evidence of BPH by the time they reach the ninth decade 
(209). The third possibility is that men suffering from lower urinary tract symptoms 
have a reduced life expectancy, leading to selection out of the population in this age 
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group. If the last of these is true, it could be due to either the effects of the disease 
or the complications of treatment. This explanation is consistent with the results of the 
study by Wennberg et. al. that suggested that transurethral prostatectomy was 
associated with an increase in mortality compared with men not undergoing surgery 
(125). If any of these suggestions, or a combination thereof, are true there are 
important implications for urology research and practice, especially as new therapies 
designed to prevent the development of lower urinary tract symptoms become 
available. For example, it would be useful to compare the characteristics of those men 
who do and do not suffer from BPH, including for example, differences in androgen 
responsiveness. 
6.3.2 Impact of symptoms on general health status and quality of life 
Although 20.4% of men have moderate or severe symptoms, this does not reflect the 
degree of concern that they express. Only 6% of men report that their symptoms are 
a medium or big problem and 2% report that they interfere with their daily activities 
all or most of the time. In contrast, 11 % feel unhappy or terrible about the prospect 
of a future with their current level of symptoms, indicating a difference between the 
extent to which men are affected at present and how they would like to be in the 
future. A possible explanation for this is that men are able to cope with their existing 
level of symptoms but feel that they will be unable to do so in the future as they 
become older and more infirm. 
This study measured the extent to which lower urinary tract symptoms affect general 
health status and quality of life using the NHP and the SF-36. Measures of lower 
urinary tract dysfunction can be considered within the impairment - disability -
handicap model, in which impairment describes an anatomical or physiological defect, 
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disability reflects the limitations to an individual's activities resulting from the 
impairment, and handicap describes the extent to which the environment obstructs or 
supports the individual in leading a normal life with the disability. In the case of lower 
urinary tract disease, a decreased rate of urinary flow can be considered as an 
impairment, symptom scores are disease-specific measures of disability, as are the 
NHP-Part 1 and some components of the SF-36; the NHP-Part " and the remaining 
components of the SF·36 are measures of handicap. The factors influencing each 
step in this set of interactions explain the imperfect correlation between each of the 
measures and demonstrates that factors that related to the individuals' expectation 
and environment, as well as clinical factors, must be taken into account in the 
decision to offer surgery. 
In this study, both the NHP and the SF·36 performed as expected: the health status 
of men worsened as the severity of their lower urinary tract symptoms increased. The 
energy, emotional reactions and physical mobility dimensions of the NHP were 
associated with increasing symptoms severity, as were the social function, mental 
health, physical role and general health dimensions of the SF·36. 
These findings are consistent with results in the U.S.A. that have found that worry and 
embarrassment about urinary symptoms were associated with increasing AUA 
frequency and bother scores (211) and that men with heightened bother were more 
anxious and had lower general psychological well-being that those without (211). The 
results with the SF-36 are consistent with a study in the U.S.A that compared mean 
SF·36 scores in men with: no, occasional (up to twice a night) and frequent (3 or 
more times) nocturia. It found Significant differences in scores on the dimensions of 
physical functioning, role limitations due to emotional problems due to pain (212). 
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It was possible to compare median NHP scores in the survey with those of men 
undergoing prostatectomy. The proportion of men undergoing prostatectomy and who 
had median NHP scores greater than 0, was higher than men in the population-based 
sample. This suggests that, for a given level of symptoms, the impact of symptoms, 
the patients quality of life influences the decision to seek treatment. This is intuitive, 
although few studies have shown it. It is also consistent with the decision to seek 
treatment, which is affected by the person's physical, sociological and psychological 
environment. This has been demonstrated previously in the U.K. in a comparison of 
men with BPH being treated in the public sector with those treated privately (213). 
It was also possible to compare mean SF-36 scores with recently published 
population norms. On the evidence presented here, it appears that, men with 
moderate or severe symptoms are less affected on most dimensions of general health 
status and quality of life than people with low back pain, menorrhagia or suspected 
peptic ulcer, but more affected than those with varicose veins. However, this crude 
comparison obscures both the need to take into account the threshold for inclusion 
of each group, defined in terms of a disease specific measure, and the extent to 
which men with a particular level of symptoms are bothered by them and how they 
impinge on their quality of life. In addition, this analysis should be treated with caution 
as the use of means may not be appropriate because the distribution of item scores 
is strongly skewed. Surprisingly, median SF-36 scores for the population were 
unavailable. 
The NHP and SF-36 provided a reasonably valid and robust method for measuring 
the general health status of men with urinary symptoms. They responded in 
predictable ways to the presence and severity of urinary symptoms. However, some 
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unexpected responses were found and these, together with the absence of an explicit 
measure of sleep disturbance in the SF-36, and the high number of men with perfect 
health (ie 0 for NHP and 100 for the SF-36) suggest that alone, they may not be 
sufficiently sensitive for the detailed assessment of men with urinary symptoms. They 
may nonetheless provide a basis for comparing the health of such men with other 
groups of potential patients and could be used in making comparisons of the likely 
gain in health status that might be achieved following treatment. 
6.3.3 Illness-related behaviour 
Few men in this survey reported seeking advice from relatives, friends or the practice 
nurse for their symptoms. This may be because they believe that lay carers and 
nurses have little to offer for urinary problems or it may reflect under-reporting; having 
received advice from family or friends to see their GP, they only reported that they 
saw a GP. It is also possible that there is some reporting bias because they view 
these sources of advice in a less formal way. It has been estimated that 25% to 75% 
of symptoms are dealt with by patients themselves or friends and family (181,182) 
and that the decision to consult a GP is dependent on the influence of advisers, the 
effectiveness of self-care and the need for information (183). Many men may consider 
their urinary symptoms as part of the normal aging process and thus do not consider 
their condition worthy of consulting their GP. The findings in this study are consistent 
with those of a study in Denmark that found that men aged 70 and over with voiding 
difficulties did not consult a doctor for their urinary symptoms (184). 
Although, men are more likely to visit their GP as their symptoms worsened, the 
decision of the GPs to refer appears to be independent of symptom severity. This 
study confirms the important gatekeeper function of general practitioners: half of the 
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men who went to see their GP had not been referred to a surgeon. This is consistent 
with research on the referral decision that shows that a wide variety of factors, and 
not just the patient's condition are important (167). Semi-structured interviews with 
family physicians in Canada found that of non-medical factors in the decision to refer, 
patient wishes were the most important (186). Difficulties with travel, access to a 
consultant, and family wishes also influenced the decision (186). The effect of these 
factors in this study is unknown. 
Some men were prescribed medication for their urinary symptoms, either by their GP 
(16.6%) or their urologist (7.9%) despite a lack of any definitive evidence of the 
efficacy of such treatments and the recommendation that prostatectomy is still the 
treatment of choice for BPH (3-7,147). During the period of the study, Finasteride 
(Proscar®), was being marketed and some men may have been prescribed it as 
participants in studies to evaluate the drug. 
6.3.4 Patient preference 
Thirteen per cent of responders did not answer this question and, of those who did 
answer, 45.2% were unsure whether they would choose surgery. It is not known 
whether their uncertainty arose from the wording of the question, insufficient 
information being provided, or from the difficulties in deciding about treatment. It is 
likely that some have what has been termed an 'external locus of control' and would 
transfer the decision to treat to the surgeon. A study of 55 men undergoing 
prostatectomy who were questioned about their opinion on informed consent found 
that 54% (25/46) trusted their doctor to do the right thing and did not think detailed 
explanation was important (171). 
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As part of the preparation of the AHCPR guidelines, 53 patients with mild, moderate 
or severe symptoms judged by the AUA symptom score, were presented with a 
booklet that listed the important outcomes offour treatments (watchful waiting, TURP, 
alpha-blocker therapy and balloon dilation)(7). The results showed that a similar 
proportion of patients with mild symptoms reported that they would choose TURP 
(30% in U.S patients vs. 29% in the survey). More U.S. patients with moderate (40% 
vs. 31%) or severe symptoms (75% vs. 46%) said that they would choose surgery. 
However, important distinctions exist between the two studies. The American 
preference analysis consisted of men whose symptoms bothered them to the extent 
that they sought care for their symptoms. In addition, the American were presented 
with other treatment choices, whereas the men in the survey were only asked whether 
or not they would choose TURP. 
Although men in the survey reported that they would definitely or probably choose 
treatment, it is unknown whether their attitude towards treatment would correspond 
to their actual behaviour. Published research relates to patient preference for 
treatment alternatives, as part of the patient-physician interaction, rather than about 
the prOVision of information by questionnaire as a basis for decisions about treatment 
preference. 
6.3.5 Sensitivity analyses 
A range of values of prevalent need were presented depending on combination of 
symptom severity, level of comorbidity, extent of agreement about appropriateness 
and degree of individual preference. It was decided to include the group of men with 
mild symptoms in the sensitivity analysis despite the fact that men with mild symptoms 
are less likely to benefit from treatment, the enormous cost implications of treating 
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4329 men, and that the AHCPR guidelines advocate that men with mild symptoms be 
followed with a strategy of 'watchful waiting'(7). This was because men with mild 
symptoms were considered by the consensus panel and panellists felt that surgery 
was appropriate in men with mild symptoms, low comorbidity and no retention. This 
group is likely to represent a large portion of men in the community and many men 
in this category reported that they would probably or definitely want a prostatectomy. 
It is important that the estimate should be used with caution. The decision about 
which estimate of need commissioning agencies on which to base their purchasing 
decisions must be left to local authorities. 
Although this estimate was consistent with the panel's ratings, inspection of the 
relationship between symptom level and health status (Section 5.3.3) suggests that 
it may be more suitable to consider men with severe symptoms separately. 
Accordingly, the estimate was reduced to 225 if only those men with severe 
symptoms who would definitely want surgery were considered. This figure rose to 
4329 if men with mild symptoms, men who were only inclined to want surgery, and 
indications about which the panel members were equivocal, were included. The 
decision about which estimate of need, commissioning agencies use, should be a 
matter for local discussion 
6.3.6 Application of the results to purchasing 
In Britain, prostatectomy for BPH was the subject of one of a series of needs 
assessments commissioned by the NHS Management Executive based on existing 
epidemiological and utilisation data, evaluation studies, and economic analyses (72). 
It estimated that the number of prostatectomies in a typical district of 250,000 was 
179 per year (82), rather lower than the existing level of provision of approximately 
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220 (based on National Hospital Episode data for 1989/90). The report concluded that 
'either the definition of clinical BPH bears little relation to the requirement for surgery 
or there is a huge pool of need not being satisfied'. 
The underlying rationale for assessing local health care needs is to allow local 
authorities to purchase appropriate care to meet local needs. Purchasing may be 
thought of as a way of both increasing the effectiveness of health care and saving 
costs. The existence of information about health care need for a given procedure is 
only the first step in ensuring that local populations receive appropriate treatment. The 
results of this study raise several issues relevant to purchasing. 
The first step in using information from needs assessment to inform the purchasing 
process is to examine existing provision of services in order to find out if health care 
is already being provided at levels which meet the health needs of their population. 
This may require extensive cooperation with local providers because despite some 
recent improvements, routine data in the NHS is still notoriously unreliable (67). 
Furthermore, the contract minimum dataset provides little information about the 
appropriateness of the specific treatments being provided. As up to 20% of 
prostatectomies are performed in private hospitals (31), it is essential to obtain data 
from the private sector, an issue that has received very little attention so far (68). 
Another possible application is the development of referral guidelines, although the 
difficulties involved in their development and Implementation, should not be 
underestimated. This is because there is a lack of research-based evidence and a 
genuine uncertainty about the appropriateness of many interventions. Second, for 
guidelines to be locally acceptable, there is a need for local ownership which must 
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involve extensive discussion with local GPs, FHSAs and providers. Guidelines may 
be unhelpful in the case of patients with multiple conditions or unclear diagnosis, if 
patients fall outside of the study populations upon whom the research evidence is 
taken, such as the exclusion ofthe elderly and women from studies of cardio-vascular 
disease. Comprehensive effectiveness reviews for many conditions are currently 
unavailable, although the U.K. Clearing House on Health Outcomes will publish an 
effectiveness bulletin for prostatectomy in 1995. Nevertheless, the existence of 
guidelines does not ensure that they will be used. If clear and acceptable guidelines 
are available, then the issue arises about how purchasers are to ensure that they are 
being met. Currently, it is unclear how purchasers will monitor providers' adherence 
to guidelines, espeCially when they are constrained by the lack of meaningful 
information (187). 
Third, a question remains about whether purchasing authorities have the resources 
to conduct all of these activities. The purchasing function is still underdeveloped in 
many commissioning agenCies. Many services are purchased through block contracts 
by specialty, and consequently do not consider specific conditions or treatments. It 
has been suggested that purchasing agencies require the following skills: public 
health medicine, finance, contracting, health services evaluation, information 
technology, communications and public relations (188). Staff with formal training or 
expertise in all of these areas may be in short supply. When the potential number of 
conditions that purchasing authorities should provide services for is considered, the 
amount of time and resources required to follow through the results of health care 
needs assessment, is considerable. 
Finally there is the dilemma raised by issues of resource allocation and priority 
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setting. The results in this study and other research which examined the need for 
services for people with visual disabilities (75) suggest that there may be a 
considerable volume of unmet need for common procedures. It is possible that 
purchasing authorities could be faced with high unmet needs for many treatments with 
demonstrated effectiveness. It is unclear how purchasers are to resolve the dilemmas 
that could arise from the need to allocate scarce resources and how to include the 
views of public. An attempt to include the public in establishing health care priorities, 
the Oregon experiment, proved unworkable (63). 
This study supports the view that there is a volume of unmet need for prostatectomy, 
but offers a range of possible values for prevalent need contingent on indications and 
patients' attitudes to surgery. Which figure to apply in purchasing must be a matter 
for local policy and priorities. Although the higher prevalence estimates would support 
greatly increased provision of urological services for a limited period, the need for 
surgery would stabilise at the incidence level once the backlog had been cleared. It 
is uncertain how long it would take to work off the backlog at different rates of 
surgery. In principle a model could be built to explore this question, but it would need 
to be a dynamic one because, as this study has shown, general practitioners may 
respond to perceived increases in availability of treatment with higher levels of 
referral, and thus maintain waiting times near their current levels. 
A number of alternative medical and surgical treatments are becoming available. 
Although they are thought of as substitutes for prostatectomy, in practice there is 
growing evidence that they are additive, being used on men with symptoms below the 
threshold currently used by individual surgeons. This rapid change in technology 
combined with the time required to undertake research means that research results 
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can lose much of their relevance by the time they are published. This is not yet the 
case for this study, because of the absence of evidence of the effectiveness of 
alternative treatments, but this may not last for much longer. 
6.4 Implications of findings 
6.4.1 Further research 
This study has identified a number of areas of potential further research. Some of 
these have been raised by the review of the literature and others arise directly from 
the findings of this study. 
A review of the literature identified a number of gaps of knowledge. First, although 
there is good evidence on the outcomes of TURP, there is little information about the 
outcomes of emerging alternative treatments, despite their use by many GPs and 
urologists, and aggressive marketing techniques by drug companies of medical 
therapy. More research is under way to study the long term benefits of these different 
treatments, but there is an urgent need for randomised control trials that compare the 
outcome of TURP with other surgery (open, microwave, laser), medical treatments 
and watchful waiting. The last of these would have to be defined explicitly in order to 
distinguish it from 'no treatment'. A further issue relates to what measures of outcome 
will be used, given the lack of concordance between symptoms and urinary flow. As 
drug treatment may need to be continued for many years, what is the most 
appropriate time atwhich to measure outcomes? The AUA symptom index, measures 
of generic health status, such as the NHP or SF-36, and quality of life measures 
should be included to determine which patients would be more likely to benefit from 
treatment. These studies would also have to consider that men with symptoms often 
spontaneously remit, and the possibility that men modify their behaviour, ie, limit the 
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amount that they drink. 
Despite continued uncertainty about the effectiveness oftreatment for BPH, urologists 
in Britain have been reluctant to participate in a randomised controlled trial comparing 
transurethral resection of the prostate with open surgery, medical treatments and 
watchful waiting. Other issues arise. Are the treatments to be seen as a substitute for 
TURP among patients currently offered treatment? Is it envisaged that they will be 
offered to patients with less severe disease than those currently being treatment? If 
two treatments are shown to have the same effectiveness, then economic arguments 
may become more important. 
There is considerable debate about the relationship between symptoms, urological 
measures, and autopsy evidence of BPH. It has been suggested that lower urinary 
tract symptoms can arise from either, obstruction or detrusor instability, and that 
symptom scores are unable to distinguish between the two. Large scale stUdies to 
distinguish which men are most likely to benefit on the basis of these measures are 
needed. Results ofthe Royal College of Surgeons of England Regional Prostatectomy 
Audit may be able to answer some of these questions. 
Little is known about the natural history of BPH, although three points should be 
considered in future studies. From this study it is clear that lower urinary tract 
symptoms begin to occur to some men under the age of 55. Future prevalence 
studies should include men over the age of 40. It is clear from the autopsy evidence 
and the findings from this study that some men may not develop the lower urinary 
tract symptoms of BPH and modelling of incident need required an assumption that 
there was a low-risk and a high-risk group. If this assumption is true, then a case-
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control study could elucidate the reasons for this difference. Androgen responsiveness 
or other genetic factors may help to explain aetiology. 
This study found that some men are more willing to tolerate their lower urinary tract 
symptoms, than others. Further qualitative research should examine the factors that 
determine patient perceptions of disease. These could be explained by individual 
values to health and whether or not individuals health-related behaviour follows an 
external or internal 'locus of control'. These factors will differ between individuals. In 
particular, much more work is required to explore the wide variation in scores using 
both instruments on men with severe symptoms, with some men apparently relatively 
unaffected but others affected severely. 
Similarly, there was a difference with regards to whether men sought treatment for 
symptoms and whether or not they would choose surgery. The extent to whether men 
eventually receive treatment is complex, and is influenced by: their health-related 
values, the willingness to accept risk, and the doctor-patient interaction. A related 
question is what happens to men who do not seek treatment. A follow-up survey of 
men with symptoms could discover the extent to which symptoms remit, or whether 
their symptoms develop to the point where they develop acute retention, which 
requires an emergency admission to hospital. 
The provision of outcomes information and the question on patient choice, by survey 
is new. Further work needs to be done to test the reliability and validity of providing 
information, and to explore ways of providing complex information on treatment 
outcomes by questionnaire. This could be accomplished by detailed qualitative work 
or a follow-up survey which compares the reported preference for treatment with their 
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actual behaviour if offered treatment. Further work is needed to examine the 
relationship between characteristics of the doctor, the patient and their interaction. 
6.4.2 Implications for policy 
This study was conducted in order to provide information to inform purchasing. The 
next step would be to work with a purchasing authority in order to determine the 
usefulness of the results of this study in informing local strategy for urological 
services. This work is in progress, in close cooperation with a local purchasing 
authority. There are two applications. 
First, the estimated incident need identified in this study is being compared with 
existing utilisation data from NHS and private hospitals in order to find out whether 
current proviSion is congruent with local needs. As a first step, all episodes with a 
recorded diagnosis of BPH or a procedure of prostatectomy have been extracted from 
the local minimum data-set. It had been planned to augment this with information from 
private hospitals, but they were not all willing to cooperate. Consequently, the 
estimates of NHS provision have been inflated based upon the estimated contribution 
of the private sector of prostatectomy (31). The results of such study do not tell us 
about the appropriateness of care, however, as this could only be accomplished with 
a detailed history from each patient undergoing prostatectomy. 
Second, referral guidelines are being developed as an aid for general practitioners in 
treating patients with lower urinary tract symptoms. The feasibility of introducing 
treatment thresholds based on the AUA symptom index into GP surgeries is being 
explored. These guidelines are likely to take the form of a decision tree, based on the 
results of physical examination and symptom scores. Ideally, this process would also 
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include provision of information about the procedure and involve patients in the 
decision whether to be referred to a urologist. The AHCPR clinical practice guidelines 
and the results of this study provide a starting point for the development of local 
guidelines. The development of guidelines must include local input from GPs and 
urologists, for it to succeed. 
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Chapter 1 - Introduction 
Prostatectomy for benign prostatic hypertrophy (BPH) is a common operation for men 
that has been performed since the tum of the century (1). It has been estimated that 
the probability of a 40 year old man having this surgery before he reaches 80 is one 
in ten in the U.K. and one in three in the U.S.A. (2,3). Prostatectomy is performed in 
order to improve quality of life and to prevent mortality, morbidity by reducing 
symptoms. Over 90% of operations are performed by the transurethral route. However 
concern has recently been expressed about the indications for and outcome of TURP. 
Wide variations in the rates of surgery arise because there is no clear agreement 
about appropriate indications. Urologists often disagree about whether individual 
patients should undergo surgery (4,5,6). It has been suggested that 75% of 
prostatectomies performed in the U.S.A. are inappropriate and if these operations 
were avoided SUS 2-3 billion could be saved annually (7). In addition, a recent study 
suggested mortality following TURP, may be significantly higher than that following 
open operation (8). After a brief account of BPH, this paper will review the literature 
on the indications for and outcome of TURP. 
1.1 Definition of benign prostatic hyperplasia 
Benign prostatic hyperplasia (BPH) is a adenomatous growth of the prostate gland 
that gradually obstructs the urethra leading to difficulty in urinating. The consequences 
of an untreated obstruction include: chronic urinary retention predisposing to bladder 
and renal damage; episodes of acute retention; and progressively severe obstructive 
and irritative symptoms (9). There is sometimes confusion about the use of the term 
BPH: some authors use BPH to describe the pathological process while others use 
it to describe the symptoms associated with the process. 
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1.2 Natural History of BPH 
The prevalence of enlarged prostate estimated from digital rectal examination and the 
reporting of obstructive symptoms increases with age (10). The benign growth of the 
prostate or a hypertrophy of muscles at the neck of the bladder, or a combination of 
both leads to the obstruction. It is probable that the pathogenesis of prostatic 
hyperplasia starts at the age of 30 (autopsy prevalence of 8%) and increases steadily 
so that by the age of 70 the prevalence of BPH has reached 70% (11). While 
symptoms associated with BPH are persistent in most cases, in 25% to 30% of men, 
urinary symptoms resolve spontaneously (12). 
1.3 Etiology 
Risk factors that have been associated with the development of BPH include: 
increasing age (10,11,13,14,), non-smoking (13,14), and ethnicity [higher in Africans, 
American Blacks, Jews, Welsh; lower in Asians] (2,14,15,16,17,18). Two studies that 
have examined the relationship between BPH and socio-economic status have 
produced contradictory results (14,20). Other suggested risk factors include coffee 
consumption, diet [milk, yellow and green vegetables], sexual activity, leanness, high 
urine alkalinity, a history of renal x-rays, and tuberculosis (13,14,19). BPH never 
develops in men who have been castrated early in life, and indeed castration used 
to be recommended as a treatment for obstructive uropathy (21). 
1.4 Epidemiology 
The epidemiology of BPH has been studied using a variety of data sources: 
autopsies, stUdies of the prevalence of symptoms in populations, operation rates, and 
the prevalence of prostatectomy. 
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1.4.1 Autopsy studies 
A meta-analysis of 1075 autopsies from 5 independent studies found that 61% 
of males over the age of 40 have pathological evidence of BPH (11). The 
frequency of nodular hyperplasia was 42%, 71 %, 82% and 88% in men aged 
51-60, 61-70, 71-80 and 81-85 years old, respectively (11). 
1.4.2 Prevalence surveys 
Surveys have examined either the prevalence of prostatic symptoms or 
enlargement of the prostate. A community survey of the health status of 217 
men aged 65 and over in Israel found that 40% of men reported having 
undergone prostatectomy or suffered probable BPH on the basis of symptoms 
(frequency, nocturia, weak stream, dribbling) (23). Another study of men over 
the age of 65 living in Iowa found that the age-adjusted prevalence of those 
who responded positively to a question on prostate symptoms was between 
22% and 32% (24). A recent study of prostate size among men aged 40-79 
years living in Scotland, using ultrasound reported that the prevalence of BPH, 
defined as a prostate gland greater than 20 g, was 253 per 1000 (25). 
Prostate size was not correlated with symptoms. 
1.4.3 Operation Rates 
Annual age-adjusted prostatectomy rates in Western countries range from 60 
per 100,000 to 368 per 100,000 (26,27,28,29,30). In general these rates are 
more than twice as high in North America than in England and Wales, and 
Denmark(30). 
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1.4.4 Prevalence of prostatectomy 
Longitudinal studies measuring the prevalence of prostatectomy for BPH in 
American men belonging to a prepaid health care plan reported rates of 129 
per 1000 in men over the age of 40 [Kaiser Permanente 1972-1990J and 55 
per 1000 in men over the age of 50 [Veterans Administration Normative Aging 
Study 1968-90J (13,31). 
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Chapter 2) Indications 
Benign prostatic hyperplasia commonly presents in one or more of three ways: a 
complex of obstructive and irritative urinary symptoms [hesitancy, poor flow, terminal 
dribbling, frequency, feeling of fullness, dysuria and nocturia], chronic retention and 
, 
acute retention. In a recent study, about one third of patients were symptomatic, one 
third had evidence of chronic retention (with or without a history of acute retention 
andlor symptoms) and one third had a history of acute retention (with or without 
symptoms) (32). There is considerable uncertainty about the appropriate indications 
for prostatectomy because there has been little research relating outcomes of 
treatment to indications. This section will review the available evidence. 
2.1 History and Urinary Symptoms 
Symptoms are generally regarded as either obstructive [hesitancy, poor flow, 
dribbling, a feeling of fullness] or irritative [frequency, nocturia and dysuria]. In studies, 
four commonly used symptom scoring systems [Madsen-Iversen, Boyarsky, Fowler 
and the American Urological Association Measurement Committee] have been used 
in the U.S.A. to assess the severity of symptoms (33). These indices consist of a 
number of questions on the frequency and severity of symptoms. Irritative symptoms 
may be idiopathic or secondary to BPH, although there is conflicting evidence about 
this (5). Symptoms are difficult to standardise and depend on subjective reports which 
will differ between individuals (34). 
2.2 Chronic Retention 
Chronic urinary retention may be defined incomplete emptying of the bladder and is 
distinguished from acute retention by the absence of pain. Symptoms include: 
recurrent urinary tract infection, residual urine after micturition, overflow incontinence, 
-165-
bladder damage and eventually symptoms of renal failure. In one series of 388 
patients undergoing surgery for chronic retention, all had either a history of acute 
retention or obstructive or irritative symptoms (32). 
2.3 Acute Retention 
The presenting features of acute retention are: abdominal pain, a full bladder, and a 
continued inability to urinate. Acute retention is generally considered to be an absolute 
indication for prostatectomy in the absence of detrusor failure or neuropathic 
obstruction (35). Fifty eight to seventy per cent of patients presenting with acute 
retention had another episode of retention within one week in a trial without catheter 
(36,37). In two reports, 28% to 34% of prostatectomies were performed for acute 
retention (38,39). In contrast, others have argued that acute retention is not an 
absolute indication for prostatectomy, as it can often be explained by prostatic 
infarction. Men who are able to void successfully after a period of catheter drainage 
has allowed post-infarction oedema to resolve are eligible for conservative treatment 
with regular follow-up, providing there is no evidence of chronic retention (40,41). It 
has been argued that this is also true for acute retention precipitated by bed rest, 
diuresis or anticholinergic drugs (42). 
2.4 Examination 
2.4.1 Abdominal examination 
Abdominal examination will provide evidence of incomplete emptying of the 
bladder. The bladder is palpated for fullness and pain may be evidence of 
infection. 
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2.4.2 Digital Rectal Examination 
Digital rectal examination is not predictive either of the extent of obstruction, 
symptoms, or post-operative outcomes (43,44,45). Thus an enlarged prostate 
in itself is not an indication for an operation. The usefulness of digital rectal 
examination lies in its ability to distinguish prostatic cancer from BPH due to 
its texture. It is believed that an enlarged prostate from BPH will exhibit a 
symmetrical and smooth, rubbery character; prostatic cancer will exhibit more 
of a hard, craggy mass (44). 
2.5 Investigations 
Routine pre-operative investigations include blood pressure and tests for 
haemoglobin, blood urea and serum creatinine. As many patients are elderly, a chest 
x-ray and ECG will usually be performed. A mid-stream urine will be collected and 
cultured for evidence of infection. Serum acid phosphatase levels may be measured 
to exclude the possibility of prostatic cancer, although because these levels may be 
high in the absence of cancer, they are of limited use. Some patients also undergo 
imaging (radiography or ultrasound) and pre-operative urodynamic studies to provide 
more evidence about the nature and effect of the obstruction. 
2.5.1 Imaging 
Imaging is performed to find residual urine, upper tract dilatation and bladder 
stones. Residual volume is evidence of painless retention. However, residual 
urine may originate from other causes than outflow obstruction and some 
patients with severe obstruction may present with no post-residual urine (46). 
Residual volume is not correlated well with symptoms, results of urodynamic 
studies, cystoscopy and post-operative outcome (5,47). No study has reported 
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a positive correlation between pre-operative residual urine and post-operative 
outcome (5). Routine intravenous urograms are not recommended because 
it has no advantage over abdominal radiology and ultrasonography (2S,48,49). 
It is however, indicated for haematuria (5). 
2.5.2 Urodynamic Studies 
There is controversy surrounding the use of urodynamic assessment prior to 
prostatectomy (5). A current surgical textbook advocates the use of 
urodynamics (44) even though studies have concluded that measurements of 
urinary flow are not associated with symptoms or with the outcomes of 
prostatectomy (12,34,50,51,52,53,54,55,56). A recent study in the UK found 
that urodynamic studies were conducted in only 26% in patients (57). If there 
is a suspicion of detrusor instability evidenced by frequency, urgency and urge 
incontinence, then pressure flow studies may be important in order to avoid 
the unnecessary inappropriate surgery (48). 
2.5.3 Cystometry 
Cystometry to measure detrusor contractions of the bladder (which may 
explain irritative symptoms in some patients) was unable to predict those with 
detrusor contractions fol/owing surgery (50,58). In a recent review of the 
indications for prostatectomy it was stated that cystometry did not identify 
patients who would benefit from surgery (5). 
2.6 Age 
Although there is an independent effect of age on mortality, advanced age does not 
appear to be a contra-indication to prostatectomy. A case-series of men over the age 
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of 90 who underwent prostatectomy has been reported (59). Investigators in Germany 
concluded that age was not a determinant of the frequency of peri-operative 
complications (60). 
2.7 Co-morbidity 
The contra-indications for prostatectomy are few. Poor physical condition of patients 
need not preclude surgery (44). Co-morbidity may be measured in terms of the 
operative anaesthetic risk during the operation, or by life expectancy. The risks 
associated with a general anaesthetic can be avoided by using a spinal anaesthetic 
although spinal anaesthesia is associated with its own risks, especially for those 
patients who are on anti-coagulants. A study examining the effect of comorbidities on 
outcome was unable to identify subgroups of patients more likely to suffer 
complications because oftheir comorbidities (60). However, patients hospitalized with 
high risk diagnoses in the year before surgery have been found to have an increased 
relative risk of death: 1.46 [95% CI, 1.14-1.87] for those hospitalised 6 months prior 
to surgery and 1.54 [95% CI, 1.13-2.10] among those hospitalised 7 - 12 months prior 
to surgery (8,61). 
2.7.1 Cardiovascular disease 
For patients with a recent myocardial infarction (MI) or stroke, it is claimed that 
prostatectomy should be delayed by 6 months but no evidence is given (44). 
A past history of MI more than 6 months previously is not claimed to be a 
contra-indication. Following a stroke, an assessment should be undertaken to 
exclude neuropathic obstruction (44). Patients on digitalis have a relative risk 
of death of 1.4 [95% CI, 1.1-1.78] (8). 
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2.7.2 Chronic Obstructive lung Disease 
Severe bronchitis and emphysema are not thought to be contra-indications for 
prostatectomy providing a careful pre-operative assessment has taken place 
(44). 
2.8 Timing of Surgery 
The attitude of surgeons to the timing of surgery is another area of potential 
disagreement. There are two conflicting views; a preventive approach that argues that 
prostatectomy should be performed early in the course of BPH to avoid the elevated 
risks of surgery associated with advancing age, and a quality of life theory that argues 
that in the absence of actual or impending renal dysfunction, surgery should only be 
performed to produce improvements in symptoms status or quality of life (62). The 
quality of life theory argues that eventual prostatectomy is not inevitable and suggests 
that watchful waiting is the appropriate management. Early surgery also increases the 
probability of a repeat operation. 
2.9 Summary 
There appear to be three main indications for TURP; chronic retention, acute retention 
and symptoms. Digital examination appears to be of little use except to aid in the 
differential diagnosis of cancer. There is little evidence to support the use of urograms 
and imaging. Symptom scoring systems are useful to monitor outcome but are rarely 
used. There is no firm evidence of contra-indications for TURP. 
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Chapter 3 - Treatments 
Treatments for BPH may be classified broadly as either surgical or medical. In 
general, the surgical approach attempts to remove the obstruction and the medical 
approach tries to shrink or relax the smooth muscle of the prostate gland. The most 
commonly used treatment for BPH is prostatectomy (63). A recent editorial in the 
Journal of the American Medical Association stated that it was unlikely that medical 
therapies would replace prostatectomy as the standard treatment for BPH (7). 
3.1 Surgical 
3.1.1 Transurethral Resection of the Prostate (TURP) 
The standard treatment for BPH is transurethral resection of the prostate. A 
resectoscope is passed along the urethra and either a cold punch or hot loop 
is used to resect the obstructing tissue from the lumen of the urethra. TURP 
accounts for 90-95 percent of prostatectomies performed in the U.S.A. under 
Medicare and at least 95% in the UK (8,64,65). 
3.1.2 Open 
A suprapubic or retropubic incision is made and the adenoma is excised. One 
textbook of surgery advises open prostatectomy if the prostate gland is greater 
than 100 g (44). 
3.1.3 Urethral Stenting 
A tube woven out of specially treated wire is placed endoscopically into the 
urethra and left there. Often stents are used for patients who are unfit for 
prostatectomy. Stents are being evaluated at a number of centres in Europe 
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and by the Federal Drug Administration (FDA) of the U.S.A. (66). 
3.1.4 Hyperthermia 
A probe is inserted into the urethra or rectum and microwaves are generated 
to heat the prostate to a temperature no greater than 44°C (less than the level 
where necrosis occurs). A variation of this approach uses alternate cooling 
and heating of the prostate. Repeated treatments are usually necessary (66). 
3.1.5 Crvo-surgery 
A cryoprobe is inserted into the urethra and the obstructive tissue is frozen 
into an iceball. The necrotic tissue is then voided naturally - in some 
circumstances, the tissue must be resected. Cryo-surgery is used for those 
who are unfit for surgical intervention (66). 
3.1.6 Balloon Dilatation 
A balloon is placed in the urethra in the location of the obstruction and inflated 
to displace the obstructing tissue. The success of this procedure is uncertain; 
some centres report favourably, while others report little long-term benefit. It 
has been extensively evaluated and been found that the effects are temporary 
- symptoms often return within a year (66). 
3.1.7 laser 
Several centres are evaluating the use of lasers that originate from a balloon 
inflated in the obstructive tissue. laser treatment of BPH is still in the early 
stages of development (66). 
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3.1.8 Other 
A number of other treatments have been suggested as possible treatments for 
BPH; they include high intensity focused ultrasound, high energy shock wave 
treatment, and pyrotherapy (66). 
3.2 Medical 
Although pharmacological agents have been successful in reducing the size of the 
prostate and relieving symptoms of obstruction, many individuals do not respond to 
medical treatment and a recent review article concluded that non-operative 
management of BPH was unlikely to challenge prostatectomy as the preferred 
treatment (21). 
3.2.1 Alpha-adrenergic Blockers 
Alpha-adrenergic blockers cause the relaxation of the smooth muscle of the 
prostate and bladder neck (21). 
3.2.2 Hormonal 
The use of hormonal treatments for BPH rests on the observation that men 
who have been castrated or lack testosterone never develop BPH. 
Consequently treatments have been tried which inhibit the binding effect of 
these hormones resulting in a shrinkage ofthe prostate gland, although there 
are unpleasant adverse effects (21). 
3.2.3 Proscar 
Proscar is 5-a reductase inhibitor that prevents the conversion of testosterone 
to dihydrotestosterone that is associated with the growth of the prostate. The 
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results of one clinical trial of Proscar are inconclusive (7). 
·174· 
Chapter 4 • Outcomes of TURP 
Outcomes research is a way of answering the basic question of whether patients 
benefit from surgery. Commonly used measures of outcome are: mortality, 
complications, symptom change, general health status, quality of life, and reoperation. 
The data reported here are derived from (a) case ser:ies or longitudinal administrative 
databases with followup of mortality, further illness episodes and reoperation rates, 
and (b) prospective cohort studies which follow patients for up to one year. The 
following sections refer exclusively to TURP. 
4.1 Mortality 
Published case-series from several different countries suggest that 90 day post-
operative mortality rates range from 1% - 9% (8,28,38,39,59,64,67,68,69,60,71,72). 
The age-adjusted cumulative risk of dying obtained from population-based studies 
within 90 days was found to be 1 % and 4% in two studies (60,73). In-hospital 
mortality rates are of little relevance as sixty per cent of deaths within 90 days occur 
after discharge from hospital (72). A meta-analysis incorporating the results of 150 
studies and reflecting a sample of 50,000 patients determined that the 90 day 
mortality was 1.5% [95% confidence interval (CI), 1.3· 1.7] (44). Mortality increases 
with increasing length of time after surgery. Roos and colleagues have reported that 
the risk of death in three different countries [Canada, Denmark and the U.K.] increase 
from 10% at 1 year to 50% at 8 years (8,72,75). The higher rates observed in 
population stUdies may arise in part from selection bias that is a recognised feature 
of case-series. Different investigators may use different inclusion criteria for patients 
and results are more likely to be reported if they demonstrate an improvement on 
previous case-series. The extent to which deaths are associated with TURP is 
uncertain. Results of the comparison of post-operative death rates with mortality in the 
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general population are conflicting. In Rochester, Minnesota average annual mortality 
rates over a 6 year period following prostatectomy were not statistically different from 
the rates of men who had not undergone prostatectomy (28). Similar results were 
obtained in the U.K. (39). In contrast, a study in men between the ages of 65 and 69 
undergoing prostatectomy had more than twice the expected mortality rate compared 
with age-matched men who had not undergone prostatectomy (76). There are 
considerable differences in the mortality achieved by different hospitals. There 
appears to be an association with hospital size in the USA (72). Compared with 
hospitals of over 300 beds, the relative risk of death is 1.51 (95% CI, 1.01-2.27) in 
hospitals of 150-300 beds and 1.79 (95% CI, 1.24-2.59) in hospitals of under 150 
beds. In summary, the 90 day mortality associated with TURP is around 1.5%. 
4.2 Complications 
The incidence of post-operative complications prior to discharge has been reported 
as about 18% to 23% (38,39,62,70). A meta-analysis reported that 'general 
complications' will develop in 6% - 32% [95% Cll following surgery (74). Problems 
arise in measuring the prevalence of complications because: definitions differ; severity 
is dependent on who reports the symptoms; and on the length of time following 
surgery. The most common complications of prostatectomy are bleeding, urinary 
retention, urinary infection, incontinence, and impotence. The incidence of 
complications depends partly on whether the surgeon or the patient is the source of 
information; patients report complications more than surgeons (77). 
4.2.1 Bleeding 
Widespread differences in the reporting of bleeding following prostatectomy 
can be attributed to differences in the definition of bleeding. Bleeding requiring 
-176-
transfusion has been reported in 3% - 4% of cases prior to discharge (38,68). 
Bleeding leading to clot retention was found in 11 % before discharge (39). 
Most patients (90%) reported some post-operative bleeding, but only 14% saw 
their GP and only 1 % required readmission (39). In two studies, 2.3% - 5.8% 
of patients required re-hospitalization because of bleeding (28,73). 
4.2.2 Urinary Retention 
Between 15% and 19% of patients reported one or more episodes of urinary 
retention due to blood clots within 3 months of discharge from hospital (78). 
In two studies, 4% - 5% of patients developed retention serious enough to 
require hospitalization following surgery (28,39). Five years post-discharge, 
19% of patients reported the 'sensation of retention' (79). 
4.2.3 Infection 
Urinary tract infection (UTI) is a commonly reported complication of 
prostatectomy. Reported rates following surgery vary from 2% - 20% 
(38,39,65,68,78). In general these rates are high; the low rate of 2% refers to 
UTI confirmed by culture in one study. 
4.2.4 Incontinence 
Thirty eight percent reported incontinence 3 weeks after discharge (39). This 
had fallen to between 1% - 20% (50,65,67,68,78,79) one year after surgery 
and to 3% at 5 years later (79). A meta-analysis reported the long-term 
prevalence of incontinence was 0.8% [95% CI, 0.6%-1.2%] (74). 
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4.2.5 Sexual Problems 
Sexual problems such as erectile impotence or retrograde ejaculation are 
reported following surgery. Of men who were able to have an erection before 
surgery, 5% report that they were unable to have an erection 3, 6, and 12 
months after surgery (39,78). In contrast, a study in Germany reported that 
surgery had no significant effect on the prevalence of impotence (80). A meta-
analysis suggested that 3.4% - [95% CI, 3.3 - 3.5] will develop impotence (74). 
Between 50% and 93% percent of men reported retrograde ejaculation 
(69,79). Thirty four percent of sexually active men reported that the operation 
had made their sex life worse (69). 
4.2.6 Strictures 
The occurrence of stricture is a complication of surgery. Temporary stricture 
after surgery occurs in 0.6 - 0.8% (65,68,69). Stricture that was serious 
enough to require regular intermittent dilatation or a urethroplasty ranged from 
1.2% - 7% one year after discharge (65,73). Those patients 3.9% - 4.6% 
serious enough to have dilatation at within 5 years from discharge (76,79). 
4.2.7 Deep Vein Thrombosis 
The occurrence of pulmonary embolism as a result of deep vein thrombosis 
has been reported in two case-series as 0.1 % - 0.4% (65,68). 
4.2.8 Perforation 
Perforations that were large enough to be noticed and serious enough to 
warrant drainage have been reported in 0.4% - 0.5% of patients undergoing 
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TURP (65,68). 
4.3 Symptoms 
A number of studies have assessed changes in post-operative symptoms using 
symptom scoring indices, where ordinal scales for symptoms obtained by a 
questionnaire are combined into a single measure. Following prostatectomy, the 
proportion of men who reported an improvement in symptoms ranged from 70% - 90% 
(39,51,52,53,65,68,69,74,79). The extent of improvement is related to: pre-operative 
severity; when the symptoms are reported; and differences in the patient perceptions 
of severity. After a year, 93% of severely symptomatic and 79% of those with 
moderate symptoms experienced improvement in a symptom index (78). Seventy two 
per cent reported that they passed water more easily, between 5 and 8 years 
following their operation (69). Nevertheless, a small percentage (5%) of patients 
reported a worsening of symptoms, and 7% of those with severe symptoms reported 
no improvement (78). Further, it is estimated that symptoms will improve 
spontaneously in 50% of elderly men with no treatment, and 31 % will experience an 
improvement in their symptoms within 5 years of having presented with symptoms of 
BPH (12). Generally, obstructive symptoms appear to respond better to TURP than 
irritative ones (61). 
4.4 Health Status 
The Nottingham Health Profile was used to assess self-perceived health status in a 
cohort of 388 men at 3, 6 and 12 months following surgery (32). Sixty per cent of 
those with a health problem prior to operation reported an improvement a year after 
surgery. Patients experienced improvement for all health problems and activities of 
daily living; the most notable change was for sleeping (32). 
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4.5 Quality of Life 
A series of 263 patients in Maine, were interviewed about their quality of life before 
and after prostatectomy (78). Twelve months following surgery, quality of life had 
improved only in those patients who had reported severe symptoms (and especially 
those with a history of acute retention) before surgery. Markov modelling has been 
used to predict that immediate surgery for a 70 year old man with moderate 
symptoms would result in a loss of 1 month in life expectancy, and a net benefit of 3 
quality-adjusted life months (42). However the latter figure is sensitive to the weighting 
used for different health states. In a prospective series of 100 patients, quality of life 
improved significantly (80). 
4.6 Reoperation 
Reoperation rates vary depending on the type of study; case-series will report lower 
rates because of selection and reporting biases, and the length offollowup. One study 
reported a two year cumulative probability of a repeat operation of 3% (81).The 
probability of having a repeat prostatectomy increases with length of followup. At 6 
months reported rates vary from 1% to 9% (8,28,62,65,68,72,74). The eight year 
cumulative reoperation rate is 12% - 20% (8,53,72,73,82). A study using decision 
analysis with American data suggested that a 70 year old man undergoing 
prostatectomy for moderate symptoms but with no evidence of chronic retention had 
a cumUlative probability of at least one further operation during his lifetime of 21% 
(42). In a case series of 2015 cases, 12% reported a previous transurethral 
prostatectomy (70). 
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4.7 Summary 
TURP appears to be associated with post-operative mortality rates of 1 % - 9%; and 
these rates increase with increasing length of time following surgery. The main 
complications of surgery include: bleeding, infection, incontinence, sexual problems, 
strictures, deep vein thrombosis and perforation. Symptoms improve for most men 
undergoing TURP. 
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Appendix A2 - Consensus panel questionnaire 
Appropriateness of TURP 
Consensus Panel Exercise 
The purpose of this exercise is to rate the appropriateness of various indications for TURP, 
taking into account severity of symptoms and levels of comorbidity. 
Assumptions 
We would like you to assume that patients have: a) no pre-operative evidence of prostatic 
cancer, and b) are fit enough to undergo at least a spinal anaesthetic. 
Co-morbidity can be a factor in the decision to operate. We have chosen to use life expectancy 
as an indicator of co-morbidity. Examples of patients at each level of cd-morbidity might be as 
follows. 
Less than 1 year 
1 ·4 years 
inoperable cancer with secondaries 
COAD with dyspnoea on moderate exertion; angina on moderate 
exertion 
5 or more no co-morbidity, hypertension controlled by treatment, osteoarthrosis 
Task: 
Please rate the appropriateness of chronic retention, acute retention, both chronic and acute 
retention or no retention as indications for TURP for each level of severity, and for each level 
of co-morbidity. 
1 = prostatectomy is never indicated 
9 = prostatectomy is always indicated 
Symptom definition 
Irritative symptoms include: 
Obstructive symptoms include: 
None Symptoms never occur. 
frequency, nocturia and dysuria 
hesitancy, poor flow, dribbling and a feeling of fullness 
Mild Symptoms occur occasionally or nocturia occurs once per night 
Moderate 
Severe 
Symptoms occur about half the time or nocturia occurs 2 • 3 times per night 
Symptoms occur most or all of the time or nocturia occurs 4 or more times per 
night. 
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Indications for prostatectomy 
A - Chronic retention: TURP is indicated for patients with chronic retention (but not acute) and there are: 
Irritative Symptoms 
Comorbidity (years of life expectancy) 
High Medium Low 
(less than 1) (1 - 4) (more than 5) 
None 123456789 123456789 123456789 
Mild 123456789 123456789 123456789 
Moderate 123456789 123456789 123456789 
Severe 123456789 123456789 123456789 
Obstructive Symptoms 
Comorbidity (years of life expectancy) 
High Medium Low 
(less than 1) (1 - 4) (more than 5) 
None 123456789 123456789 123456789 
Mild 123456789 123456789 123456789 
Moderate 123456789 123456789 123456789 
Severe 123456789 123456789 123456789 
Combination of Irritative 
and Obstructive Symptoms Comorbidity (years of fife expectancy) 
High Medium Low 
(less than 1) (1 - 4) (more than 5) 
None 123456789 123456789 123456789 
Mild 123456789 123456789 123456789 
Moderate 123456789 123456789 123456789 
Severe 123456789 123456789 123456789 
Indications for prostatectomy 
B - Acute retention: TURP is indicated for patients with acute retention (but not chronic) and there are: 
Irritative Symptoms Comorbidity (years of life expectancy) 
High Medium Low 
(less than 1) (1 - 4) (more than 5) 
None 123456789 123456789 123456789 
Mild 123456789 123456789 123456789 
Moderate 123456789 123456789 123456789 
Severe 123456789 123456789 123456789 
Obstructive Symptoms Comorbidity (years of life expectancy) 
High Medium low 
(less than 1) (1 - 4) (more than 5) 
None 123456789 123456789 123456789 
Mild 123456789 123456789 123456789 
Moderate 123456789 123456789 123456789 
Severe 123456789 123456789 123456789 
Combination of Irritative 
and Obstructive Symptoms 
Comorbidity (years of life expectancy) 
High Medium Low 
(less than 1) (1 - 4) (more than 5) 
None 123456789 123456789 123456789 
Mild 123456789 123456789 123456789 
Moderate 123456789 123456789 123456789 
Severe 123456789 123456789 123456789 
Indications for prostatectomy 
C - Acute and Chronic retention: TURP is indicated for patients with acute and chronic retention and there are: 
Irritative Symptoms Comorbidity (years of life expectancy) 
High Medium Low 
(less than 1) (1 - 4) (more than 5) 
None 123456789 123456789 123456789 
Mild 123456789 123456789 123456789 
Moderate 123456789 123456789 123456789 
Severe 123456789 123456789 123456789 
Obstructive Symptoms Comorbidity (years of life expectancy) 
High Medium Low 
(less than 1) (1 - 4) (more than 5) 
None 123456789 123456789 123456789 
Mild 123456789 123456789 123456789 
Moderate 123456789 123456789 123456789 
Severe 123456789 123456789 123456789 
Combination of Irritative 
and Obstructive Symptoms Comorbidity (years of life expectancy) 
High Medium Low 
Qess than 1) (1 - 4) (more than 5) 
None 123456789 123456789 123456789 
Mild 123456789 123456789 123456789 
Moderate 123456789 123456789 123456789 
Severe 123456789 123456789 123456789 
Indications for prostatectomy 
o - No retention: TURP is indicated for patients with no retention (but not acute) and there are: 
Irritative Symptoms 
None 
Mild 
Moderate 
Severe 
Obstructive Symptoms 
None 
Mild 
Moderate 
Severe 
Combination of Irritative 
and Obstructive Symptoms 
None 
Mild 
Moderate 
Severe 
High 
(less than 1) 
123456789 
123456789 
123456789 
123456789 
High 
(less than 1) 
123456789 
123456789 
123456789 
123456789 
High 
(less than 1) 
123456789 
123456789 
123456789 
123456789 
Comorbidity (years of life expectancy) 
Medium 
(1 - 4) 
123456789 
123456789 
123456789 
123456789 
Comorbidity (years of life expectancy) 
Medium 
(1 - 4) 
123456789 
123456789 
123456789 
123456789 
ComOrbidity (years of life expectancy) 
Medium 
(1 - 4) 
123456789 
123456789 
123456789 
123456789 
Low 
(more than 5) 
123456789 
123456789 
123456789 
123456789 
Low 
(more than 5) 
123456789 
123456789 
123456789 
123456789 
low 
(more than 5) 
123456789 
123456789 
123456789 
123456789 
Appendix A3 - Initial questionnaire 
London School of Hygiene and Tropical Medicine 
(University of London) 
Men's Urinary Symptom Questionnaire 
Please circle one number for each question that best 
describes your experience over the past month. 
L ... About M_ 
Novo< HlrdIy 111ft MW ,.." Almo., 
..... 
- tho tho _tho otwly' lime ..... ..... 
~ 1·19% 20-39% «l-_ t!C).~ t!C).,~ 
1. In the past month, how often did you feel 0 1 2 3 4 5 
that your bladder did not empty fully after 
urinating? 
2. In the past month, how often did you have 0 1 2 3 4 5 
to 'go again' within 2 hours of urinating? 
3. In the past month, how often did you stop 0 1 2 3 4 5 
and start several times when you urinated? 
4. In the past month, how often have you 0 1 2 3 4 5 
found it difficult to postpone urinating? 
5. In the past month, how often have you had 0 1 2 3 4 5 
a weak urinary stream? 
6. In the past month, how often have you had 0 1 2 3 4 5 
to push or strain to start urinating? 
Times per night 
7. In the past month, how many times did you 1-3 4-5 6-7 8·8 1~11 12 or more 
get out of bed at night to urinate? 
No 'V.ry ,meU Smen Medium 81g 
problem problem problem problem problem 
8. Overall, how bothersome has any trouble 0 1 2 3 4 
with urinating been during the past month? 
R.r·'y Enough to H.d to we., I 
orn,v" .mb.". .. me I ptd 10 lilY dry 
9. Over the past month, have you had any 0 1 2 
leakage of urine? 
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10. If you were to spend the rest of your life with your current urinary condition, how would you feel 
about it? 
Delighted Pleased 
o 
Not bothered 
either way 
2 
Unhappy Terrible 
3 4 
11. In the past month, how much of the time has any urinary problem kept you from doing the kinds 
of things you would usually do? 
Never 
o 
Some of 
the time 
1 
Most of 
the time 
2 
All of 
the time 
3 
12. Has your prostate condition ever caused you to be blocked up completely so that you could not 
urinate at all? 
Yes No 
1 2 
13. Have you ever had prostate surgery? Yes No 
If so, when? _______ _ 1 2 
14. Have you been prescribed any antibiotic tablets for urine infection by your doctor within the last 
two years? 
Yes No 
1 2 
15. Do you have any other health conditions that affect the way you feel or the things that you can 
do at this time? 
a ____________________ _ b ______________ _ c. ________________ _ 
16. Date of Birth _____ day _____ month _____ year 
17. Which situation best describes how you and your household occupy your accommodation? 
Buying the property 
through mortgage or loan 
1 
Owning the 
property 
2 
Rented 
Privately 
3 
Rented from 
local authority 
4 
18. How many cars or vans are normally available for use by you or members of your household? 
None One Two Three or more 
o 1 2 3 
19. How would you define your ethnic background? 
'Nhite Black Black Black Indian Pakistani Bangladeshi Chinese Other (sp,clff) 
Caribbean African Other 
1 2 3 4 5 6 7 8 
Thank-you very much for your help. Please return the completed questionnaire in the envelope provided. 
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Appendix A4 - Covering letter to the initial survey 
[address here] 
DRS JONES KARAME HESLOP BAKER AND TAINE 
BROOK END SURGERY 
POTTON,SANDY,BEDS 
SG192QS 
TEL POTTON 260 340 
Dear [name here], 
We are writing to ask you to participate in a study being conducted by the London 
School of Hygiene and Tropical Medicine. The study will find how many men in the 
community have trouble with their prostate that leads to difficulties urinating. The 
results will be important for planning health services. 
The questionnaire should take you less than 5 minutes to complete and your name 
and answers will remain strictly confidential. If you have any specific questions about 
the study please contact either of us. 
Please return the completed questionnaire in the envelope provide. Thank-you for 
your help 
Sincerely yours 
Dr M A Karame 
Duncan Hunter 
Research Fellow 
Health Services Research Unit 
London School of Hygiene and 
Tropical Medicine 
071 9272258 
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Appendix AS - Follow-up questionnaire 
London School of Hygiene and Tropical Medicine 
(University of London) 
Men's Urinary Symptom Questionnaire 
Please circle one answer for each question that best describes 
your experience over the past month. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
In the past month, how often did you have 
to 'go again' within 2 hours of urinating? 
How often did you avoid some activity (eg. 
going out with friends, shopping etc.) 
because you are worried about needing a toilet? 
How often do you avoid some activity 
because you are worried about wetting yourself 
in public? 
How often do you avoid using public toilets 
Lo.. AbouI U.,.. 
N_ Hardly"'" haW ..." AJmo., 
...,., hlW the the hili the IIwIYO 
............ 
~ ,.,~ 2O-~.o-~ ~N'Mo 110-100'lI0 
o 1 2 3 4 5 
0 1 2 3 4 5 
0 1 2 3 4 5 
0 1 2 3 4 5 
because you may have difficulty starting to urinate? 
How often are you embarrassed about 0 1 2 3 4 5 
having to use the toilet often? 
How often do you limit the amount you drink 0 1 2 3 4 5 
because of any urinary symptom you might 
experience? 
Times per night 
In the past month, how many times did you Non. 1 2 :s .. 15 Of more 
get out of bed at night to urinate? 
No Very .mell Smen Medium Big 
pIOblem pIOblem pIObl.m ptObltm ptOblem 
Overall, how bothersome has any trouble 0 1 2 3 4 
with urinating been during the past month? 
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9. In general, compared to other persons of your age, would you say that 
your health is: 
Excellent Very Good Good Fair Poor 
0 1 2 3 4 
10. Overall, how long would you say you have had your urinary symptoms? 
Less than 1 - 2 3-4 5-9 10 or more 
a year years years years years 
0 1 2 3 4 
We would now like to know about anything you've done about your 
urinary symptoms. 
11. Have you sought advice from any of the following? Tick more than 1 if 
necessary 
relatives [] 
friends 
chemist 
nurse 
] 
] 
GP ] if yes, please answer Question 12. 
12. If you have spoken to your GP, what happened? 
I was offered reassurance [ ] 
I was prescribed pills [1 
I was referred to a hospital [ J if yes, please answer Question 13. 
surgeon or urologist 
13. If you were referred to a hospital surgeon or urologist, what happened?, 
I am still waiting to be seen [ ] 
I did not attend [ 1 
I was offered reassurance [ ] 
I was prescribed pills [ ] 
I was offered surgery but declined [ ) 
I was offered surgery and accepted [ 
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The Nottingham Health Profile 
Listed below are some problems people may have in their daily life. Look 
down the list and put a tick in the box under yes for any problem you have at 
the moment. Tick the box under no for any problem you do not have. Please 
answer every question. If you are not sure whether to say yes or no, tick 
whichever answer you think is more true at the moment. 
I'm tired all the time 
I have pain at night 
Things are getting me down 
I have unbearable pain 
I take tablets to help me sleep 
I've forgotten what its like to enjoy myself 
I'm feeling on edge 
I find it painful to change position 
I feel lonely 
I can only walk about indoors 
I find it hard to bend 
Everything is an effort 
I'm waking in the early hours of the morning 
I'm unable to walk at all 
I'm finding it hard to make contact with people 
The days seem to drag 
I have trouble getting up and down the stairs or steps 
I find it hard to reach for things 
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Yes No 
[ ] [ ] 
[ ] [ ] 
[ ] [ 
Yes No 
[ ] [ ] 
[ ] [ ] 
[ ] 
Yes No 
[ ] [ ] 
[ ] [ ] 
[ ] [ ] 
Yes No 
[ ] [ ] 
[ ] [ ] 
[ ] [ ] 
Yes No 
[ ] [ ] 
[ ] [ ] 
[ ] [ ] 
Yes No 
[ ] [ ] 
[] ] 
[ ] [ ] 
Remember if your are not sure whether to answer yes or no to a problem 
tick whichever answer you think is more true at the moment 
I'm in pain when I walk 
J lose my temper easily these days 
I feel there is nobody I'm close to 
I lie awake most of the night 
I feel as if I'm losing control 
I'm in pain when I'm standing 
I find it hard to dress myself 
I soon run out of energy 
I find it hard to stand for long 
(eg. at the kitchen sink, waiting for a bus) 
I'm in constant pain 
It takes me a long time to get to sleep 
I feel I am a burden to people 
Worry is keeping me awake at night 
I feel that life is not worth living 
I sleep badly at night 
I find it hard to get on with people 
I need help to walk about outside 
(eg. a walking aid or someone to support me) 
I'm in pain when going up & down stairs or steps 
I wake up feeling depressed 
I'm in pain when I'm sitting 
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Yes No 
[ ] [ ] 
[ ] [ ] 
[ ] [ ] 
Yes No 
[ ] [ ] 
[ ] [ ] 
] [ ] 
Yes No 
[ ] [ ] 
[ ] [ ] 
[ ] [ 1 
Yes No 
[ 1 [ ] 
[ ] [ ] 
] ] 
Yes No 
[ ] [ ] 
[ ] [ ] 
[ ] [ ] 
Yes No 
[ ] [ ] 
[ ] [ ] 
[ [ ] 
Yes No 
[ ] [ ] 
] [ ] 
Now we would like you to think about the activities in your life which may 
be affected by health problems. 
In the list below, tick yes for each activity in your life which Is being 
affected by your state of health. Tick no for each activity which Is not 
being affected, or which does not apply to you. 
Is your present state of health causing problems with your ... 
Job of work 
(that is paid employment) 
Yes No 
[ ] [ ] 
Looking after the home [ ] [ ] 
(Examples: cleaning & cooking, repairs, 
odd jobs around the home) 
Social life ] [ 
(Examples: going out, seeing friends, 
going to the pub etc.) 
Home life [ ] [ 
(That is: relationships with other 
people in your home) 
Sex life [ ] 
Interests and hobbies [ ] [ 
(Examples: sports, arts and crafts, 
dO-it-yourself etc.) 
Holidays [ ] [ 
(Examples: summer or winter holidays, 
weekends away etc.) 
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The SF·36 Health Status Questionnaire 
The following questions ask for your view about your health, how you fell and 
how well you are able to do your usual activities. If you are unsure about how 
to answer any question, please give the best answer you can and make any 
comments in the space available after question 10. Please tick one 
1. In general would you say your health is: Excellent [ ] 
Very good [ ] 
Good [] 
Fair [] 
Poor [] 
2. Compared to one year ago, how would you rate your health in general now? 
Much better than one year ago [] 
Somewhat better than one year ago [ ] 
About the same [ ] 
Somewhat worse than one year ago [ ] 
Much worse now than one year ago [ ] 
HEALTH AND DAILY ACTIVITIES 
3. The following questions are about activities you might do during a 
typical day. Does your health limit you in these activities? If so how 
much? 
Please tick one box on each line 
a. 
b. 
vigorous activities, such as 
running, lifting heavy objects, 
participating in strenuous sports 
Moderate activities, such as 
moving a table, pushing a 
vacuum cleaner, bowling or 
playing golf 
c. Lifting or carrying groceries 
d. 
e. 
f. 
Climbing several flights of stairs 
Climbing ~ flight of stairs 
Bending, kneeling or stooping 
g. Walking more than a mile 
h. Walking half a mile 
I. Walking 100 yards 
j. Bathing and dressing yourself 
Yes, 
limited 
a lot 
[ ] 
[ ] 
[ 
[ 
[ 
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Yes, 
limited 
a little 
[ ] 
[ J 
~nt 
t'TiJj 
at all 
[ ] 
[ ] 
4. During the past 4 weeks, have you had any of the following problems 
with your work or other regular daily activities as a result of your 
physical health? 
Answer Yes or No to each question 
a. Cut down on the amount of time, you spent on 
work or other activities 
b. Accomplished less than you would like 
c. Were limited in the kind of work or other activities 
d. Had difficulty performing the work or other activities 
(ego it took extra effort) 
YES NO 
I ] [ ] 
J [ 
] [ 
5. During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)? 
a. Cut down on the amount of time you spent on 
work or other activities 
b. Accomplished Jess than you would like 
Answer Yes or No to each question 
YES 
[ ] 
NO 
] 
c. Didn't do work or other activities as carefully as usual 
6. During the past 4 weeks, to what extent has your physical health or 
emotional problems interfered with your normal social activities with 
family, friends, neighbours or groups? 
Please tick one 
Not at all [ ] 
Slightly [ ] 
Moderately [ ] 
Quite a bit [ ] 
Extremely [ ] 
7. How much bodily pain have you had during the past 4 weeks? 
None [] 
Very mild [ ] 
Mild [] 
Moderate [ ] 
Severe [] 
Very severe [ ] 
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8. During the past 4 weeks, how much did pain interfere with your normal 
work (including work both outside the home and housework)? 
YOUR FEELINGS 
Not at all [ ] 
Slightly [] 
Moderately [ ] 
Quite a bit [ ] 
Extremely [ ] 
9. These questions are about how you feel and how things have been with 
your during the past month, (for each question, please indicate the one 
answer that comes closest to the way you have been feeling) 
How much time during 
the past month: 
a. did you feel full of life? 
b. Have you been a very nervous 
person? 
c. Have you felt so down in the 
dumps that nothing could cheer 
you up? 
d. Have you felt calm and peaceful? 
e' Did you have a lot of energy? 
f. Have you felt downhearted and 
low? 
g. Did you feel worn out? 
h. Have you been a happy person? 
i. Did you feel tired? 
j. Has your health limited your 
social activities (like visiting 
friends or close relatives)? 
Please tick one box on each line 
All Most A good Some A little None 
of the of the bit of of the of the of the 
time time the time time time time 
[ 
[ 
] 
] 
HEALTH IN GENERAL 
10. Please choose the answer that best describes how true or false each 
of the following statements is for you? 
Definitely Mostly Not 
true true 
a. I seem to get ill more easily [ ) [ 1 
than other people 
b. I am as healthy as anybody 
I know 
c. I expect my health to get 
worse 
d. My health is excellent 
Comments 
-204-
Mostly 
sure 
[ I 
Definitely 
false 
[ I 
false 
( I 
Choice of treatment 
The most common treatment for urinary problems caused by enlargement of 
the prostate gland is surgery. This involves passing an instrument like a small 
telescope up the penis to clear the blockage. It usually involves a hospital stay 
of about 8 days. About 80% of men experience an improvement in their 
symptoms following surgery, about 15% are unchanged and 5% worse off. 
Some men will also have difficulty getting an erection after surgery. In addition, 
about 10% have complications, such as bleeding, infections and leakage of 
urine, which normally clear up within a few weeks. 
If your urinary symptoms were found to be due to an enlarged prostate and 
you were offered surgery for it, feeling the way you do now, would you choose 
to have it? 
defin~ely 
want 
o 
probably 
want 
1 
not lure but 
Inclined to yes 
2 
not lure but 
inclined to no 
3 
probably 
don' want 
4 
definHaly 
don' want 
5 
Thank you very much for your help. Please return the completed questionnaire in the 
envelope provided. 
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Appendix A6 - Covering letter to the follow-up survey 
[address here] 
Dear [name here], 
Dr. Helen M. Murphy 
Dr. N. Elizabeth Lee 
'The Surtjery 2 HlnWIIY Place London WI9 90F 
Telephone: 071·32~760 
Thank you for returning out recent questionnaire about urinary symptoms. For the 
final part of this project, we are sending a more detailed questionnaire to those who 
reported symptoms. The purpose of the second questionnaire is to learn about the 
effect that urinary symptoms may have on your quality of life. 
We would be very grateful if you took about ten minutes to complete the enclosed 
questionnaire and return it in the envelope provide. Your name and answers will 
remain strictly confidential. 
If you have any further questions about the study or would like to receive the results 
of the survey, please contact either of us. Thank-you in advance for your help. 
Sincerely yours, 
Dr. N. Elizabeth Lee 
The Surgery 2 Hanway Place 
London W1 P 9DF 
Tel: 071 323 0760 
Duncan Hunter 
Research Fellow 
London School of Hygiene and 
Tropical Medicine 
071-927-2258 
-206-
Appendix A7 • Data checks of SF·36 scores 
Formal scoring checks are recommended for the SF·36. After items have been 
recoded the correlations should be positive in direction and substantial in magnitude 
(0.30 or higher). The following table presents the correlation between each scale and 
the component items. 
Scale Item Correlation coefficient 
Physical functioning 3a 0.65 
3b 0.84 
3c 0.82 
3d 0.83 
3e 0.86 
3f 0.78 
3g 0.84 
3h 0.85 
3i 0.79 
3j 0.72 
Physical role 4a 0.87 
4b 0.86 
4c 0.91 
4d 0.87 
Bodily pain 7 1.0 
8 1.0 
General health 1 0.83 
11a 0.65 
11b 0.80 
11c 0.64 
11d 0.81 
Vitality 9a 0.84 
ge 0.82 
9g 0.79 
9i 0.76 
Social functioning 6 0.87 
10 0.92 
Emotional role 5a 0.89 
5b 0.90 
5c 0.86 
Mental health 9b 0.75 
9c 0.85 
9d 0.82 
9f 0.81 
9h 0.78 
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Appendix AS - Modelling Incident need 
The model was developed by Colin Sanderson. 
Methods 
Data on prevalence from the survey were used to estimate the incidence of men with 
moderate or severe urinary symptoms who would probably or definitely want surgery 
if offered it (,candidates for surgery'). A multiple decrement life-table model for men 
aged 0 to 89 was constructed with the following 'states': never a candidate for 
surgery; currently a candidate for surgery; no longer a candidate as a result of 
surgery; candidature withdrawn (due to symptom remission or change of mind about 
wanting surgery); and dead. The overall mortality experience of the population was 
defined by the life table for North West Thames region (178). The model was 
Markovian in the sense that probabilities of moving from one state to another 
depended only on age and the two states involved, and not on any 'history'. Thus for 
candidate for surgery, the probability of having surgery in anyone year was 
dependent on age rather than, for example, duration of symptoms. (These 
probabilities were set to match the observed age-specific rates for prostatectomy in 
the region.) Also it was assumed that, following surgery, all patients had their 
symptoms relieved in the short term, but that there was a constant probability of 
relapse during each year of life thereafter. The model allowed for the division of the 
cohort into two groups with different risks of developing symptoms for which surgery 
was wanted. It was assumed that within a risk group, the incremental Incidence 
(defined in Table 1, with other model parameters would not decrease with Increasing 
age). 
Output consisted of age-prevalence curves that could be matched to the observed 
data, together with figures for cumulative withdrawal and cumulative post-operative 
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rates. Root-mean-square measures of absolute error in the predicted numbers of 
candidates for surgery in five-year bands in a population of 250,000 indicated 
goodness of fit. Using different sets of structural assumptions and age-specific 
incremental incidence rates, a process of trial and error was used to reproduce the 
observed prevalence curves. 
Results 
The first scenario reported here (Table A9.1 and Figure A9.1) involves a simple set 
of assumptions consistent with what is currently known. There was no high-risk group. 
The lifetime rate of candidate withdrawal for the cohort was set at 40% (7) and the 
lifetime post-surgical relapse rate was set at 15%. These were reproduced by the 
model by setting the annual withdrawal rate for all current candidates for surgery to 
6.7% per year and the relapse rate to 1.8% per year. To provide a reasonable match 
to the observed prevalence curves, it was necessary for incidence rates to Increase 
very sharply in men aged between 50 and 59, and for there to be no material 
increase with age thereafter. 
Although the results of scenario 1 lie within the confidence intervals of the observed 
prevalence curve, it was not possible under this set of assumptions to reproduce the 
sharpness of the rise in prevalence from 55-59 at the same time as the flattening after 
the age of 60, and so a high-risk group was introduced. With p as the proportion of 
the cohort in the high risk group and r as the 'risk' or incremental Incidence ratio as 
defined in Table A 10.1, a variety of combinations of p and r were tried. In general, 
values of p around 10% and values of r around 20-50 (e9 scenario 2 with p = 10% 
and r = 50: Table A 10.2, Figure A 10.2) provided better fits than values of p around 
25-50% and values of r around 2-5 (eg scenario 3 with p = 50% and r = 3: Table 
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A 10.2). In addition scenario 2 involved a relative risk of mortality of 2 In the high risk 
group. The sensitivity of the incidence to the assumed candidature withdrawal rate Is 
shown by scenario 4, which is similar to scenario 2 but with a rate of 25% rather than 
40% (Table A10.2). 
The results of this modelling exercise suggest that in a population containing 35,000 
men aged between 50 and 90 (a typical figure for a catchment population of250,OOO) 
there would be 400 to 500 new cases of men with moderate or severe urinary 
symptoms per year, who would probably or definitely choose to have surgery. 
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TableA9.1. Parameters used in the model to estimate incident need. 
Base incremental 
incidence rate 
Surgical rate 
Operative risk 
Post-operative relapse 
Withdrawal rate 
Risk fraction, p 
Relative incremental risk 
for high risk group, r 
Risk lead period for 
high risk group 
Relative risk of mortality 
in high risk group 
for each year of life, the increment in the proportion of the unaffected population who become candidates for surgery, either in the whole population or in the 
low risk group 
the proportion of candidates for surgery that have surgery during the year, for different age groups 
the excess death rate amongst those having surgery in the year following their operation 
the proportion of current non-symptomatic post-surgery cases that develop symptoms in the following year 
the proportion of candidates for surgery at the beginning of the year who were no longer candidates at the end of the year 
the proportion of the initial cohort that falls into the high risk group 
the ratio of the incremental risk of becoming a candidate for surgery in the high risk group to the base incremental rate 
for example, if the annual increment in incidence in the low-risk group is 0.4% in those aged 55-59, a 5-year lead period - but relative incremental risk of 1 -
would imply that the increment in the high risk group was 0.4% in those aged 50-54 
the ratio of age-specifIC mortalities in the high and low risk groups 
Table A9.2. Results from life-table model 
Scenario 1 Scenario 2 Scenario 3 Scenario 4 
Base incremental incidence rate 
0-49 .0000 .0000 .0000 .0000 
50-54 .0020 .0002 .0016 .0002 
55-59 .0028 .0028 .0015 .0024 
60+ .0000 .0004 .0000 .0003 
High risk group 
proportion in group 0 10% 50% 10% 
relative incremental risk 50 2 50 
relative risk of mortality 2 1 2 
Lifetime candidate withdrawal 40% 40% 40% 25% 
Lifetime post-surgical relapse rate 15% 15% 15% 15% 
Predicted prevalence 
50-54 .004 .002 .005 .002 
55-59 .038 .036 .043 .034 
60-64 .099 .112 .102 .110 
65-69 .038 .137 .137 .135 
70-74 .147 .140 .144 .140 
75-79 .138 .131 .133 .131 
80-84 .120 .114 .113 .113 
85-89 .106 .107 .097 .102 
EsUmated incidencel10,OOO men aged 55-89 141 131 137 119 
EsUmated incidence in a typical population of 250,000 492 460 478 416 
Root mean square of model fit (cases) 
age 55-79 71.5 34.6 64.6 32.8 
age 80+ 61.2 68.6 69.9 71.0 
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Appendix A9 - Consensus panel ratings 
A - Chronic retention - median (range) 
Irritative symptoms 
Comorbidity 
High Medium Low 
None 1 (1-2) 5 (2-9) 8 (7-9) 
Mild 2 (1-2) 7 (4-9) 9 {7-9} 
Moderate 5 (3-6) 8 (7-9) 9 (8-9) 
Severe 6 (5-7) 9 (8-9) 9 (9-9) 
Obstructive symptoms 
Comorbidity 
High Medium Low 
None 1 (1-1) 6 (2-9) 8 (5-9) 
Mild 2 (2-2) 7 (4-9) 8 (8-9) 
Moderate 5 (4-6) 7 (7-9) 9 (8-9) 
Severe 7 (6-8) 8 (8-9) 9 (9-9) 
Combination of irritative & obstructive symptoms 
None 
Mild 
Moderate 
Severe 
1 = Never indicated 
9 = Always indicated 
High 
1 (1-2) 
2 (2-3) 
5 (3-6) 
7 (6-8) 
Comorbidity 
Medium 
6 (2-9) 
7 (3-9) 
8 (7-9) 
9 (8-9) 
-213-
Low 
8 (6-9) 
9 (8-9) 
9 (8-9) 
9 (9-9) 
B - Acute retention - median (range) 
Irritative symptoms 
Comorbidity 
High Medium Low 
None 1 (1-2) 3 (2-4) 5 (2-6) 
Mild 2 (2-3) 4 (3-6) 6 (3-7) 
Moderate 4 (4-5) 8 (5-8) 8 (6-9) 
Severe 8 (5-8) 8 (6-9) 9 (8-9) 
Obstructive symptoms 
Comorbidity 
High Medium Low 
None 1 (1-2) 4 (2-6) 6 (2-8) 
Mild 2 (1-4) 4 (3-7) 8 (4-9) 
Moderate 5 (4-7) 8 (6-9) 8 (7-9) 
Severe 8 (7·9) 8 (8-9) 9 (9-9) 
Combination of irritative & obstructive symptoms 
None 
Mild 
Moderate 
Severe 
1 = Never indicated 
9 = Always indicated 
High 
1 (1-2) 
2 (1-3) 
5 (4-7) 
8 (7-9) 
Comorbidity 
Medium 
5 (2-6) 
6 (4-8) 
8 (7-9) 
8 (8-9) 
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Low 
6 (2-9) 
7 (4-9) 
8 (8-9) 
9 (8-9) 
C - Acute on chronic retention - median (range) 
Irritative symptoms 
Comorbidity 
High Medium Low 
None 2 (1-3) 7 (5-9) 8 (7-9) 
Mild 2 (1-5) 8 (6-9) 8 (8-9) 
Moderate 5 (3-8) 9 (8-9) 9 (9-9) 
Severe 7 (5-9) 9 (9-9) 9 (9-9) 
Obstructive symptoms 
Comorbidity 
High Medium Low 
None 2 (1-5) 7 (6-9) 9 (7-9) 
Mild 4 (2-6) 8 (7-9) 9 (8-9) 
Moderate 6 (5-9) 8 (8-9) 9 (9-9) 
Severe 8 (6-9) 9 (9-9) 9 (9-9) 
Combination of irritative & obstructive symptoms 
None 
Mild 
Moderate 
Severe 
1 = Never indicated 
9 = Always indicated 
High 
3 (1-8) 
4 (1-8) 
6 (5-8) 
8 (7-8) 
Comorbidity 
Medium 
7 (5-9) 
8 (7-9) 
8 (8-9) 
9 (9-9) 
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Low 
9 (8-9) 
8.5(8-9) 
9 (9-9) 
9 (9-9) 
D - No symptoms - median (range) 
Irritative symptoms 
Comorbidity 
High Medium Low 
None 1 (1-1) 1 (1-1) 1 (1-1) 
Mild 1 (1-2) 1 (1-2) 1 (1-2) 
Moderate 2 (1-2) 4 (1-4) 5 (3-5) 
Severe 4 (1-4) 5 (1-6) 5 (4-6) 
Obstructive symptoms 
Co morbidity 
High Medium Low 
None 1 (1-1) 1 (1-1) 1 (1-1) 
Mild 1 (1-2) 1 (1-2) 2 (1-3) 
Moderate 3 (2-4) 5 (5-7) 7 (6-8) 
Severe 5 (3-7) 8 (7-8) a (7-9) 
Combination of irritative & obstructive symptoms 
None 
Mild 
Moderate 
Severe 
1 = Never indicated 
9 = Always indicated 
High 
1 (1-1) 
1 (1-2) 
4 (3-4) 
7 (6-7) 
Comorbidity 
Medium 
1 (1-2) 
1 (1-3) 
6 (5-7) 
a (7-9) 
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Low 
1 (1-1) 
2 (1·3) 
7 (6-a) 
a (7·9) 
Appendix A10 • Published papers related to thesis 
1. Hunter DJW, McKee CM, Sanderson CFB, Black NA. Appropriate Indications 
for prostatectomy in the U.K. - results of a consensus panel. J Epidemiol 
Comm Health 1994; 48:58-64. 
2. Hunter DJW, McKee CM, Black NA, Sanderson CFB. Urinary symptoms: 
prevalence and severity in British men aged 55 and over. J Epidemio' Comm 
Health 1994; 48:569-575. 
3. Hunter DJW, McKee CM, Black NA, Sanderson CFB. Health care sought and 
received by men with urinary symptoms, and their views on prostatectomy. Brit 
J Gen Pract 1995; 45:27-30. 
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Appropriate indications for prostatectomy in the 
UK - results of a consensus panel 
D J \X' Hunter. C M McKee. C F B Sanderson, N A Black 
Abstract 
Study objective - The use of forma) con-
sensus development to determine appro-
priate indications for prostatectomy and 
to Identify factors underlying clinical 
decisions about appropriateness is de-
scribed. 
Design - A nominal group technique was 
used. . 
Settings - The study took place In an 
academic research institution. 
Participants - The panel consisted of six 
urologists and three aenera) practi-
tioners. 
Measurements and main results - The 
panel identified agreed indications for 
prostatectomy, expressed in terms of dif-
ferent combinations of type of retention, 
type and severity of symptoms, and lnel 
of comorbidity. Agreement was reached 
for 67% of the indications considered. 
For acute on chronic retention, surgery is 
indicated, regardless of symptom sever-
ity, If life expectancy is greater than one 
year. For acute or chronic retention, Sur-
gery is generally indicated If symptoms 
are severe, or if symptoms are moderate 
and life expectancy is greater than five 
years. For patients with neither acute nor 
chronIc retention, surgery is indicated if 
symptoms are severe, or If these are 
moderate and life expectancy Is gruter 
than five years. For chronic or acute 
retention surgery is inappropriate If 
symptoms are mild and life expectancy Is 
Jess than one year, or If there is no reten-
tion and onl)' mild symptoms. An "ap-
propriateness score" was developed. This 
confirmed that In general the ratings 
were Internally consistent, that the panel 
attached little weight to mild symptoms, 
that a combinadon of irritatJve and ob-
structive symptoms was no more Indica-
tive of surgery than obstructive symp-
toms alone, and that the type ofsymptom 
was less important than the other factor. 
considered. 
Conclusions - The results provide a basis 
for population based surveys of the need 
for prostatectomy. 
(J Epidtmio] Communi,), Health 1994;41:58-64) 
ventions. I-~ The first step i$ to reach comen-
sus, based on the best available evidence. about 
the appropriate indications for the inter\'en· 
tion. The second step is to ascertain the popu· 
lation prevalence of individuals with appropri-
ate indications. The final step is to delermine 
which individuals with clinicalJ)' appropriate 
indications actually want the inter\'ention in 
question. Despite the importance of thi~ t)'pe 
of research, relatively little has b¢en under-
uken. 
Prostatectomy to remove obstruction of the 
urethra arising from benign prostatic hrper-
plasia (BPH);s one of the commonest electi\'(~ 
surgical procedures. Patients commonly pre· 
sent with acute retention, chronie retention. or 
with a complex of obstructive and irritath'e 
symptoms such IS hesitancy, poor flow, termi. 
nal dribbling, frequency, (eelina of fullneu, 
dysuria, and nocturia.' Reported prostatec-
tomy rates in western countries "If)' con$ider· 
ably, from 60 to 368 per 100 OOO.+-· In general. 
the rates in North America are more than t" ic:~ 
IS high as in Europe. E\'en within the Uniled 
Kingdom there is wide variation. The stan. 
dardised prostatectomy ratio adjusted for age 
and prh'ate sector contribution ,'aries in Eng. 
lish regions from 77 to 144 (England-IOO.:-
There is little evidence that this is the rnult of 
differences in the prevalence of BPH, and 
much of the variation seems to result from the 
supply ofsurgical services, incJudina the nail· 
ability of surgeons and their judgement of the 
clinical appropriateness ofsuraery.~ "'11 
A review of published reports suegem only 
limited agreement about the af.'prorri.l~ indio 
cations for prostatectomy. For example, whill: 
some authors state that acute retention in the 
absence of detrusor failure or neuropathic 
obstruction is an Ibsolute indication,': others 
argue in favour of consen'ath'e treatment for 
those who can void succenfully after I period 
of catheter drainage.'''''· A recent study of the 
practiee b¢haviour ofurologim concluded that 
consensus about appropriate practice has yet 
to be Ichieved." A further contro\,eur CenUe> 
on whether it is better to perform ,urier~' 
early, in order to avoid the ,reater risk When 
the patient grows older, or to limit surgen' to 
those patients with symptoms that signitic-
antly affect their quality of life,l. These ar~u. 
menrs have Issumed grealer importance after 
the publication of reports casting doubt on 
previous beliefs about the level of risk auoci. 
ated with transurethral resection of the pn'-
state (TURP)I~ and claims that up t\'\ 7S"" or 
TURPs performed in th~ United Statu mal' 
be inarpropriate." . 
In the reformed National Health Sen'ice, 
health authorities are required to assess the 
needs of their populations and to purchase 
appropriate care. There is emerging agreement 
about the means to be used in assessing need or 
the requirement for specific health care inter-
Formal conSemus developmenr is • method 
o(providing, on the belt a\'aHablt e\'idenc~, an 
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1-3 and appropriate if the median rating fell 
between 7-9. A rating of 4-6 was judged to be 
equh'ocal. The rationale for the use of this 
scoring system has been described elsewhere.~' 
Data were analysed using programs written in 
the statistical program SAS.:~ 
The practical value of listing the appropri. 
a.te~ess of each of 118 patient categories is 
limited and an attempt was made to summarise 
the results by devising a scoring system that 
could be used to estimate the appropriateness 
of surgery for any given patient categor),. With 
type of retention, symptom se\'erity, s),mptom 
type, and comorbidity as the four factors that 
determine appropriateness, this in\,oh'ed 
assigning different weights to each "point" on 
four corresponding "dimensions". An ex· 
ample of one such set of weights is shown in 
table 1. With this particular set, patients in 
acute retention with mild obstructive symp· 
toms and low comorbidity would score 
1 + 1 -to 1 -to 2 '"" 5. 
The conclusions of the panel were divided 
into three groups: "appropriate", "inappro· 
priate", and "unclear" where the panel either 
disagreed, agreed only partially, or were equi· 
\'ocal. The question was whether these conclu· 
sions were consistent with an underlying set of 
judgements about the relative importance in 
determining appropriateness of the four dif· 
ferent "dimensions" and the \'arious "scale 
__ .1-
I 2 
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points" in each dimension. If so, it would be 
possible to devise a scoring system that could 
predict the panel's ratings reasonably well. 
Patient categories with scores below a certain 
threshold would tend to have been rated by the 
panel as inappropriate for prostatectomy. Cat-
egories with scores above a second and higher 
threshold would tend to have been rated as 
appropriate. And categories with scores within 
a middle band between these two thresholds 
would tend to be those about which the panel 
results were unclear. 
1'0 examine this question the following pro-
cedure was used: (1) a set of weights was 
chosen; (2) a score was calculated for each 
category of patient; (3) a lower threshold value 
was chosen and rates of "type I" true and false 
posith'es and negatives calculated, using the 
definitions shown in table 2; (01) an upper 
threshold value was chosen and rates of "type 
2" true and false positives and negatives were 
calculated (table 2), A set of weights together 
with a lower and an upper threshold value thus 
constitute a scoring scheme. 
This procedure was repeated for a variety of 
scoring schemes. In the main analysis only 
whole numbers were considered for the 
weights and threshold values, An intuitive set 
of weights was chosen as a starting point. First, 
a variety of ways of aggregating the weights in 
each dimension to form scores, including the 
sum, the product, and combinations lfor ex· 
ample, symptom type )( symptl)m sen~ritr + r-
etention ... comorbidit\·) was tried. Then a svs· 
tematic procedure w~s fl)\1llwed to test the 
effect of giving more or less weight to each 
dimension and to selected scale points. Once a 
satisfactory weighting scheme had been found, 
the effect of various departures from it was 
examined. O\'er 010 schemes were tried in all. 
To assist in interpreting the results. an upper 
limit on the proportion of categories that could 
be correctly assigned by any scheme using the 
panel data (including one with Mn-integer 
weights and thresholds) was deri\'ed using 
conventional discriminant anal~·sis. This pro· 
duced two functions that diviJed the patient 
categories into inappropriate. unclcar. and ap-
propriate. Also it was necessary to take account 
of the fact that some categories will bc cor-
rectly assigned by chance ~\'en if a sCl,ring 
scheme has no real preJicth'c \·alue. 
Figure I represents an "ideal" result with no 
false positives or false negath'es at either 
threshold, ~n this hypothetical example. llnly 
the categories that the panel consiJcred inaI'· 
propriate scored I~ss than ~, only the categor-
Ies that thc:y conSIdered appropriate sCl'reJ b 
or more, and only thllsc about which the panel 
were unclear scored -l or 5. This is onh' ideal 
gi\'en the obsen'ed distribution of pan"cl rat· 
ings. Of course a result in which there werc 
fewer categories for which the pand re~ults 
were "unclear" would bc bener. Also it )hl,uld 
be emphasised here that the figures givcn fl'r 
the percentage agreement and disagreement. 
and for the percentage of false pl)sitivc and 
false negati\'es, would only match thllse fl)unJ 
in a survey of clinical practice if each category 
(If patient were equally pre\·alent. 
62 Hllme" .\lcK", So"dt.son. BI .. clt 
TGbl,4 Proporrirms of corr"r GSsignmenrs .ro. iMppropriatt. rmclear, and app.opriall JUi"l tliJJ~",r JlU of wtithu for lyP' of r"",rion, ItfJtriry 
and typ' of symptoms, and degr" of comorb,d,ly I 
Schmu R61mtiD'lf Symp,om Symprtml c;"",o.bidiry T1 T2 Mol"" I<li", J I'IN/>': M",,1r lUi", 21'0111"" ~"lCh lUi", 21'0U/>I: #Ve.ily tY/>I irwpp.opri"" iruppropriolf . rflll/>pr"p"'''' 
t· ,,"d'G' • "",I'G' 0 + IInt/~Q" 
t· "pprop,ill" 
'-.1 of. "".,,prill/' (%1 " "pprop,i,,11 ("1.1 
I 0123 0123 012 012 3 6 76·3 89-0 87-3 
2 0122 0123 012 012 3 6 iH 881 87-3 
3 0123 0023 012 012 3 6 7/)·7 91'4 88 I 
4 0123 0023 0\1 012 3 5 812 941 88·1 
5 0223 0023 0\1 023 4 6 8)9 94·9 890 
6 0224 0024 0\1 024 4 7 856 96·6 890 
7 0224 0024 000 024 4 6 780 96·6 81-4 
8 0222 0024 011 024 4 7 80" 93·2 87-3 
9 0222 0023 0\1 023 4 6 831 94·9 88·1 
10 0000 0024 011 024 2 4 73-7 89-8 83-9 
TI-Iower duabold, between inappropriate and unclear; T2 -uppcf threshold, bctwccn unclear and appropriate. 
Match - % 0( ~tI thar match the conclusion. of the panel about whether appropriate, IIDdar or iDappropriate. 
In scheme 6, the weights given to retention, 
symptom severity, and comorbidity are all' 
increased relative to symptom type. This is the 
best overall scheme using integer weights. 
Scheme 7 explores the extent to which the 
appropriateness of surgery can be determined 
without information about the type of symp-
toms. Plainly this is much worse than other 
schemes at identifying appropriate cases, but is 
as good as any at identifying inappropriate 
ones, and is still better overall than schemes 1 
and 2. Scheme 8 explores the question of how 
far the appropriateness of surgery can be pre-
dicted with no information about type. ~f 
. retention - whether it is acute, chronic, or 
acute on chronic. Scheme 9 is a slightly better 
variant of this in which less weight is given to 
severe symptoms and low comorbidity. 
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Scheme 10 confirms that information about 
whether the patient is in retention or not is, as 
one might expect, an important factor in deter-
mining the appropriateness of surgery. 
The analysis in table 4 makes no distinction 
between false positives and false negatives. 
This matter is addressed in table 5. If the 
scores were to be used as part of a screening 
procedure in primary care, it would be import-
ant to avoid false negatives. If the risks of. 
surgery were generally substantial compared 
with the benefits, it would be important to 
avoid false positives. 
. One further consideration is that scheme 4 is 
one that avoids ·the situation in which patient 
categories which have been rated by the panel 
as. appropriate have the san:'e score as categor-
ies that have been rated as inappropriate. One 
can thus say with scheme 4 that groups scoring 
3 or less include all those judged by the panel 
as inappropriate for prostatectomy, and that 
groups with scores of 4 or more include all 
those for which prostatectomy was judged ap-
propriate: , . 
Tables 4 and 5 suggest a number of points. 
Firstly, retention, symptom severity, and the 
d~ of comorbidity were given roughly 
equal·weight by the panel when rating patient 
Categories, whereas tIle type of symptoms was 
much less important. Secondly, the presence 
oC retention is important. The difference 
between acute and chronic retention is less so, 
and acute on chronic retention is a stronger 
indication than either acute or chronic reten-
tion alone. Thirdly, in effect the panel did not 
distinguish between patients with mild symp-
toms and patients with no symptoms at all. 
FowthIy, the panel considered obstructive 
symptoms to be more important in indicating 
surgery than irritative symptoms. And fifthly, 
the type of symptom was not important in 
determining the groups for which prostatec-
tomy was inappropriate. 
Dlscussfon 
Consensus development has been advocated as 
a means of making explicit the basis for clinical 
decisions. Although the nominal group tech-
nique of consensus development is well estab-
lished, the development of a model to explain 
the ratings given by a panel is new. We belie\'!! 
that this approach has clarified much of the: 
thinking behind the normally implicit dedsil.)n 
.1fP'~l'riat~ j .. Ji:alio"s for I'r(lrlaltClo",y 63 
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to recommend prostatectomy, and we suggest 
that it could be usefully employed with the 
results of similar panels that have consi'dered 
other procedures. The panel discussion was 
lively, with all members participating, and 
very little clear disagreement. 'In addition, as 
can be seen from fig 2, the ratings were 
generally internally consistent. This internal 
consistency may have been helped by the lay-
out of the forms which the participants were 
asked to complete. 
The panel did not consider that surgery was 
necessarily appropriate in patients with a his" 
tory of acute retention, although there is a 
large group of these patients in whom surgery 
will sometimes be appropriate. There is also 
support for the approach described as "watch-
ful waiting". 
This study has highlighted a question that 
has received little anention in the published 
reports: do irritative symptoms have a dif-
ferent prognostic implication than obstructive 
symptoms? Some panellists felt that the exer-
cise had involved an artificial distinction 
between obstructive and irritative symptoms 
which was seldom made in practice, whereas 
others expressed the view that prostatectomy 
should be performed for obstructive but not 
for irritative symptoms. because irritative 
symptoms were caused by detrusor instability 
rather than an enlarged prostate. The weight-
ing analysis showed that the laner view was the 
more consistent with the panel's final judge-
ments. Anaching equal weight to obstructive 
and to combined obstructive plus irritative 
symptoms but less weight to irritative symp-
toms alone gave the best "fit", but the type of 
symptom was the least important of the four 
"~imensions" considered by the panel. It also 
confirmed, despite the view of SOme that com-
orbidity,js unimportant because of the ability 
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to perform prostatectomy under spinal anaes-
thesia, that comorbidity does play a part in 
determining appropriateness. 
The weighting analysis also indicated that if 
the objective is simply to eliminate patients 
who are inappropriate for TURP, then al-
though the presence of retention is important, 
the type of retention is less so. This suggestS 
that it may be possibre to devise useful guide-
lines fotgeneral practitioners about what kinds 
of patients to refer. ' 
, In considering these results, the limitations 
of consensus development techniques need to 
be remembered. Firstly, there is a potential 
bias in the selection of the panellists. We 
cannot be sure of the extent to which our panel 
reflected the views of other urologists and 
general practitioners. Although it has been 
shown that those dOctors Who are willing to 
participate in expert panels are representative 
of their colleagues,25 the exact composition of a 
panel can effect the results obtained.%' In this 
study, all the panel members came from one 
health region, in which the prostatectomy rate 
was 23% lower than the national average in 
1985.7 It may well be that a panel consisting of 
consultants from other regions would have 
given different results. Secondly, as well as any 
selection bias, the results will also be affected 
by any "random It variation in panel behaviour. 
Ideally the whole process should be replicated 
using different panels. 
Thirdly, the ratiogs of a panel are dependent 
on the definitions used. As in many areas of 
clinical work, terms in everyday use arc used 
differently by different clinicians. Although 
there was some uncertainty among a few of the 
panellists at first, agreed definitions were de-
veloped and used as a basis for the second 
round, in some cases leading to modification of 
earlier scores. We do not know to what extent 
panellists made use of the review of published 
repons that had been provided, although most 
stated that they had found it helpful. 
Fourthly, we do not know how far stated 
opinions correspond to actual clinical practice, 
though this will be examined and reported in 
another paper. 
Fifthly, the importance that should be 
attached to the figures given for the percentage 
agreement and disagreement, and to the per-
centage of false positive and false negatives, 
remains uncertain. As was pointed out earlier, 
they would only match those found in a survey 
of clinical practice if each category of patient 
was equally prevalent. In practice, some of the 
combinations of signs, symptoms, and comor-
bidity that the panel was asked to consider may 
be very rare. A proper interpretation of the 
importance of the alent of agreement over 
ratings would need to take the prevalence of 
each patient category into account, and the 
necessary data are not yet available. This is the 
subject of current research. 
Finally, the existence of a consensus does 
not in itself mean the consensus view is correct 
and there is a danger that the nom:inal group 
process will arrive at collective ignorance 
rather than wisdom. As such it is not a replace-
ment for either rigorous scientific .reviews of 
pu~lished reports or for research, but rather a 
means of identifying current medi~ opinion 
. and 'areas of dis!igr~ent. Ideally, indicati~ns 
for surgery should be based on studies of the' 
relationship between patient characteristics 
and clinical outcome. To be reliable these need 
to be based on large numben of patients and 
such data are beginning to become available. 
How will the results of the study be used? In 
the immediate future, it will be used to assess 
the prevalence of individuals with appropriate 
indications for surgery among the population. 
The appropriateness score could be used to 
develop guidelines for general practitioners 
about the kind of patients to refer. Further 
work will examine its ability to predict out-
come and the extent to which surgeons follow 
these policies in practice. 
We are arateful to those who participated OIl the panel: Mr 
Allen. Mr B Elhs. Mt M Emberton. Dr T S V Bostock. Dr M 
Cayson. Dr N Rea. Mt R Sbcarer. Mr M Snell. Mr N 
Waterfall. Mt G Williams. We thank Mt PIul Abel for review-
in, badlfOund material .... the panel. 'lie would lite to thank 
Dr Sbeila Adam of the Public Health DireaDralC. North West 
Thames Rqional Health Authority for providin, financial 
IUpport for WI project. 'I'hmks are abo due to Dr Aileen 
Qarke for reviewm& a dnft of thillIIIDUlClipt. 
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Health care sought and received by men with 
urinary symptoms, and their views on 
prostatectomy 
DJWHUNTER 
eM MCKEE 
N A BLACK 
C F B SANDERSON 
SUMMARY 
Background. Urinary symptoms are common among 
middle aged and elderly men. 
Aim. A study was undertaken to describe the health care 
sought by men aged 55 years and over with urinary symp-
toms, the action taken by general practitioners and uro-
logists, and the men's views on prostatectomy. 
Method. A postal questionnaire was sent to 516 men aged 
55 years and over in the North West Thames Regional 
Health Authority, with previously identified mild, moderate 
or severe urinary symptoms. 
Results. The response rate among eligible subjects was 
83%. Of 420 respondents 45% had seen their general practi-
tioner for their symptoms. General practitioners had 
referred 62% of these men to a urologist, reassured 21% 
and prescribed medication to 17%. The probability of a 
man seeking medical advice increased with increasing 
symptom severity. In contrast, the decision to refer was 
independent of symptom severity. Of the men referred to a 
urologist. the majority (71%) were offered and accepted 
surgery. The remainder were reassured (17%), or received 
8 prescription (4%). Eight per cent were offered surgery but 
declined. When presented with details and information on 
the risks and benefits of prostatectomy, 22% of men with 
symptoms would probably or definitely refuse treatment, 
while a further 47% of men were unsure. 
Conclusion. There are many men who do not seek treat-
ment for urinary symptoms and, of those who do, sub-
sequent referral is not associated with symptom severity. 
There is scope for improving the referra' process through 
the shared development of guidelines between general 
practitioners, hospitals and commissioning agencies. 
Keywords: urination disorders: prostate diseases: men's 
health: patient self referral. 
Introduction 
M ODERATE or severe urinary symptoms affect up to 25% of middle aged and elderly men.'·3 These are commonly 
due to benign prostatic hyperplasia. a condition for which an 
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effective intervention exists.·" However. many men with symp-
toms do not receive treatment.3 The relationship between the 
need for and use of health care involves a chain of events in 
whicb intervention rates are influenced by: whether individuals 
seek medical advice; whether clinicians judge the intervention to 
be appropriate; and if. when presented with information about 
the intervention and its risks and benefits. individuals choose to 
receive it. Planning and purchasing of health care require an 
understanding of this process. 
Little information on these three steps is available. First. as 
regards whether or not individuals seek medical advice. a Danish 
study found that a third of bealthy men with urinary frequency, 
post-micturition dribbling. and a weak urinary stream believed 
that these symptoms did not justify seeking treatment. 6 Secondly. 
variation in clinical judgement about the appropriateness of 
surgery is believed to account for much of the variation in 
prostatectomy rates within countries although this view is based 
largely on studies of men undergoing prostatectomy. with no 
information about those who have symptoms but do not undergo 
surgery.' Thirdly. even after being offered treatment. men may 
not wish to accept it. In a British study. 30% of 107 men with 
minimal symptoms who were on a waiting list for prostatectomy 
declined surgery after being reassured about the natural history 
of prostatic obstruction.' An American study to validate a quality 
of life questionnaire among men awaiting prostatectomy had to 
exclude 37 men (55%) who elected not to have surgery.9 
Preliminary results from studies in the United Kingdom and the 
United States of America of symptomatic men considering 
prostatectomy found that many declined surgery after viewing an 
interactive video disc that provided information on the risks and 
benefits of treatment.IO,11 
While these studies give some indication of the importance of 
these factors in different countries, there is little information 
about their overall effect on the relationship between need and 
use in a defined population. This study sought to: determine the 
advice-seeking behaviour of men with mild. moderate or severe 
urinary symptoms; describe their subsequent management by 
general practitioners and urologists; and determine whether these 
men would choose surgery when provided with information 
about the outcomes of prostatectomy. This paper describes the 
results of a two-stage survey, the first stage of which is being 
-reponed elsewhere.) 
Method 
A two-page questionnaire was sent to 2000 men over the age of 
55 years selected from eight randomly chosen general practices 
in Nonh West Thames Regional Health Authority in 1992. With 
the exception of the smallest practice. where the entire list was 
used. 265 men were randomly sampled from the whole of each 
practice's list to create a database of 2000 names 'lind addresses. 
The purpose of the survey was to measure the prevalence and 
severity of urinary symptoms. Th! Survey achieved a response 
rate of 77.7% (1480) among eligible respondents. Questions on 
urinary symptoms were taken from the American Urological 
Association symptom index. with some minor modifications to 
the wording of some questions to make them more appropriate 
for a British population. 11 
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A symptom index, ranging from 0 to 30, was calculated by 
adding together the scores of six urinary symptoms (fullness, fre-
quency, intermittency, urgency, poor flow and hesitancy) where 
each symptom was assigned one of the following values: 0 = 
never. 1 = hardly ever, 2 = less than half the time, 3 = about half 
the time, 4 = more than half the time and 5 = almost always. The 
symptom index was categorized into five levels of severity: none 
(0), very mild (1-6), mild (7-9), moderate (10-18) and severe 
(19-30). These cut-off points were derived from information 
gained from the results of a consensus panel that considered the 
appropriateness of indications for treatment. tl Further details of 
the method are described elsewhere.3 
The follow-up survey inVOlved 516 men (34.9%) in the initial 
survey who reponed a symptom index score of seven or more, 
that is mild. moderate or severe symptoms. They were sent a sec-
ond questionnaire six weeks after the initial survey that sought 
information about their health behaviour and views on prostatec-
tomy. The seven page questionnaire was sent together with a per-
sonal covering letter from the man's general practitioner and a 
stamped, addressed envelope for reply. All non-respondents were 
sent a reminder letter and a second questionnaire one month 
later. Participants were asked whether they had sought advice for 
their urinary symptoms and from whom. whether they had vis-
ited their general practitioner or urologist, and what had been the 
results of these consultations. 
To investigate the possible effects of response bias, the non-
respondents were compared with the respondents in terms of age, 
severity of symptoms. previous surgery and previous episodes of 
acute urinary retention. using data from the initial survey. 
In order to discover whether men would accept treatment or 
not. panicipants were presented with currently available evi-
dence about the outcome of treatment and a simple description of 
the procedure. The information was worded as follows: 'The 
mosl common treatment for urinary problems caused by enlarge-
ment of the prostate gland is surgery. This involves passing an 
instrument like a small telescope up the penis to clear the block-
age. It usually involves a hospital stay of about eight days. About 
80% of men experience an improvement in their symptoms fol-
lowing surgery, about 15% are unchanged and 5% worse off. 
Some men will also have difficulty getting an erection afler 
surgery. In addition. about 10% have complications. such as 
bleeding. infections and leakage of urine, which normally clear 
up within a few weeks. If your urinary symptoms were found to 
be due to an enlarged prostate and you were offered surgery for 
it. feeling the way you do now, would you choose to have it?' 
Respondents were asked to score their preference on a scale of 
zero to five (0 = definitely want, I = probably want. 2 = not sure 
but inclined to yes. 3 = not sure but inclined to no, 4 = probably 
do not want,S = definitely do not want). 
Data analysis consisted of frequency distributions. Confidence 
intervals for proponions were calculated at the 95% level using 
the method of Aeiss. 14 The significance of observed differences 
was tested using chi square statistics calculated using procedures 
written in SAS. Wilcoxon matched-pairs signed-ranks were 
calculated to test for a change in bothersome ness and urinary 
frequency between the initial and follow-up surveys using 
procedures written in SPSS. 
Results 
Characteristics of the sample 
Of the 516 men with mild, moderate or severe symptoms who 
were sent a questionnaire, eight had died and three had moved, 
so that the final study population was 50S. Seventy two question-
naires were not returned and a further 13 were retumed without 
response, so that the response rate was 83.2%. A comparison of 
non-respondents and respondents showed little difference in 
mean age (69.5 years versus 67.1 years, respectively). 
Respondents were significantly more likely than non-respondents 
to have moderate or severe symptoms (239/420 respondents ver-
sus 7185 non-respondents, Mantel Haenszel Xl .. 70.2, 2 degrees 
of freedom, P<O.OI). Respondents were also more likely than 
non-respondents to have had previous prostate surgery, and to 
have experienced an episode of acute urinary retention. although 
these differences were not significant. In total, 420 men with 
mild, moderate or severe symptoms were included in the ana-
lyses. 
To test the extent to which men's urinary problems may have 
changed between the initial survey (from which their symptom 
index scores were derived) and the follow-up survey (from 
which patient preference was determined), questions on bother-
someness and urinary frequency were included in both. The 
results of a Wilcoxon matched-pairs signed-ranks test suggested 
that while there was no significant change in the measures of 
bothersomeness. urinary frequency decreased between the two 
surveys (2 = -3.02, P<O.05). 
Adl'ice-seeking behal'iour 
The pattern of the advice-seeking behaviour by men with urinary 
symptoms is shown in Table I. About half the men had not 
sought any advice for their symptoms; this was more common 
among those with mild or moderate symptoms than among those 
with severe symptoms. Of those seeking advice, the principal 
source was their general practitioner (88.8% of those with mod-
erate symptoms, 97.2% of those with severe symptoms). The 
percentage of men who sought advice from their general practi-
tioner about their symptoms increased from 40.3% of those with 
mild symptoms to 64.8% with severe symptoms. 
Action by general practitioners and urologists 
Of the 175 men who had consulted their general practitioner and 
for whom data were available, 2 I.J % were reassured, 16.6% 
were prescribed medication, and 62.3% were referred to a sur· 
geon or urologist (Table 2). The percentage referred to a uro-
logist or surgeon did not vary with symptom severity. Of the 109 
men who were referred, nine were still waiting to see their sur-
Tabl. 1. Source of advice used by men with urinary symptoms, by symptom severity. 
% of men with symptoms 
Mild Moderate Severe Total 
(n - 181) In. 185) In- 54) (n- 420) 95%CI 
Sought no advice 56.9 51.9 33.3 51.7 46.8 to 56.3 
Consulted GP 40.3 42.7 64.S 44.5 39.7 to 49.2 
Other' 2.8 5.4 7.9 3.8 2.3 to 6.0 
n. number of men in group. CI • confidence interval. "Other. friends, relatives, practice nurse. 
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geon. The majority (71.4%) had been offered and accepted 
surgery (Table 2). Of the remainder, J S had been reassured, four 
had been prescribed medication and seven had been offered and 
declined surgery. There was no significant difference between 
symptom severity and action by the urologist, but the numbers 
were small. 
Men s views on prostatectomy 
The distribution of men's views on prostatectomy, by symptom 
severity is also shown on Table 2. At their current level of symp-
toms, 30.6% of men would definitely or probably choose to have 
a prostatectomy, while 22.1 % would probably or definitely not 
want treatment. Nearly half of men (47.3%) were unsure what 
they would cboose, although more men were inclined to bave the 
operation than not (32.0% versus 15.3%). Overall, men were 
more likely to choose surgery (62.6% versus 37.4%). The pro-
ponion of men choosing surgery was not significantly related to 
symptom severity, a history of previous prostate surgery or of an 
episode of acute urinary retention (Table 3). 
Using data from all 420 respondents, a separate analysis was 
undenaken of only those men who expressed a firm view about 
surgery (that is, that they definitely or probably would or would 
not choose it). In this group, men who had consulted their gen-
eral practitioner were mOTe likely to have indicated that they defin-
itely or probably would choose surgery (63, 71.6%) than those 
who had not consulted their general practitioner (64, 57.1 %). 
Although this difference was small, it was statistically significant 
(X2 = 4.4, ) df, P<:O.05). 
Discussion 
This study has described the pattern of advice-related behaviour 
of middle-aged and elderly men who experience mild, moderate 
or severe urinary symptoms, and the response made by clini-
cians. Slightly fewer than half of men with symptoms (45%) 
reponed that they had consulted their general practitioner, of 
whom the majority (62%) were referred to a surgeon. and of 
these the majority (71 'k) reponed that they were offered and 
accepted surgery. However. a substantial proportion (22£}) of 
men said that in theory they would choose to accept their symp-
Table 3. Choice of whether or not to have a prostatectomy. by 
symptom severity, previous prostate surgery and a previous 
episode of acute urinary retention. 
% of men choosing 
prostatectomy 95% CI 
Symptom seve rift 
Mild In _ 122) 60.7 51.4 to 68.5 
Moderate In - 128) 64.1 55.1 to 71.5 
Severe In _ 31) 64.5 45.4 to 77.6 
Previous prostate surgerY' 
Yes (n-14) 77.4 42.0 to 86.0 
No (n- 266) 62.4 56.3 to 67.8 
Acute urinary retention" 
Yes (n- 22) 68.2 45.1 to 82.0 
Noln-253) 67.3 54.9 to 66.9 
n. number of men in group. CI • confidence interval. 'Oata miSSing for 
34 men. bOata missing for 35 men. "Data missing for 40 men. 
toms and forego surgery, and a funher 47% were unsure whether 
or not to go for surgery. 
Before any conclusions may be drawn, two aspects of the 
method need to be considered: the response rate and the validity 
and reliability of the questions about symptoms and preferences. 
The response rate in the initial survey had been 78% and in this 
survey was 83%. Although the response rate was high, it is of 
concern that respondents to this survey were more likely than 
non-respondents to have modetate or severe urinary problems. 
This means that the proportions of the population seeking and 
receiving treatment may have been slightly overestimated. 
The way in which the questions were phrased could bias the 
results. The symptom index used has been extensively tested and 
shown to be internally consistent and have good test-retest reli-
ability, as judged by the Pearson correlation coefficient. 12 The 
question about men's views on prostatectomy was developed 
specifically for this study and has not been tested for its reliabil-
ity and validity, in panicular, its power to predict the decision 
that a man will take in practice. Eleven per cent of respondents 
Table 2. Action taken by general practitioners and by urologist or surgeon, and patient choice for surgery. 
% of men with symptoms 
Mild Moderate Severe Total 95%CI 
Action taken by GP • (n-69) (n- 71) (n-35) (n-175) 
Reassured patient 17.4 25.4 20.0 27.7 75.5 to 27.5 
Prescribed a drug 20.3 11.3 20.0 76.6 71.6 to 22.5 
Referred patient 62.3 63.4 60.0 62.3 54.6 to 68.9 
Action taken by urologist/surgeoni' (n-39) Cn - 351 (n.H) (n-91) 
Reassured patient 10.3 20.0 23.5 16.5 9.8 to 24.8 
Prescribed a drug 0 11.4 0 4.4 1.4 to 10.0 
Offered surgery: 
Patient declined 10.3 5.7 5.9 7.7 3.4 to 14.3 
Patient accepted 79.5 62.9 70.6 71.4 60.9 to 79.2 
Men's views on prostatectomy< In.122) In. 128) Cn.31) (n-281) 
Definitely want 13.9 17.2 25.8 16.7 72.7 to 27.3 
Probably want 74.8 14.1 9.7 73.9 10.2 to 18.2 
Not sure, inclined to yes 32.0 32.8 29.0 32.0 26.7 to 37.5 
Not sure, inclined to no 13.9 76.4 16.1 15.3 11.4 to 19.8 
PrObably do not want B.2 6.3 12.9 7.8 5.1 to 11.4 
Definitely do not want 77.2 73.3 6.5 14.2 70.5 to 18.6 
n. number of men in group. CI • confidence interval. 'Data missing for 12 men. bData missing for nine men; another nine men still waiting to .ee 
urologist. COata missing for 34 men; excludes those seen by • urologist. 
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Urinary symptoms: prevalence and severity in 
British men aged 55 and over 
D J W Hunter, C M McKee, N A Black, C F B Sanderson 
Abstract 
Objectil1e - To measure the prevalence and 
severity of urinary symptoms among men 
aged 5S and over in the British population. 
Desi/ln - Cross sectional population survey 
using a postal questionnaire. 
Settin/l - North West Thames health re-
aion. 
Subjects -1480 men aged 5S years and over 
randomly selected from 8 general prac-
tices. 
Maln outcome measures - Self reported 
frequency and severity of urinary symp-
toms, their bothersomeness and previous 
prostate surgery. 
Results - The response rate among eligible 
subjects was 78%. The prevalence of mod-
erate and severe symptoms was 204 per 
1000, rising from 160 per 1000 in the 55-59 
.ge group to 2S9 per 1000 in the 70-74 age 
group and declining after the age of 80 to 
119 per thousand in the 85 + age group. 
Twelve per cent of men reported previous 
prostate surgery, and the probability of 
having had surgery increases steadily with 
age. About a third of those undergoing 
surgery have recurrence or persistence of 
symptoms after surgery. Of men with 
moderate and severe symptoms, 27·9% re-
ported that their symptoms were a me-
cllum or big problem, 36·9% reported that 
their symptoms interfered with their dally 
activities at least some of the time, and 
43'I%were unhappy or 'feltterrible' about 
the prospect of a future with their current 
symptoms. 
Conc1us,'on - The prevalence of urinary 
symptoms in men is lower than previously 
reported, although there is a substantial 
number of men who are bothered by, or 
who find their lives adversely effected by 
them. 
(J Epidemiol Conmlullio' Htolrh J 994,48:569-575) 
Benign prostatic hyperplasia is the commonest 
cause of urinary symptoms affecting middle 
aged and elderly men. It is becoming an in-
creasing challenge to the health service because 
of an aging population and the introduction of 
new {orms of treatment. Knowledge of the 
prevalence of urinary symptoms and their im-
pact on men form the basis of the three meas-
ures required by those involved in the planning 
and provision of services {or benign prostatic 
hyperplasia: the number o{ men in the popu-
lation experiencing urinary symptoms that 
bother them (felt need); the number of men 
with symptoms who seek treatment (demand); 
-226-
and the number of men considered by surgeons 
to be in need of treatment, based on both men's 
urinary symptoms and on clinical findings 
(normative need). 
Estimates of the prevalence of urinary symp-
toms among men vary widely. In general health 
surveys of men over the age of 65, between 16 
and 40% report having either urinary symptoms 
or a previous prostatectomy, or both (Spain 
16%; USA 25%; 15raeI40%).I-' A household 
survey undertaken in Michigan in 1983-84 
found that 35 % of men over the age of 60 had 
one or more symptoms ofprostatism.4 A review 
of general practice case notes in the UK sug-
gested that 6% of men over the age of 60 had 
undisclosed 'marked prostatism', based on the 
presence of four urinary symptoms, and a fur-
ther 14% had 'mild prostatism', with three 
symptoms.' In a questionnaire administered to 
men over the age of 60 who attended a health 
screening clinic in the UK, 18% reported five 
or more urinary symptoms.' A recent study, 
defining benign prostatic hyperplasia using a 
combination of urinary symptoms, flow rates, 
and prostatic size, reported a prevalence among 
Scottish men aged 40 to 79 of 253 per 1000.7 
A virtually identical study in the USA found 
that prostatism rose from 26% in the 40-49 
age group to 46% in 70 + age group, higher 
than the prevalence found in the Scottish 
study.· 
These studies are not sufficient to assess the 
'felt need'. They provide little information on 
the severity of symptoms and do not measure 
the extent to which men are bothered by their 
symptoms. The latter point is imponant as it 
has been suggested that a third of men \\ith 
mild symptoms may not want treatment.o This 
paper describes a survey of felt need for treat-
ment of benign prostatic hyperplasia in the UK 
that addresses these issues. A subsequent paper 
\\ill repon on the relationship between the 
prevalence of urinary symptoms and demand 
for treatment. 
Methods 
A cross sectional population survey of the pre-
valence of urinary symptoms in men aged 55 
years and over was carried out in North \X'est 
Thames health region. This age group was 
selected on the basis of the results of a stud\' 
in the Oxford and North West Thames region~ 
in which more than 99% of men undergoing 
prostatectomy were aged 55 or more.l~ Initiallv 
30 general practices were seleCted random!)' 
from all practices in North West Thames region 
and invited to participate. The 15 practices 
that expressed an interest in the study were sem 
further information and a background literature 
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did not answer this question and, of those who did answer, 47% 
were unsure whether they would choose surgery. It is unclear 
whether this uncertainty arises from the wording of the question, 
insufficient information being provided, or from the difficulties 
in deciding about treatment. Studies of patient preference are 
susceptible to variations in the amount of data presented and the 
way that questions are framed (that is, whether the question 
refers to the probability of a good or adverse effect)." Most of 
the published work about patient preferences has been applied to 
cancer patients where trade-offs between quality of life and life 
expectancy are made using methods taken from econometrics. 
Other studies have found low levels of test-retest reliability.16 
Among the substantial proportion of men who were unsure if 
they would choose to have surgery it is likely that some have 
what has been termed an 'extemallocus of contro),17 and would 
transfer the decision to treat to the surgeon. 
Few men in the present survey reported seeking advice from 
relatives, friends or the practice nurse for their symptoms. This 
may be because they believed that lay carers and nurses have 
little to offer for urinary problems or it may reflect under-report-
ing - having received advice from family or friends to see their 
general practitioner, they only reported that they saw a general 
practitioner. It is also possible that there was some reporting bias 
because they viewed these sources of advice in a less formal 
way. It has been estimated that 25% to 75~ of symptoms are 
deal! with by patients themselves or friends and familyl8.19 and 
that the decision to consult a general practitioner is dependent on 
the influence of advisers. the effectiveness of self-care and the 
need for information.2o Many men may consider their urinary 
symptoms as part of the normal ageing process and thus do not 
consider their condition worthy of consulting their general practi-
tioner. A study in Denmark found that men aged 70 years and 
over with voiding difficulties did not consult a doctor for their 
urinary symptoms.'1 
Although men were more likely to "isit their general practi-
tioner if their symptoms were more severe, the decision of the 
general practitioners to refer appeared to be independent of 
symptom severity. This study confirms the important gatekeeper 
function of general practitioners: 381ff of the men who went to 
see their general practitioner were not referred on to a surgeon. 
This is consistent with the considerable volume of work done on 
the referral decision that shows that a wide variety of factors, and 
not just the patient's condition are important," Semi-structured 
interviews with family physicians in Canada found that of non-
medical factors in the decision to refer, patients' wishes were the 
most important.2~ Difficulties with travel. access to a consultant. 
and family wishes also influenced the decision.B 
Some men were prescribed medication for their urinary symp-
toms. either by their general practitioner (17'K) or their urologist 
(4'K) despite a lack of any definitive evidence of the efficacy of 
such treatments and the recommendation that prostatectomy is 
still the treatment of choice for benign prostatic hyperplasia.~~·27 
During the period of the study. finasteride (Proscar<l>, MSD), was 
being marketed and some men may have been prescribed it as 
participants in studies to evaluate the drug. 
How will the results of the study be used? When combined 
with information on clinicians' views of appropriateness of 
prostatectomy!) and population estimates of the prevalence of 
urinary symptoms from the initial survey.) these data will pro-
vide evidence of the level of prOVision of treatment a population 
requires and thus infonn planning and commissioning of urolo-
gical services. The findings are being applied to the purchasing 
process. This involves collaboration between genera) practi-
tioners, urologists and the commissioning agency to set agreed 
activity levels and develop referral guidelines. The results of this 
process will be reported in a separate paper. 
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Tabk 1 Demographic characteristics oj responders, 
urina". symprom pmJalence sU~'ey, North West Thames 
heallh region, 199Z 
Ale group (y): 
"-59 
60-64 
65--69 
70-74 
75-79 
80-84 
85. 
Total 
Ethnic1Iy (>55 y) 
~'hite 
Non-white 
Total 
Sa",pI, (%) 
275 {I 9) 
322 (22) 
298 (21) 
236 (16) 
157 (I IJ 
104 (7) 
51 (4) 
1443 (100) 
1389 (97) 
40 (3) 
1429 (100) 
PopulatIon "') 
89073 (24) 
80261 (22) 
68962 (19) 
51 837 (14) 
41 059 (11) 
23932 .(6) 
13 437 (4) 
lfl8 561 (100) 
).15756 (92) 
30829 (8) 
376585 (l00) 
Notes on table: (I) Missin, data arc not included In column 
totals. (2) Populanon esnmates for North \l'eS! Regional Health 
Authonry arc taken from the OPCS 1991 Census, COII"I)' 
MO'lIlors. 
review. Seven practices withdraw at this stage. 
The remaining eight practices were distributed 
throughout the region and included inner city, 
suburban, and rural practices, These practices 
were asked to provide a list of all men aged 
55 years and over, In total, 3716 men were 
identified, with the number in each practice 
ranging from 143 to 1180. With the exception 
of the smallest practice, where the entire list 
was used, 265 men were randomly sampled 
from the whole of each practice's list to create 
a database of 2000 names and addresses. This 
number was chosen to yield 95% confidence 
intervals of ± 1'5% if the true prevalence of 
moderate or severe symptoms was around 25%. 
A two page questionnaire, together with a 
personally addressed covering lener from the 
individual's general practitioner and a stamped, 
addressed envelope for reply, were sent to each 
man. Non-responders were sent a reminder 
letter and a second questionnaire one month 
later. The questionnaire sought information 
about the men's sociodemographic char-
acteristics (age and ethnicity) and any urinary 
symptoms they had experienced over the pre-
ceding month. Questions on urinary symptoms 
were taken from the recently published Am-
erican Urological Association (AUA) symptom 
index, II with some minor modifications to the 
wording of the questions to make them more 
appropriate to a British population. For ex-
ample, the AUA question on fullness 'Over the 
past month or so, how often have you had a 
sensation of not emptying your bladder com-
pletely after you finished urinating?' was 
changed to 'In the past month, how often did 
you feel that your bladder did not empty fully 
after urinating?'. A pilot version of the ques-
tionnaire, sent to 30 men selected from a gen-
eral practice in the North East Thames region, 
achieved a response rate of 80% and led to 
minor modifications in the layout of the ques-
tions. For comparison, population estimates 
and demographic infonnation for residents of 
North West Thames region were obtained from 
the 1991 census. U Ethical approval was sought 
and obtained from the relevant district ethics 
committees. 
To investigate the possible effects of response 
bias, general practice case notes from 100 ran-
domly selected non-responders were compared 
with the case notes of 100 randomly selected 
responders. Information taken from these case 
notes included age, history of urinary symp-
toms, previous prostate surgery, and medical 
history. Reasons for the unavailability of any 
case notes, such as the patient having died or 
moved away, were recorded. 
A symptom index, ranging from 0 to 30, was 
calculated by summing the scores of six urinary 
symptoms (fullness, frequency, interminency, 
urgency, poor flow, and hesitancy) where each 
symptom was assigned one of the following 
values: never=O, hardly ever-I, less than half 
the time =2, about half the time- 3, more than 
half the time = 4, and almost always = 5. Unlike 
the AUA-7 symptom index, nocturia was not 
included in our symptom index for three 
reasons: (a) it has many causes other than 
urinary tract disorders, such as cardiovascular 
disease and the person's fluid intake before 
going to bed, and is the symptom that responds 
least well to prostatectomy;1l (b) in a validation 
study of the AUA index, the highest in-
tersymptom correlation was between nocturia 
and frequency, and frequency was already in-
cluded in the index; and (c) the categories of 
nocturia severity we obtained were too crude 
to use. The symptom index was categorised 
into four levels of severity; none (0), very mild 
(I), mild (2-9), moderate (10-18), and severe 
(19-30). These cut off points were consistent 
with those used in a cohort study of men 
undergoing prostatectomy in Oxford and North 
West Thames region. U 
Data analysis consisted of frequency dis-
tributions. Confidence intervals for proportions 
were calculated at the 95% level using the 
method of Fleiss. l • Panerns of symptoms and 
surgical status based on age by individual years 
were smoothed using five point moving av-
erages. 
Table 2 Characrerisrics 0/ rtspontkn arId "on-rtspo"den, urinary symp'om pmll:denCl SU"'t,)I, Nonh Wesr Tha",es 
healrh rrgion, 199Z 
Mean .ge (y): 
Status (no (%»): 
On GPIISI 
Decreased'moved ahost 
Notes nOI fOllnd 
Total 
Urinary symptoms (no ('Io)): 
No unnary symptoms 
Prc\"OUI prostate sUliery 
Urinary symplOms 
Unnary symptom, referral 
Other urololY 
Total 
• p<O·OS, •• p<O·O I. 
70 
98 (98) 
o (0) 
2 (2) 
100 (100) 
79 (81) 
7 (7) 
~ (5) 
4 (") 
3 (3) 
98 (100) 
-227-
71 
81 (81) 
8 (8) 
II (II) 
100 (100) 
72 (89) 
J (I) 
4 (5) 
2 (2) 
2 (2) 
81 (100) 
Slan""rd "",r tI/ 
,I" drfj",,,,, 
417" 
2·7\·· 
3'43" 
5-33 
2'80· 
3-92 
2·50 
2-31 
Urjn(1)' symplOms: prrvalence ami stVerity in Brilish men aged 55 and over 
100 Fullness 100 Frequency 90 90 
80 80 
70 70 
60 
~ ~ 50 
20 
10 
0 
Intermittency 100 Urgency 
90 
~ Never 80 
I1':a Hardly ever 70 
• <Half 
~ o Ha!' ~ g>Half 
o Always 
20 20 
10 
0 
#. ~ 
40 40 
30 30 
20 20 
10 10 3 0 0 
Flgurt 1 Dism'bulion of urina,,. symplom.', men agd 55 years and owr in Nonh 
Thames nea"h regiol1. 
25 
20 
15 
5 
2 4 6 8 10 12 '4 16 18 20 22 24 26 28 30 
Symptom index 
F!gun? 2 DlSlnbulion of symplom index (95% el) in ",tII aged 55 years and pt'rr in 
.'\orrh Tham.'s heallh Tegl"", 1992. 
Results 
CHARACTERISTICS OF THE SAMPLE 
Of the 2000 men who were sent a ques-
tionnaire, 21 had died and 74 were unknown 
at the address in the general practice records, 
so that the final study population was 1905. 
The response rate after the first mailing was 
64%, rising to 78% (1480 returned ques-
-228-
571 
tionnaires) after a postal reminder. The age 
structure of those responding was similar to 
that of all men living in NOM West Thames 
region, except for those in the 55 to 59 age 
group, who seemed to be under-represented in 
our sample (table 1). Responders were more 
likely to be white than would be expected from 
the male popUlation in this age group. 
The comparison of subs am pIes ofresponders 
and non-responders (table 2) found no differ-
ence in mean age. Apparent non-responders 
included 8% who had either died or moved 
or for whom the general practitioner had no 
evidence of a medical record. In addition, for 
2% of responders and J J % of non-responders, 
although there was evidence that a record ex-
isted, these records could not be located. Com-
parison of the medical records available showed 
that responders were more likely to have un-
dergone previous prostate surgery (7% tI 1 %j 
p<0·05), but there was no significant difference 
in their medical histories of urinary symptoms. 
PREVAlENCE AND SEVERITY OF SYMPTOMS 
The distribution of each urinary symptom in 
relation to the level of severity is shown in 
figure 1. Most men report that they never, or 
bardly ever, experience these symptoms. The 
distribution of the symptom index is also 
strongly skewed to the left (fig 2); few men 
experience high composite symptom scores. 
On categorising the data, 20'8% report no 
symptoms, 10·4% very mild symptoms, and 
48·5% mild symptoms (table 3). The overall 
proportion of men with moderate/severe symp-
toms was 20'4%. This increased from 16·2% 
in those aged 50 to 59 years to a plateau of 
between 20 and 25% in the age group between 
65 and 79. It then fell to 11'9% in the over 
85s. 
IMPACT OF SYMPTOMS 
The extent to which men were bothered by 
their symptoms increased significantly with in-
creasing symptom severity (table 4). Of those 
with very mild and mild symptoms, only 0'5% 
felt they were a medium or big problem; this 
increased to 15·9% of those with moderate 
symptoms and 66'2% of those \\ith severe 
symptoms. Of those with moderate symptoms, 
2'8% reported interference in their daily ac-
tivities most or all of the time (table 5). This 
increased to 17·9% for those with severe symp-
toms. When asked about spending the rest of 
their life with their current symptoms, 11 % 
of men reported they would feel unhappy or 
terrible (table 6). This proportion varied in 
relation to symptom severity from 3·5% of 
those with very mild and mild symptoms to 
76·4% \\ith severe symptoms. 
PREVIOUS PROSTATE SURGERY AND OTHER 
UROLOGICAL SYMPTOMS 
The prevalence of urinary symptoms will partly 
depend on prostatectomy rates in the past and 
the effectiveness of this surgery. Altogether 164 
(12%) men reported hayins undergone pre-
vious prostate surgery (table 7). To allow for 
'72 Hunrer, McK", Bloc., Sandmon 
Table 1 Frequency dismbution of symptom sn'tril)' in relation 10 age poup in men aged 55 and Dtltr, Nonh West Thames health "'tion, 1992 
Symprom .... .."ry 
Mod.:ralt & 1ft.". 
All roup /l:Off' ltry ",iId Mild M.>derar, Seww Tor,,/ combln,d (95" .. CI o/~ 0 .. 0") .'·0 (!.) .... ·0 ('S) /1,'0 ("'oj "'0 ('oj No (""J /1,'0 (%) /1:0 (%) ",od.:rQr, (:0 m""') 
55-59 57 (21'0) 32 (11,8) 139 (51'1) 35 (12,8) 9 (3,3) 272 (100) 44 (lb 2) (12'1,20'8) 
bO-~ 72 (23-2) 34 (11,0) 14-1 (46 b) 49 (15'8) II (36) 310 (100) 60 (19-4) (15·2.2H) 
65--69 63 (22'0) 30 (10-5) 134 (46,7) 49 (17'1) II (38) 287 (100) 60 (20'9) (16-4.25'8) 
70-74 43 (18'9) 22 (9,7) 104 (45 8) 38 (lb·7) 21 (9'2) 228 (100) 59 (25-9) (2H,3\'7) 
75-79 30 (20'3) II (704) 77 (52'0) 22 (14'9) 8 (5'4) 148 (100) 30 (20'3) (14'1,27'1) 
80-84 12 (12'8) 10 (10'6) 48 (51'1) 18 (19·2) 6 (6'4) 94 (l00) 24 (2505) (17'3,346) 
85+ 10 (23-8) 4 (H) 23 (54-7) 5 (11-9) 0(0) 42 (100) 5 (11'9) (405,23-5) 
Total 287 (208) 143 (10'4) 669 (48·5) 216 (lH) 66(4'8) 1381 (100) 281 (20'4) (18'3,22-5) 
1" - 1480, 99 m ... mll; perc.ntag~ have been rounded, 
Table 4 F",quency dislriburion of borhmomeness in ",lario" ro symptom sn'en'l)' i" men aged 55 and Dtltr, Nania WiSI Thames htaM rtgion, 1992 
Sy,"p,om set .... ry 
Mod.:rQr, & uwrr 
Sorlreno,"''''1J /1:0'" rm'",i/d Mild Mod.:ra't S .. .". TOlill c"",I",,,d (95% Clof" 
No f") /1.'0' ('-0) No (".4) /1.'0 ("4) No (%) No ("4) .... 0 (""J ",ot/vor. (:0 I ....... ) 
No problem 290 (99'0) 142 (97'3) 509 (73-7) 44 (20'5) 4 (H) 989 (70'0) 48 (17'0) (12·9,21'6) 
Very .mall problem 1 (1,0) 4 (2-7) 143 (20'S) 75 (34 9) 3 (H) 228 (16'2) 78 (27-6) (22'5, 32-9) 
Small problem 0(0) 0(0) 34 (49) 62 (28'8) 16 (23'5) 112 (7-9) 78 (27,6) (2205,329) 
Medium problem 0(0) 0(0) 4 (0'6) 30 (14-0) 30 (44'1) 64 (4-5) 60 (21'2) (16'7; 26'1) 
BI' problem 0(0) 0(0) 0(0) 4 (1'9) 15 (22' I) 19 (t·4) 19 (6,7) (4'2, 10'0) 
Total 293 (100) 146 (100) 690 (100) 2" (100) 68 (100) 1412 (100) 283 (100) 
1" • 1-&80, 68 mlsslftll; percentalltS h,,·c been rounded, 
Table 5 Frequency dismbunon of intnftrtnce i" daily aclit'ities in relation 10 symptom sn'lril)' in men 01:er the age of 55, /l."onh Wh, Thames latalrla 
regio", 199] 
Symptom k't'",ry 
MocUral. ();; Itt:trr 
III/iifo',."" '" "·0'" 't." mild Mild Mo.u,."r, Sft'trr Total combi",d (95~'. CI o/~' dJrJ)' <I"It·ltl<l 1\'0 ('-0) /1.'0 (",.) "'0 ("-.) "'0 (%) "'0 ('!o) /1.'0 (!OJ ""0 (%) mod.:ralt (:0 Ut·.",) 
~ever 2M (99,0) 145 (100) 625 (92-8) 15-& (71'6) 24 (35-8) 1232 (88'1) 178 (6301) ("'2.684) 
Some of the time 3 (I I) a (0) 57 (6'9) 55 (25'6) 31 (46'3) 146 (10·4) 86 (305) (25'2, 35-9) 
~~05t of the time 0(0) 0(0) 3 (0'4) 6 (N) 9 (I H) 18 (1,3) 15 (5,3) (H,84) 
All of the lime 0(0) 0(0) 0(0) 0(0) 3 (4'5) 3 (0·2) 3 (1'1) (0'3,2,8) 
Total 28i (100) 145 (l00) 685 (100) 215 (100) 67 (100) 1399 (100) 282 (lOa) 
1" - 1480, 81 miUIftIl; percenta,es h .. ·c been rounded. 
Table 6 Frtquenc}' dismbunon oj perreption oj furure in relation 10 sy"rptom sef.'erit)' in men Ot'er rhe age oj 55, North W~st Thames health rrglon, 
199Z 
Sj'ltlpro", yt""IJ' 
P(rctPruJ1I 0/ /I.'OM r""",ild M.td ModtrDr, Set'ere 
lulUIY .,~o ("'oj /1.'0 ("i) I.'"D ("0) /1.'0 ("1.) "'0 (!'o) 
Dehehted 213 (75 3) 85 (59'9) 183 (27 I) 3 (1'4) 0(0) 
Pleased 59 (20,9) 47 (.33·1) 310 (45-9) 49 (22 8) 3 (44) 
~ 01 bothered II (H) 10 (7'0) 155 (22'9) 93 (43,3) U (19'1) 
L'nhappy 0(0) 0(0) 29 (4'1) 65 (302) 43 (63-2) 
Temble 0(0) 0(0) 0(0) 5 (23) 9 (IN) 
TOlal 283 (100) 142 (100) 617 (100) 215 (100) 68 (tOO) 
~ - 1480, 95 mlnlftg; percentages have been rounded. 
the different numbers of men at risk of having 
surgery, the probability of having surgery when 
in each age group was calculated by dividing 
the number of men who had surgery when in 
each age group by the number of men that 
had reached that age group (table 7). The 
probability of having surgery when under 50 
years of age was only 0'1 % and increased to 
8% in the age group 7S to 79 years, This is 
equivalent to a doubling in the probability of 
having surgery every five years, Because there 
are fewer men in older age groups, this gives 
a different picture to that seen in urological 
practice, Almost half (45,7%) the men who 
had undergone surgery were aged between 60 
and 69. 
Of the 156 (6%) men who reported a pre-
vious episode of acute retention, only 38,5% 
had undergone surgery (table 8), Altogether 
8% of men reported a previous urinary tract 
infection, When asked about urinary in-
-229-
ModerQ,e ();; ,.-&_ 
TorQ/ combi •• d (95% Cl o/~' 
"'0 (%) 1'1'0 (','o) modert/tt & ItI.~ ... ) 
484 (35'0) 3 (1.1) (0'3,2-8) 
4b8 (33-8) 52 (18'4) (14'1,23-1) 
282 (20'4) 106 (37'5) (31·9, nO) 
137 (9-9) 108 (38,2) (32-5,438) 
14 (1·0) 14 (H) (2'8,7'9) 
1385 (100) 283 (100) 
continence, 7'5% leaked enough urine to be 
embarrassed, and 0'8% needed to wear pads. 
SUMMARY 
The current pattern of urinary symptoms in 
men aged S5 and over and the urological re-
sponse to them is best illustrated by combining 
the data on the prevalence of men with a history 
of prostate surgery (table 7) and the prevalence 
of urinary symptoms (table 3). Figure 3 shows 
the proportions of men in each age group in 
each of the following states: (a) no, very mild, 
or mild symptoms and no previous surgery; 
(b) moderate/severe symptoms but no previous 
surgery; (c) previous surgery with no current 
moderate/severe symptoms; and (d) previous 
surgery and current symptoms. The percentage 
of men with either moderate or severe symp-
toms or a history of previous prostate surgery, 
or both, increased from 17% at age 57 years 
573 
Table 1 ExperinKt 0/ prostate SII'fet:Y ;" "'", OWl' the Dg( 0/55, /l.'ol1h ~Sl Thames heallh "gion, 1992 
<50 
5~54 
55-59 
6G-64 
65-69 
7~74 
75-79 
8~84 
85~ 
Total 
No ofsampl. 
rr4l:Md Dr "uNtied 
4It1"DUP 
14.3 
1443 
14.3 
Jl68 
846 
548 
312 
155 
51 
Nil ~i.) 1Iavi", ''''7'''' 
... ,10,,, "gt cart"",· 
2 (1'3) 
8 (5'2) 
17 (11-1) 
34 (22'2) 
36 (23-5) 
21 (13-7) 
25 (16-3) 
8 (5-2) 
2 (1'3) 
153 (100) 
,. probab,llIY of 
1o,,,,i"l ''''7'''' 
filii", '" ai' roup 
0-1 
0-6 
1-2 
2-9 
4-3 
3'8 
8'0 
5-2 
3-9 
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to 38% at age 81. The percentage of men with 
moderate/severe symptoms who have not had 
prostate surgery increases until the age of 73 
and then seems to decrease. Of men who have 
had prostatectomy, the percentage with re-
currence or persistence of moderate or severe 
symptoms seems to remain relatively constant 
across the age range, at about 30%. 
Discussion 
This study has described the prevalence and 
severity of urinary symptoms in British men 
aged 55 and over. Although most men repon 
no urinary symptoms, 20% reponed moderate 
or severe symptoms. Of these, only 28% found 
their symptoms a medium or big problem. 
Thirty seven per cent experienced interference 
with their daily activities at least some of the 
time, and 43% would be unhappy at the pro-
spect of a future \\ith their symptoms con-
tinuing at their current level. 
Before any conclusions may be drawn, the 
limitations of this survey should be considered. 
Men in the 55 to 59 year age group were 
under-represented compared with the general 
population, although comparison of the mean 
o No or mild symptoms and no surgery 
m Moderate/severe symptoms and no surgery 
m Moderate/severe symptoms and previous surgery 
o No or mild symptoms and previous surgery 
Age (5 y moving average) 
Figun: J A/~ specrfic probab,1lli~s 0/ mod .. .,.au 'St't'ffls),"'ploms a'IJ PI'I"l'j(lus proSlOIt 
'"If''''' Irr me" 0led 55 years a"d Wit, /I.'onn Wisl Thll",';s h~a/ln rrgi,,". 1992. 
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age of responders and non-responders suggests 
that this may have been due to characteristics 
of the practices studied rather than a difference 
in response rate. 
Secondly, those who do not respond to sur-
veys may differ in some way from those who 
do. From the examination of case notes we 
found that 8% of men who did not respond 
had died, moved, or had no general practice 
medical records. This suggests that our true 
response rate may have been as high as 80%. 
Non-responders did not differ from responders 
in terms of their history of urinary symptoms 
as recorded in the general practice records 
but they were less likely to have had previous 
prostate surgery. 
Thirdly, the way the questions were phrased 
could bias the results. The AUA symptom 
index for the symptoms of benign prostate 
hyperplasia has been extensively tested and has 
been shown to be internally consistent and have 
good test-retest reliability, as judged by Pearson 
correlation coefficients. II Symptom severity 
categories were derived from cut off points 
used in a previous study. The use of different 
cut offs would have imponant implications for 
the numbers of indi\iduals in each category. 
For example, we defined moderate or severe 
symptoms as a symptom index of greater than 
9, giving a prevalence in the male population 
aged 55 and over of 204 per 1000. Reduction 
of the threshold to 8 would result in a pre-
valence of 227 per J 000; a threshold of II 
would result in a pre\'alence of 170 per J 000. 
Our surve), measured the felt need for treat-
ment rather than the normative need. The 
clinical decision to offer treatment is based on 
a combination of urinary symptoms and the 
results of urological investigation. Assessment 
of normative need is complicated by the ab-
sence of an accepted definition of benign pro-
state hyperplasia. Currently, there is a debate 
in the urological literature about the impon-
ance of each. Several studies have shown a poor 
correlation between symptoms and objective 
urological measures such as flow rates and 
residual volume. I5-IR Given that most surgery 
Tabl., 8 Dimib",icIII of pr,;!'io"s ''''lI''". ,PI IT/ali,,,, /(} 
OCUI' u""al'\' IYlenr,on i" m.·" aj,'J 55 anJ Ot'(1; ,,'''l1h 
West Tham.:s l'I'giOIl, J 992 
Ptn',ou, '''rr~' 
R'''"II~" y" /1,'" To,~1 /1,'0 ~o) /1,'(1 r.J /1,'0 (0.) 
Yeo 60 (38 S) 96 (61-5) IS6 (100) 
So 24 (HI) 1239 (98'1) 1263 (100) 
Total 84 (H) 1335 (94'1) 1419 (100) 
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is carried out to improve a man's quality of 
life, we therefore believe that the presence of 
urinary symptoms is an essential, though not 
the only, factor that should be measured when 
assigning the need for surgery in the population. 
It has been suggested that there is a large 
proponion of men in the British population 
with undiagnosed but symptomatic pro-
statism. l Our study sup pons this view. The 
only other study on the prevalence of urinary 
symptoms in men in the UK has been reponed 
by Garraway et aI. They reponed a prevalence 
in men aged 40-79 years of 104 per 1000.19 
These figures refer to men with a symptom 
score of at least 11 out of a possible 48 points 
(eight symptoms each with a maximum score 
of six). If we were to use an equivalent cut-off 
point with our data, 7 out of 30, we would 
produce a prevalence of 292 per 1000. How-
ever, some imponant methodological differ-
ences between the two studies remain. In the 
study by Garraway et ai, the men were younger 
(over 50% were under 55 years), 9% of men 
in the study population were excluded, and the 
response rate was lower (only 64%19 compared 
with 78%). All of these might explain why they 
obtained a lower estimate of prevalence than 
we did. These factors could therefore reconcile 
our results with theirs. 
The finding that 61·5% of men with a history 
of acute retention had not undergone surgery 
indicates that the view that this is an almost 
absolute indication for surgeryZ° is no longer 
held. This finding is consistent with the views 
of a consensus panel on the appropriate in-
dications for prostatectomy that was held re-
cently.21 
These results and evidence from other stud-
ies suggest that prostatism begins to develop 
in some men under the age of 50. Although 
we based our sample on evidence that pro-
statectomy was almost never performed on men 
under the age of 55, the relatively high pre-
valence of moderate or severe symptoms among 
men in the 55 to 59 age group indicates that 
future studies should include younger men. 
This is consistent with the population based 
survey by Garraway et al that described the 
onset of urinary symptoms among men in their 
40s' and a review of necropsy data by Berry et 
al suggesting that the first changes in prostatic 
weight appear in men as young as under 30.22 
From the age-of 55 until the early 70s, the 
percentage of men with moderate or severe 
symptoms who have not had surgery increases 
slowly from 15% to 20%, decreasing thereafter. 
A few individuals have surgery under 50, but 
the probability of surgery only exceeds I % in 
the 55 to 59 age group. Thereafter it increases 
steadily. This leads to a progressive increase in 
the number of men who have had surgery by 
the age of 85. Of those who have had surgery, 
the proponion who have residual or recurring 
symptoms is roughly constant. The figure of 
about a third in this study is higher than that 
found in two cohort studies of men undergoing 
surgery" 2' but both followed up patients for 
only one year. Some of the men in our survey 
had surgery up to 10 years previously. 
These results suggest that prostatism, shown 
·231· 
Hunlt" McKel, Black, Sandmon 
by the prevalence of either urinary symptoms 
or a past history of prostatic surgery, increases 
steadily throughout middle and old age, with 
the first signs appearing under the age of 55 
and with almost 40% of men having been 
affected by the age of 80. After 80, the pre-
valence of prostatism does not increase funher, 
and may actually decrease. These findings may 
occur by chance because there were only 29 
men over the age of 80 in our sample with 
moderate or severe symptoms, but if the sug-
gested decrease is true, there are three possible 
explanations. The first is that some cases of 
benign prostate hyperplasia resolve spon-
taneously. This has been suggested by other 
authors, although there is no strong empirical 
supponing evidence.l4 Secondly, most of those 
men who are going to suffer from benign pro-
state hyperplasia begin to do so by the time 
they reach 80, and the population contains 
subgroups with varying susceptibilities to the 
disease. Some suppon for this hypothesis 
comes from a review of series of necropsy data 
that suggested that at least 10% of men have 
no histological evidence of benign prostate hy-
perplasia by the time they reach the ninth 
decade. 22 The third possibility is that men with 
benign prostate hyperplasia have a reduced 
life expectancy, leading to selection out of the 
population in this age group. If the last of these 
is true, it could be due to either the effects of 
the disease or the complications of treatment. 
This explanation is consistent with the results 
of the study by Wennberg et al that suggested 
that transurethal prostatectomy was associated 
with an increase in mortality compared with 
men not undergoing surgery.2' If any of these 
suggestions, or a combination thereof, are true 
there are important implications for urology 
research and practice, especially as new treat-
ments designed to prevent the development of 
benign prostatic hypenrophy becomes avail-
able. For example, it would be useful to com-
pare the characteristics, such as differences in 
androgen responsiveness, of those men who 
will and will not suffer from benign prostate 
hyperplasia. 
Although 20'4% of men have moderate or 
severe symptoms, this does not reflect the de-
gree of concern that they express. Only 5·9% 
of men repon that their symptoms are a me-
dium or big problem and 1·5% repon that they 
interfere with their daily activities all or most 
of the time. In contrast, 10·9% feel unhappy 
or terrible about the prospect of a future with 
their current level of symptoms, indicating a 
difference between the extent to which men 
are affected at present and how they would like 
to be in the future. A possible explanation for 
this is that men are able to cope with their 
existing level of symptoms but feel that they 
will be unable to do so in the future as they 
become older and more infinn. This is sup-
poned by evidence from a study of women 
suffering from urinary incontinence. 26 
How will the results of this study be used? 
A second survey of those men who reponed 
moderate or severe symptoms has been un-
denaken. This will repon on the ways that 
their symptoms affect their health status and 
Uri"Or;}' symptoms: prnJQUl'ICe arid JeWrily i" Bmisll ",e" aged 55 o"d over 
whether or not they would choose to have 
surgery. When combined with infonnation on 
clinicians' views of appropriateness and patient 
preference for treatment. these data will provide 
estimates both of the nonnative need for treat-
ment and demand in the population and infonn 
planning of the provision of urological services, 
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